<SEC-DOCUMENT>0001104659-21-050228.txt : 20210414
<SEC-HEADER>0001104659-21-050228.hdr.sgml : 20210414
<ACCEPTANCE-DATETIME>20210414162137
ACCESSION NUMBER:		0001104659-21-050228
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20210408
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210414
DATE AS OF CHANGE:		20210414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHEQUITY, INC.
		CENTRAL INDEX KEY:			0001428336
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36568
		FILM NUMBER:		21825940

	BUSINESS ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020
		BUSINESS PHONE:		801-727-1000

	MAIL ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHEQUITY INC
		DATE OF NAME CHANGE:	20080227
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2112741d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:hqy="http://healthequity.com/20210408">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_hqy_healthequity.com_20210408 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20210408_20210408 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001428336 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityCentralIndexKey">0001428336</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="hqy-20210408.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-04-08to2021-04-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-08</xbrli:startDate>
        <xbrli:endDate>2021-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_902_edei--DocumentType_c20210408__20210408_zR8lr7cEs4Xc"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)&#160;of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event
reported): <b><span id="xdx_90A_edei--DocumentPeriodEndDate_c20210408__20210408_zoJM04Lcm012"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 8, 2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="1" style="border-bottom: Black 1pt solid; font: bold 18pt Times New Roman, Times, Serif; text-align: center"><p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityRegistrantName_c20210408__20210408_z15Idg3FPAUd"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityRegistrantName">HealthEquity, Inc.</ix:nonNumeric></span></b></span></p></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="1" style="font: normal 18pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b style="font-style: normal; font-weight: normal">(Exact
    name of registrant as specified in charter)</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20210408__20210408_zbzKDxwFgoI"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Commission File No. <span id="xdx_90D_edei--EntityFileNumber_c20210408__20210408_zuYvtdcSGpoh"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityFileNumber">001-36568</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20210408__20210408_zgKgLBhnSAZ4"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityTaxIdentificationNumber">52-2383166</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction<br />
 of Incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission<br />
File Number)</p>
<span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer<br /> Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20210408__20210408_zo3IKeY9r1P9"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityAddressAddressLine1">15 West Scenic Pointe Drive</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_904_edei--EntityAddressAddressLine2_c20210408__20210408_zQW7QVve19v2"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityAddressAddressLine2">Suite&#160;100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20210408__20210408_zkmsDJO2SMPl"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityAddressCityOrTown">Draper</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20210408__20210408_zkdWp17gFNOh"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Utah</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20210408__20210408_z94cGf6oL441"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:EntityAddressPostalZipCode">84020</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(<span id="xdx_90A_edei--CityAreaCode_c20210408__20210408_zADSepKAMOVa"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:CityAreaCode">801</ix:nonNumeric></span>) <span id="xdx_905_edei--LocalPhoneNumber_c20210408__20210408_ztx3NydHl839"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:LocalPhoneNumber">727-1000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Registrant&#8217;s
telephone number, including area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span> General Instruction A.2 below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90F_edei--WrittenCommunications_c20210408__20210408_zonBBWmqV2mc" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Written communications pursuant to Rule&#160;425 under
the Securities Act (17 CFR 230.425)</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_903_edei--SolicitingMaterial_c20210408__20210408_zCe9HHPw1g02" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Soliciting material pursuant to Rule&#160;14a-12 under
the Exchange Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_900_edei--PreCommencementTenderOffer_c20210408__20210408_zQY4oLpDqng3" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20210408__20210408_z2ox0yamKgti" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 37%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title&#160;of&#160;Each&#160;Class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 26%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading&#160;Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name&#160;of&#160;each&#160;exchange&#160;on&#160;which<br />
&#160;registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--Security12bTitle_c20210408__20210408_ziw3HpM4vJRi"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:Security12bTitle">Common stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--TradingSymbol_c20210408__20210408_zVy2Zl890Y86"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" name="dei:TradingSymbol">HQY</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--SecurityExchangeName_c20210408__20210408_ztI28VuRyBRl"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The NASDAQ Global Select Market</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; text-align: justify; text-indent: 0.5in; font-size: 10pt">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0pt 0; text-align: right; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;Emerging
growth company <span style="font-family: Wingdings"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20210408__20210408_zFx6X5ROU5Wb"><ix:nonNumeric contextRef="From2021-04-08to2021-04-08" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; text-align: justify; text-indent: 0.5in; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin: 0pt 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April&#160;8, 2021, HealthEquity,&#160;Inc.,
a Delaware corporation (&#8220;HealthEquity&#8221;), entered into an Asset and Unit Purchase Agreement (the &#8220;Purchase Agreement&#8221;)
with Viking Acquisition Corp., a Delaware corporation and wholly owned subsidiary of HealthEquity (&#8220;Viking&#8221;), MII Life Insurance,&#160;Incorporated
d/b/a Further, a Minnesota corporation (&#8220;MII Life&#8221;), and Aware Integrated,&#160;Inc., a Minnesota nonprofit corporation (&#8220;Aware&#8221;
and, together with MII Life, &#8220;Sellers&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement provides that Viking will,
at the closing of the transactions contemplated thereby (the &#8220;Closing&#8221;), pay an aggregate purchase price of $500 million (the
&#8220;Purchase Price&#8221;) as consideration for its acquisition of, among other things, MII Life&#8217;s and Aware&#8217;s (through
its wholly owned subsidiary SamCo Services, LLC (&#8220;SamCo&#8221;)) business of establishing, administering and providing custodian
and other related services to HSAs and other Accounts (each as defined in the Purchase Agreement) (the &#8220;Spending Account Business&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement provides that, upon the
terms and conditions set forth therein, Viking will acquire (the &#8220;Acquisition&#8221;) the Spending Account Business through (a)&#160;the
purchase from MII Life of certain assets and the assumption of certain liabilities related to the operation of the Spending Account Business,
and (b)&#160;the acquisition from Aware of 100% of the issued and outstanding units of SamCo. Pursuant to Section&#160;4.10 of the Purchase
Agreement, HealthEquity will guarantee, among other things, the performance of Viking&#8217;s obligations and the payment of the Purchase
Price. The guarantee provided by HealthEquity terminates upon the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement provides that, unless otherwise
agreed to by HealthEquity, Viking and Sellers, the Closing will occur on the later of September 7, 2021 and the second Business Day (as
defined in the Purchase Agreement) following the date on which the last of the conditions to the Closing (discussed below) is fulfilled
or waived.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consummation of the Acquisition is subject to
satisfaction of certain conditions at the Closing, including, without limitation (i)&#160;the nonexistence of any governmental order prohibiting
the consummation of the Acquisition, (ii)&#160;the delivery of certain required consents, (iii)&#160;Viking receiving customary lien release
documentation in respect of the Spending Account Business, (iv)&#160;there being no Material Adverse Effect (as defined in the Purchase
Agreement) between the signing of the Purchase Agreement and the Closing and (v)&#160;the execution and delivery of certain customary
closing certificates, instruments, documents and other items by the parties to the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contains customary representations,
warranties and covenants for a transaction of this type, including representations and warranties by (a)&#160;each Seller regarding, among
other things, (i)&#160;its corporate organization, (ii)&#160;its authority to enter into the Purchase Agreement and perform its obligations
thereunder, (iii)&#160;the absence of certain legal proceedings, (iv)&#160;compliance with law and (v)&#160;title, and (b)&#160;each of
HealthEquity and Viking regarding, among other things, its (i)&#160;corporate organization and (ii)&#160;authority to enter into the Purchase
Agreement and perform their respective obligations thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement provides that, except in
the case of fraud, no Seller will have liability after the Closing with respect to any of such Sellers&#8217; representations or warranties
to be performed prior to the Closing. Sellers shall be jointly and severally liable for, among other things, any loss incurred by Viking
and its affiliates arising from (a)&#160;Sellers&#8217; failure to perform any of their covenants under the Purchase Agreement and certain
other transaction documents, (b)&#160;Excluded Assets and Excluded Liabilities (each as defined in the Purchase Agreement) and (c)&#160;certain
pre-Closing Taxes (as defined in the Purchase Agreement) of SamCo. Viking will obtain a customary buyer&#8217;s representation and warranty
insurance policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Purchase Agreement, at the Closing,
Viking and Stella Resources Co., Inc., a Delaware corporation and affiliate of MII Life (&#8220;Stella&#8221;), will enter into a customary
transition services agreement pursuant to which Stella will provide to Viking certain mutually agreed upon transition, migration and separation
services. Such agreed-upon services will generally be provided for periods ranging from one month to 24 months following the Closing.
In addition, Stella will provide Viking with such other services requested to be received by Viking and that were previously provided
by Stella to the Spending Account Business in the 12 months prior to the Closing. Such other services will generally be provided for a
period of 6 months following the Closing (or 12 months in the case of certain recurring services provided on an annual basis).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contains certain customary
termination rights prior to the Closing for both Viking and Sellers. In addition, the Purchase Agreement provides that each of Viking,
on the one hand, and Sellers, on the other hand, may terminate the Purchase Agreement if the Closing has not occurred before September
15, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In consideration of the Purchase Price, each Seller
has agreed to (a)&#160;a customary non-competition provision preventing such Seller from participating in certain competitive activities,
and (b)&#160;a customary non-solicitation provision preventing such Seller from soliciting, among others, clients, accounts or vendors
obtained by Viking in connection with the Acquisition, in each case, for a period of seven years following the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement has been included as an
exhibit to this Form 8-K to provide investors with information regarding its terms. It is not intended to provide any other factual information
about HealthEquity, Viking, MII Life, Aware, SamCo or any of their respective subsidiaries or affiliates. The representations, warranties
and covenants contained in the Purchase Agreement were made only for purposes of the Purchase Agreement and as of specific dates, were
solely for the benefit of the parties to the Purchase Agreement, may be subject to limitations agreed upon by the contracting parties,
including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the
Purchase Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting
parties that differ from those applicable to investors. Investors are not third-party beneficiaries under the Purchase Agreement and should
not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts
or condition of the parties thereto or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject
matter of representations and warranties may change after the date hereof, which subsequent information may or may not be fully reflected
in HealthEquity&#8217;s public disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Purchase Agreement
does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, a copy of
which is filed as Exhibit&#160;2.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Cautionary Statement Regarding Forward-Looking Statements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Form 8-K and the exhibits attached hereto
and incorporated herein by reference contain &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221;
provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the proposed transaction
between HealthEquity, Viking and Sellers and the timing of such proposed transaction. All statements other than statements of historical
fact that address activities, events or developments that HealthEquity expects, believes or anticipates will or may occur in the future
are forward-looking statements. Forward-looking statements reflect current expectations regarding future events, results or outcomes,
and are typically identified by words such as &#8220;will&#8221;, &#8220;shall&#8221; or similar expressions that convey the prospective
nature of events or outcomes. Factors that could cause actual results to differ include, but are not limited to: the conditions to the
completion of the proposed transaction, including the receipt of all required regulatory approvals; the ability of HealthEquity to successfully
integrate the Spending Account Business into HealthEquity&#8217;s current business; that such integration may be more difficult, time-consuming
or costly than expected; that operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining
relationships with employees, customers or suppliers) may be greater than expected following the proposed transaction or the public announcement
of the proposed transaction; and that the retention of certain key employees of the Spending Account Business may be difficult. Although
HealthEquity believes the expectations reflected in the forward-looking statements are reasonable, HealthEquity gives no assurance these
expectations will prove to be correct. Actual events, results and outcomes may differ materially from expectations due to a variety of
known and unknown risks, uncertainties and other factors, including those described above. For a detailed discussion of other risk factors,
please refer to the risks detailed in HealthEquity&#8217;s filings with the Securities and Exchange Commission, including, without limitation,
HealthEquity's most recent Annual Report on Form 10-K and subsequent periodic and current reports. HealthEquity undertakes no intention
or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Forward-looking statements should not be relied upon as representing views as of any date subsequent to the date of this Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>(d)&#160;Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px; text-align: center"><b>Exhibit</b></td>
    <td style="width: 10px">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Number</b></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Description</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2112741d1_ex2-1.htm">2.1</a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2112741d1_ex2-1.htm">Asset and Unit Purchase Agreement, dated as of April&#160;8, 2021, by and among Viking Acquisition Corp., HealthEquity,&#160;Inc., MII Life Insurance,&#160;Incorporated d/b/a Further and Aware Integrated,&#160;Inc.*</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page&#160;Interactive Data File (formatted in Inline XBRL and contained in Exhibit&#160;101)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* Schedules and exhibits have been omitted pursuant
to Item 601(b)(2)&#160;of Regulation&#160;S-K.&#160;HealthEquity hereby undertakes to furnish supplementally copies of any of the omitted
schedules upon request by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify">Dated: April&#160;14, 2021</td>
    <td colspan="2" style="text-align: justify"><b>HealthEquity,&#160;Inc.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 50%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 5%">By:</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 45%; text-align: justify"><i>/s/ Tyson Murdock</i></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">Name: </td>
    <td style="vertical-align: bottom; text-align: justify">Tyson Murdock</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">Title:</td>
    <td style="vertical-align: bottom; text-align: justify">Executive Vice President and Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5LppWRO2jRUWsIkXE19huJdhmyyb+HclbGlvEZWFZZr4ZIUKxoqWukeE0zzM4YNPWyiHkWCGjKdA70vUmAX9zvGjrWBnXvT8wJc+gZ8YDeS680Fnv2mKZgJwMR9EwmoGcJnEM+60IvnpKptIlGqdVDcqUsGdqWaNT/OoTDupJhppXV3VEtppMAtFA9vIbYhnFsKO7ehBfLWRZKoKwm0CsmG7tt+ZmHTWwqLHxXbZH/xt8AD1TSYE= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>tm2112741d1_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Execution Version&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSET AND UNIT PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">by and among</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VIKING ACQUISITION CORP.,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>HEALTHEQUITY, INC.,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MII LIFE INSURANCE, INCORPORATED D/B/A FURTHER,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AWARE INTEGRATED, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Dated April 8, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><U>Page</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="padding-top: 2; width: 90%; text-align: left; text-indent: -1.2in; padding-left: 85.7pt; padding-bottom: 2">Article I&nbsp;&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;THE TRANSACTION</TD>
    <TD STYLE="padding-top: 5; width: 10%; text-align: right; padding-bottom: 2">1</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.1&nbsp;&nbsp;&nbsp;Purchase and Sale of Assets</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">1</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.2&nbsp;&nbsp;&nbsp;Excluded Assets</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.3&nbsp;&nbsp;&nbsp;Liabilities</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.4&nbsp;&nbsp;&nbsp;Purchase and Sale of Units</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.5&nbsp;&nbsp;&nbsp;Consideration</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">5</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.6&nbsp;&nbsp;&nbsp;Initial and Final Cash and Investment Asset Balances in the Purchased Accounts</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">5</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.7&nbsp;&nbsp;&nbsp;Closing</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">5</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.8&nbsp;&nbsp;&nbsp;Allocation of Consideration</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">5</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.9&nbsp;&nbsp;&nbsp;Wrong Pocket</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">5</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.10&nbsp;&nbsp;&nbsp;Subsequent Documentation</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">6</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">1.11&nbsp;&nbsp;&nbsp;Assignability and Consents</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">6</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -1.2in; padding-left: 85.7pt; padding-bottom: 2">Article II&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;REPRESENTATIONS AND WARRANTIES OF SELLERS</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">6</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.1&nbsp;&nbsp;&nbsp;Organization</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">7</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.2&nbsp;&nbsp;&nbsp;Due Authorization</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">7</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.3&nbsp;&nbsp;&nbsp;No Breach</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">7</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.4&nbsp;&nbsp;&nbsp;Title to Acquired Assets</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">8</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.5&nbsp;&nbsp;&nbsp;Litigation</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">8</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.6&nbsp;&nbsp;&nbsp;Data Privacy</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">8</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.7&nbsp;&nbsp;&nbsp;Tax Matters</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.8&nbsp;&nbsp;&nbsp;Absence of Certain Developments</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">10</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.9&nbsp;&nbsp;&nbsp;Undisclosed Liabilities</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">11</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.10&nbsp;&nbsp;&nbsp;Compliance with Laws and Account Agreements</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">12</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.11&nbsp;&nbsp;&nbsp;Material Contracts</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">12</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.12&nbsp;&nbsp;&nbsp;Permits</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">14</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.13&nbsp;&nbsp;&nbsp;Intellectual Property</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">14</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.14&nbsp;&nbsp;&nbsp;No Guarantees</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">18</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.15&nbsp;&nbsp;&nbsp;Brokers</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">18</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.16&nbsp;&nbsp;&nbsp;Sanctions</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">18</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.17&nbsp;&nbsp;&nbsp;Anti-corruption</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.18&nbsp;&nbsp;&nbsp;Sufficiency and Condition of Acquired Assets</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.19&nbsp;&nbsp;&nbsp;Bankruptcy</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.20&nbsp;&nbsp;&nbsp;Intracompany Arrangements</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.21&nbsp;&nbsp;&nbsp;Certain Account Matters</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.22&nbsp;&nbsp;&nbsp;Employees; Employee Benefit Plans</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">20</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.23&nbsp;&nbsp;&nbsp;Ultimate Parent Entity</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">22</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">2.24&nbsp;&nbsp;&nbsp;No Other Representations and Warranties</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -1.2in; padding-left: 85.7pt; padding-bottom: 2">Article III&nbsp;&nbsp;&nbsp;&#8239;&#8239;&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF BUYER</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">3.1&nbsp;&nbsp;&nbsp;Organization</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">3.2&nbsp;&nbsp;&nbsp;Due Authorization</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">3.3&nbsp;&nbsp;&nbsp;No Breach</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">3.4&nbsp;&nbsp;&nbsp;Brokers</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">3.5&nbsp;&nbsp;&nbsp;Litigation</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">24</TD></TR>

<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">3.6&nbsp;&nbsp;&nbsp;Sufficiency of Funds</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 2; text-align: left; text-indent: -0.5in; padding-left: 1in; padding-bottom: 2">3.7&nbsp;&nbsp;&nbsp;No Other Representations and Warranties</TD>
    <TD STYLE="padding-top: 2; text-align: right; padding-bottom: 2">24</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>TABLE OF CONTENTS</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">(continued)</P>

<P STYLE="text-align: right; margin: 0"><U>Page</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -1.2in; padding-top: 5; padding-bottom: 2; padding-left: 85.7pt; width: 90%">Article IV&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;&nbsp;PRE-CLOSING COVENANTS</TD>
    <TD STYLE="text-align: right; padding-top: 5; padding-bottom: 2; width: 10%">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.1&nbsp;&nbsp;&nbsp;General</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.2&nbsp;&nbsp;&nbsp;Third Person Notices and Consents</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.3&nbsp;&nbsp;&nbsp;Operation of Business</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">27</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.4&nbsp;&nbsp;&nbsp;Inspection and Access to Information</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">27</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.5&nbsp;&nbsp;&nbsp;Exclusivity</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.6&nbsp;&nbsp;&nbsp;Accrued Interest on Account Deposits in Purchased Accounts</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.7&nbsp;&nbsp;&nbsp;Representation and Warranty Insurance</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.8&nbsp;&nbsp;&nbsp;Termination of Related Party Contracts</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.9&nbsp;&nbsp;&nbsp;Release</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">4.10&nbsp;&nbsp;&nbsp;Guarantee</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -1.2in; padding-top: 2; padding-bottom: 2; padding-left: 85.7pt">Article V&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;CONDITIONS TO OBLIGATIONS TO CLOSE</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">5.1&nbsp;&nbsp;&nbsp;Conditions to Obligation of Buyer</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">5.2&nbsp;&nbsp;&nbsp;Conditions to Obligation of Sellers</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">32</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -1.2in; padding-top: 2; padding-bottom: 2; padding-left: 85.7pt">Article VI&nbsp;&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;SURVIVAL; INDEMNIFICATION</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">33</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.1&nbsp;&nbsp;&nbsp;Non-survival of Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">33</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.2&nbsp;&nbsp;&nbsp;Survival of Covenants</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">33</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.3&nbsp;&nbsp;&nbsp;Indemnification by Sellers</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">33</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.4&nbsp;&nbsp;&nbsp;Indemnification by Buyer</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.5&nbsp;&nbsp;&nbsp;Indemnity as Sole Recourse</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.6&nbsp;&nbsp;&nbsp;Method of Asserting Claims</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.7&nbsp;&nbsp;&nbsp;Limitations on Indemnification</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">36</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">6.8&nbsp;&nbsp;&nbsp;Adjustments to Consideration</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">36</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -1.2in; padding-top: 2; padding-bottom: 2; padding-left: 85.7pt">Article VII&nbsp;&#8239;&#8239;&#8239;&nbsp;&nbsp;TERMINATION</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">36</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">7.1&nbsp;&nbsp;&nbsp;Termination</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">36</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">7.2&nbsp;&nbsp;&nbsp;Effect of Termination</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">37</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -1.2in; padding-top: 2; padding-bottom: 2; padding-left: 85.7pt">Article VIII&nbsp;&nbsp;&#8239;&#8239;&nbsp;POST-CLOSING COVENANTS</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">37</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">8.1&nbsp;&nbsp;&nbsp;Agreement Not to Compete or Solicit by Sellers and their Affiliates</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">37</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">8.2&nbsp;&nbsp;&nbsp;Tax Matters</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">39</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">8.3&nbsp;&nbsp;&nbsp;Books and Records</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">40</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">8.4&nbsp;&nbsp;&nbsp;Use of Names</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">40</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">8.5&nbsp;&nbsp;&nbsp;Employee Matters</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">40</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">8.6&nbsp;&nbsp;&nbsp;Amendments to R&amp;W Insurance Policy</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">44</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">8.7&nbsp;&nbsp;&nbsp;License of Excluded Intellectual Property</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">44</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>TABLE OF CONTENTS</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">(continued)</P>

<P STYLE="margin: 0; text-align: right"><U>Page</U></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -1.2in; padding-top: 5; padding-bottom: 2; padding-left: 85.7pt; width: 90%">Article IX&nbsp;&nbsp;&#8239;&#8239;&#8239;&nbsp;MISCELLANEOUS</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2; width: 10%">45</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.1&nbsp;&nbsp;&nbsp;Press Releases and Public Announcements</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">45</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.2&nbsp;&nbsp;&nbsp;Confidentiality</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">45</TD></TR>

<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.3&nbsp;&nbsp;&nbsp;Further Acts and Assurances</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">46</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.4&nbsp;&nbsp;&nbsp;No Third-Party Beneficiaries</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">46</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.5&nbsp;&nbsp;&nbsp;Entire Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">46</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.6&nbsp;&nbsp;&nbsp;Succession and Assignment</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">46</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.7&nbsp;&nbsp;&nbsp;Counterparts</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">47</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.8&nbsp;&nbsp;&nbsp;Headings; Definitions</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">47</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.9&nbsp;&nbsp;&nbsp;Notices</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">47</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.10&nbsp;&nbsp;&nbsp;Governing Law; Venue</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.11&nbsp;&nbsp;&nbsp;Amendments and Waivers</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.12&nbsp;&nbsp;&nbsp;Severability</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.13&nbsp;&nbsp;&nbsp;Expenses</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.14&nbsp;&nbsp;&nbsp;Construction</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.15&nbsp;&nbsp;&nbsp;Incorporation of Exhibits, Annexes and Schedules</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 2; padding-bottom: 2; padding-left: 1in">9.16&nbsp;&nbsp;&nbsp;Specific Performance</TD>
    <TD STYLE="text-align: right; padding-top: 2; padding-bottom: 2">49</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>List of Annexes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Annex I &ndash; Definitions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>List of Schedules</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule A &ndash; Purchased Accounts and Further Investment Securities
Transfer Mechanics</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule B &ndash; Further Investment Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule 1.1(c) &ndash; Assumed Contracts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule 1.1(e) &ndash; Acquired IP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule 1.6 &ndash; Initial Cash and Investment Asset Balances in
the Purchased Accounts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule 5.1(c) &ndash; Required Consents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule 8.5(b) &ndash; Specified Employees</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>List of Exhibits</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit A &ndash; Form of Services Agreement<BR>
Exhibit B &ndash; Form of Distribution Partnership Agreement<BR>
Exhibit C &ndash; Form of Transition Services Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit D &ndash; Allocation Methodology</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSET AND UNIT PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS ASSET AND UNIT PURCHASE
AGREEMENT</B> (this &ldquo;<B>Agreement</B>&rdquo;), dated as of April 8, 2021, is made and entered into by and among HealthEquity, Inc.,
a Delaware corporation (&ldquo;<B>Guarantor</B>&rdquo;), Viking Acquisition Corp., a Delaware corporation (&ldquo;<B>Buyer</B>&rdquo;),
MII Life Insurance, Incorporated d/b/a Further, a Minnesota corporation (&ldquo;<B>MII Life</B>&rdquo;), and Aware Integrated, Inc., a
Minnesota nonprofit corporation (&ldquo;<B>Aware</B>&rdquo;) (together with MII Life, each a &ldquo;<B>Seller</B>&rdquo; and together,
 &ldquo;<B>Sellers</B>&rdquo;). Buyer and Sellers are sometimes each referred to herein individually as a &ldquo;<B>Party</B>&rdquo; and
collectively as the &ldquo;<B>Parties</B>.&rdquo; A list of defined terms used herein is set forth in the attached <B>Annex I</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MII
Life and SamCo Services, LLC, a Delaware limited liability company (&ldquo;<B>SamCo</B>&rdquo;) are in the business of, among other things,
establishing, administering and providing custodian and other related services to HSAs and other Accounts (the &ldquo;<B>Spending Account
Business</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aware
is the sole owner of 100% of the issued and outstanding units (the &ldquo;<B>Units</B>&rdquo;) of SamCo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyer
desires to (i) purchase and assume, as applicable, and MII Life desires to sell, transfer, convey, assign and deliver, as applicable,
(A) all of the assets of MII Life related to the operating of its Spending Account Business, except as set forth herein, and (B) certain
liabilities and obligations of MII Life related to the operation of its Spending Account Business, and (ii) purchase, and Aware desires
to sell, all of the Units, in each case pursuant to the terms and conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties desire that on the Closing Date, the Account Deposits be transferred from MII Life to Buyer&rsquo;s designee in accordance with
the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the mutual covenants, representations, warranties, agreements and conditions set forth in this Agreement, the receipt
and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
I</B></FONT><U><BR>
<B>THE TRANSACTION</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Purchase and Sale of Assets</B>. On and subject to the terms and conditions of this Agreement, Buyer agrees to purchase and assume
from MII Life (and with respect to the Acquired IP, Aware) and MII Life (and with respect to the Acquired IP, Aware) agrees to sell,
transfer, convey, assign and deliver to Buyer (or its designee) at the Closing, free and clear of any Encumbrances (other than Permitted
Encumbrances attributable solely to the Assumed Liabilities), all of MII Life&rsquo;s (and with respect to the Acquired IP, Aware&rsquo;s)
right, title and interest in and to all of MII Life&rsquo;s property and assets (and with respect to the Acquired IP, Aware) wherever
located&#8239;(except for the Excluded Assets) that are primarily used in its Spending Account Business, including the following properties,
assets and rights of MII Life and Aware, as applicable (collectively, the &ldquo;<B>Acquired Assets</B>&rdquo;), without duplication:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the aggregate amount of the (i) Final Accountholder Cash Deposits, and (ii)&nbsp;Final Accountholder Investment Assets, in each
case to be transferred to Buyer&rsquo;s designee in accordance with <B><U>Schedule A</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all Account Information and Files in the possession or control of MII Life or any third party on behalf of MII Life regarding former,
current and prospective holders of Purchased Accounts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) all Employer Agreements, (ii) all Health Plan Agreements, and (iii) all other agreements, contracts, purchase orders and other
similar arrangements that are primarily used in the Spending Account Business, in each case identified on <B><U>Schedule 1.1(c)</U></B>
(collectively, the &ldquo;<B>Assumed Contracts</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all rights to deposits for Purchased Accounts that are received by MII Life after Closing, which deposits MII Life hereby agrees
to forward to Buyer or its designee in accordance with <B><U>Schedule A</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all Intellectual Property used primarily in the conduct of its Spending Account Business which is owned or purported to be owned
or under control by MII Life or Aware together with (i) the right to sue and obtain damages and equitable relief for past, present and
future infringement, misappropriation, dilution or violation thereof or unfair competition therewith (including the rights to damages
and payments therefor to the extent arising from and after the Closing); (ii) all income, royalties and payments related thereto due or
payable; (iii) the right to register, prosecute, maintain and defend such Intellectual property before any public or private agency or
registrar; (iv) any and all corresponding rights that now or hereafter may be secured throughout the world, and all goodwill associated
with any of the foregoing; and (v) all information technology, in each case currently used in the operation of its Spending Account Business,
including the Intellectual Property set forth on <B><U>Schedule 1.1(e)</U></B> (all of such intangible rights, the &ldquo;<B>Acquired
IP</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all rights under confidentiality or non-disclosure agreements with respect to confidential treatment of information related to
the Acquired Assets, Assumed Liabilities or the Spending Account Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any contractual claim, right, award, recovery, indemnity, warranty, refund, reimbursement, audit right, duty, obligation, liability
or other intangible right in favor of or owed to MII Life (other than rights arising under or relating to this Agreement) related to the
Acquired Assets, Assumed Liabilities or the Spending Account Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all customer and supplier lists related to the Spending Account Business and all telephone and telephone facsimile numbers and
other directory listings of the Spending Account Business; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> all claims of MII Life against third parties relating to the Acquired Assets, Assumed Liabilities or its Spending Account Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Excluded Assets</B>. Notwithstanding anything to the contrary in this Agreement, the following assets of MII Life (collectively,
the &ldquo;<B>Excluded Assets</B>&rdquo;) are not part of the sale and purchase contemplated hereunder, are excluded from the Acquired
Assets and shall remain the property of MII Life after the Closing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all cash and cash equivalents of MII Life and all other deposit accounts, other than the Account Deposits identified on <B><U>Schedule
1.6</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all accounts or notes receivable of, acquired by or assigned to or for the benefit of MII Life and not related to the Acquired
Assets, Assumed Liabilities or its Spending Account Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all interests in real property and fixtures whether owned or leased;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all interests in tangible personal property, including any office furniture and furnishings, copying, computer and phone equipment,
supplies and other personal property, whether owned or leased;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all claims for refund(s) of Taxes with respect to periods ending prior to the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all Seller Benefit Arrangements and all assets, trust agreements or any other funding and administrative Contracts related to such
Seller Benefit Arrangements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all insurance policies and rights to recovery thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all communications between MII Life and any of its respective advisors, including the right to assert attorney client privilege
with respect to such communications made with their outside counsel;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all rights of MII Life under the Ancillary Documents and all rights which accrue or will accrue to MII Life under this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all Permits; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all other assets of MII Life that are not used primarily in its Spending Account Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liabilities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Limited Assumption of Liabilities</B>. On and subject to the terms and conditions of this Agreement, Buyer (or its designee)
agrees to assume and become responsible, from and after the Closing, for the following Liabilities of MII Life, and no other Liabilities
of MII Life of any type (the &ldquo;<B>Assumed Liabilities</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;subject
to the provisions of Section <I>&#8206;</I>1.5 hereof and the transfer mechanics set forth on <B><U>Schedule A</U></B>, all deposit liabilities,
including savings account balances, with respect to the Account Deposits identified on <B><U>Schedule 1.6</U></B>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Liabilities under the Assumed Contracts, except to the extent such Liabilities are required to be performed or are incurred prior
to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Excluded Liabilities</B>. Other than the Assumed Liabilities, Buyer assumes no other Liabilities of MII Life, and Buyer shall
not be liable or responsible for, be obligated to pay, perform or otherwise discharge, and MII Life shall retain, all other Liabilities
of MII Life (together with certain Liabilities of SamCo specifically set forth below, the &ldquo;<B>Excluded Liabilities</B>&rdquo;).
For the avoidance of doubt, Excluded Liabilities shall include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(i)</TD><TD STYLE="text-align: justify; width: 73%">any Liability relating to any breach or default of any Assumed
Contract arising prior to the Closing;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(ii)</TD><TD STYLE="text-align: justify; width: 73%">all Taxes related to the Acquired Assets for Pre-Closing Tax
Periods;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(iii)</TD><TD STYLE="text-align: justify; width: 73%">all contractually assumed Taxes of other Persons (except to
the extent otherwise assumed hereunder);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(iv)</TD><TD STYLE="text-align: justify; width: 73%">any and all Taxes allocated to, of or imposed on either Seller;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(v)</TD><TD STYLE="text-align: justify; width: 73%">any Indebtedness of either Seller, Transaction Expenses, or
transaction expenses of SamCo;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(vi)</TD><TD STYLE="text-align: justify; width: 73%">any Liability relating to any custodial agreement of either
Seller in respect of the Accounts;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(vii)</TD><TD STYLE="text-align: justify; width: 73%">any Liability to the extent arising out of any Excluded Asset;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%"></TD><TD STYLE="width: 10%; text-align: left">(viii)</TD><TD STYLE="text-align: justify; width: 73%">any Excluded Employee Liability; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"> (ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any other Liability of any kind, whether known or unknown, contingent, matured or otherwise, whether currently existing or hereinafter created, other than an Assumed Liability.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Purchase and Sale of Units</B>. At the Closing, subject to the terms and conditions of this Agreement, Aware shall sell, assign,
convey, transfer and deliver the Units to Buyer, free and clear of all Encumbrances (other than restrictions on transfer imposed by applicable
securities laws), and Buyer shall purchase and accept the Units from Aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Consideration</B>. The total cash consideration for the Acquired Assets and the Units (the &ldquo;<B>Consideration</B>&rdquo;)
shall be $500,000,000. Pursuant to the terms and conditions of the Assignment and Assumption Agreement, Buyer will assume, from and after
the Closing, all of the Assumed Liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Initial and Final Cash and Investment Asset Balances in the Purchased Accounts</B>. On the date hereof, MII Life shall provide
Buyer with (a) an estimate as of three (3) Business Days prior to the date hereof of the aggregate amount of the (i) cash balances in
all of the Accounts of the Spending Account Business, which are identified on <B><U>Schedule 1.6</U></B> (collectively, the &ldquo;<B>Initial
Accountholder Cash Deposits</B>&rdquo;) and (ii) investment assets in all of the Accounts of the Spending Account Business, which are
identified on <B><U>Schedule 1.6</U></B> (the &ldquo;<B>Initial Accountholder Investment Assets</B>&rdquo;) (all of such Accounts, which
are identified on <B><U>Schedule 1.6</U></B>, collectively, the &ldquo;<B>Purchased Accounts</B>&rdquo;), and (b) such other information
as set forth on <B><U>Schedule A</U></B> hereto. After the close of business on the Business Day immediately preceding the Closing Date,
MII Life shall provide Buyer with (x) a final <B><U>Schedule 1.6</U></B> setting forth the aggregate amount, as of the close of business
on the Business Day immediately preceding the Closing Date, of the (i) cash balances in all of the Accounts of the Spending Account Business
(collectively, the &ldquo;<B>Final Accountholder Cash Deposits</B>&rdquo;) and (ii) investment assets in all of the Accounts of the Spending
Account Business (the &ldquo;<B>Final Accountholder Investment Assets</B>&rdquo;), and (y) such other information as set forth on <B><U>Schedule
A</U></B> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Closing</B>. The closing of the transactions contemplated by this Agreement (the &ldquo;<B>Closing</B>&rdquo;) shall take place
remotely on the later of (a) the second (2<SUP>nd</SUP>) Business Day following the date on which the last of the conditions set forth
in <FONT STYLE="font-size: 13pt"><U>&#8206;</U></FONT><U>Article V</U> are fulfilled or waived and (b) September 7, 2021, or at such other
time and place as the Parties shall agree in writing (the &ldquo;<B>Closing Date</B>&rdquo;). The Closing shall be effective as of 12:01
a.m. Minneapolis time on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Allocation of Consideration</B>. Sellers and Buyer shall agree in good faith based on customary methodology on a mutually acceptable
allocation of the Consideration among the Acquired Assets and Units prior to Closing. Buyer and Sellers shall report, act and file all
Tax Returns in all respects and for all purposes consistent with such allocation. Buyer on one hand and Sellers on the other hand shall
notify and provide the other with reasonable assistance in the event of a Proceeding regarding the allocation determined pursuant to this
Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>1.8. None of the Parties shall take any action inconsistent with the allocation prepared
in accordance with this Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>1.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Wrong Pocket</B>. If at any time after the Closing (a)&nbsp;Buyer or its designee holds any Excluded Assets or Excluded Liabilities
or (b) either Seller or any of its Affiliates holds any Acquired Assets or Assumed Liabilities, Buyer or the applicable Seller will promptly
transfer (or cause to be transferred) such assets or assume (or cause to be assumed) such Liabilities to or from (as the case may be)
the other Party, without further consideration from the other Party. Prior to any such transfer, the Party receiving or possessing any
such asset will hold it in trust for such other Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Subsequent
Documentation</B>. Without limiting Section 9.3, MII Life and Buyer shall, and shall cause their controlled Affiliates to, and Aware
shall, and shall cause it controlled Affiliates to, at any time and from time to time after the Closing Date, upon the request of
the other Party, do, execute, acknowledge and deliver, or cause to be done, executed, acknowledged and delivered, all such further
deeds, assignments, transfers and conveyances as may reasonably be required for the assigning, transferring, granting, conveying and
confirming to Buyer or its successors and assigns, or for aiding and assisting in collecting and reducing to possession, any or all
of the Acquired Assets and Assumed Liabilities. MII Life hereby constitutes and appoints, effective as of the Closing Date, Buyer,
its successors and assigns as the true and lawful attorney of MII Life with full power of substitution in the name of Buyer or in
the name of MII Life for the benefit of Buyer (a) to collect for the account of Buyer all items of the Acquired Assets and (b) to
institute and prosecute proceedings in order to assert or enforce any right, title or interest in, to or under the Acquired Assets
and to defend or compromise any and all proceedings in respect of any of the Acquired Assets. Buyer shall be entitled to retain for
its own account any amounts collected pursuant to the foregoing powers, including any amounts payable as interest in respect
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Assignability and Consents</B>. At the Closing and effective as of the Closing Date, MII Life shall, and shall cause its controlled
Affiliates (as applicable) to, and Aware shall, and shall cause its controlled Affiliates to, assign to Buyer all of MII Life&rsquo;s
and each applicable Affiliate&rsquo;s rights under the Assumed Contracts. Notwithstanding the foregoing, no Assumed Contract shall be
assigned, or deemed to be assigned, contrary to law or, in the event not permitted, or any applicable consent or approval is not obtained,
pursuant to the terms of such Assumed Contract (any such Assumed Contract, a &ldquo;<B>Non-Assignable Contract</B>&rdquo;). The performance
obligations of MII Life or its applicable Affiliate under a Non-Assignable Contract shall, unless prohibited by law or by the terms of
such Non-Assignable Contract, be deemed to be subleased or subcontracted to Buyer until such Non-Assignable Contract has been assigned
to Buyer. With respect to Non-Assignable Contracts, MII Life shall, and shall cause its controlled Affiliates (as applicable) to, and
Aware shall, and shall cause its controlled Affiliates to, use commercially reasonable efforts to obtain all necessary consents and approvals
and to deliver all required notices to effect assignment thereof to Buyer; <U>provided</U>, <U>however</U>, MII Life and its Affiliates
(as applicable) shall (a) not be required to pay any material fee or payment or make any concession to any third party in order to obtain
any such consent or amendment, and Buyer acknowledges and agrees that, except as set forth herein, the procurement of any such consent
or amendment is not a condition to Buyer&rsquo;s obligations to effect the Closing, (b)&nbsp;until any necessary consent or approval is
obtained, provide Buyer in any arrangement acceptable to Buyer (including a transition services arrangement) the full benefits (including
the exercise of rights) and burdens (other than any Excluded Liabilities) under any such Non-Assignable Contracts, including enforcement,
at Buyer&rsquo;s sole expense, for the benefit of Buyer of any and all rights of Sellers or any of their controlled Affiliates (as applicable)
against a third party arising out of the breach or cancellation of any such Non-Assignable Contract or otherwise, (c)&nbsp;hold all monies
paid thereunder in trust for the account of Buyer and (d)&nbsp;remit all such monies without set-off of any kind whatsoever (other than
expenses incurred in performing under the Non-Assignable Contracts) to Buyer as promptly as possible. The obligations of the Parties under
this <U>Section 1.11</U> shall survive the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
II</B></FONT><U><BR>
<B>REPRESENTATIONS AND WARRANTIES OF SELLERS</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To induce Buyer to enter
into this Agreement, each Seller represents and warrants, with respect to such Seller and (a) in the case of MII Life, the Spending
Account Business and (b) in the case of Aware, SamCo, to Buyer as set forth in this <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&#8206;</U></FONT><U>Article
II</U>, except as set forth in the disclosure schedules referenced in this <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&#8206;</U></FONT><U>Article
II</U> delivered by Sellers to Buyer (the &ldquo;<B>Disclosure Schedules</B>&rdquo;). Such Disclosure Schedules shall be arranged in
numbered paragraphs corresponding to the sections and subsections in this Agreement. The disclosures in any part&nbsp;or
subpart&nbsp;of the Disclosure Schedules shall qualify other sections and subsections in this <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&#8206;</U></FONT><U>Article
II</U> to the extent it is reasonably apparent on its face that such disclosure is applicable to such other sections and
subsections. The inclusion of any information in the Disclosure Schedules (or any update thereto) shall not be deemed to be an
admission or acknowledgment, in and of itself, that such information is required by the terms hereof to be disclosed, is material,
has resulted in or would reasonably be expected to result in a Material Adverse Effect, or is outside the Ordinary Course of
Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Organization</B>. Such Seller is duly organized, legally existing and in good standing under the laws of its jurisdiction of formation.
Such Seller has all requisite corporate power and authority to, in the case of MII Life own and operate the Acquired Assets and the Spending
Account Business or, in the case of Aware own the Units, and in the case of MII Life to conduct its Spending Account Business as it is
now being conducted. Such Seller is duly qualified to transact business and is in good standing under the laws of every state or jurisdiction
in which the nature of its activities or of its properties owned, leased or operated requires such qualification, except where the failure
to be so qualified has not, and could not reasonably be expected to have, a Material Adverse Effect. Aware is the record and beneficial
owner and holder of all of the issued and outstanding stock and other securities or other equity and rights in SamCo and MII Life, free
and clear of all Encumbrances of any kind, nature and description whatsoever. No Person has any rights (whether by Contract or otherwise)
that obligate SamCo or MII Life to issue, transfer, buy or sell any of its membership interests or other securities or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Due Authorization</B>. The execution, delivery and performance of this Agreement and the Disclosure Schedules and the Ancillary
Documents, and the consummation of the transactions contemplated hereby and thereby by such Seller, have been duly and validly authorized
by all necessary corporate action, in accordance with Applicable Law and such Seller&rsquo;s Constituent Documents. No additional corporate
or shareholder authorization or consent is required in connection with the execution, delivery and performance by such Seller of this
Agreement or any of the Ancillary Documents to which it is or will become party. This Agreement and the Ancillary Documents to be executed
and/or delivered by such Seller pursuant to this Agreement have been or will be prior to the Closing, as applicable, duly and validly
executed and delivered by such Seller and the obligations of such Seller hereunder and thereunder are, or will be upon such execution
and delivery (assuming the due authorization, execution and delivery by Buyer), valid, legally binding and enforceable against such Seller
in accordance with their respective terms, except as the enforceability thereof may be limited by the availability of equitable principles
or bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors&rsquo; rights generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>No
Breach</B>. Such Seller has full power and authority to sell, assign, transfer, convey and deliver to Buyer the Acquired Assets in
the case of MII Life or the Units in the case of Aware. The execution and delivery of this Agreement, and the Ancillary Documents
and the consummation of the transactions contemplated hereby and thereby by such Seller will not: (a)&nbsp;violate any provision of
such Seller&rsquo;s Constituent Documents, (b) violate any Applicable Laws or Order applicable to such Seller, (c) except for
applicable requirements of the HSR Act, require of such Seller any filing with, Permit from, authorization, consent or approval of,
or the giving of any notice to, any Person, (d) result in a violation or breach of, or constitute (with or without due notice or
lapse of time or both) a default (or give another Person any rights of termination, cancellation or acceleration) under any of the
terms, conditions or provisions of any note, bond, mortgage, indenture, license, franchise, Permit (including but not limited to,
any Permits, approvals or authorizations of any Governmental Body), lease, employee benefit plan or other Material Contract to which
such Seller is a party, or by which the Acquired Assets in the case of MII Life or the Units in the case of Aware may be bound, or
(e) result in the creation or imposition of any Encumbrance on any of the Acquired Assets or the Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Title to Acquired Assets</B>. Such Seller holds good, valid and marketable title to all of the Acquired Assets in the case of MII
Life or the Units in the case of Aware, free and clear of any and all Encumbrances of any kind, nature and description whatsoever (other
than Permitted Encumbrances).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Litigation</B>. There is no Proceeding pending, or to such Seller&rsquo;s Knowledge threatened, by or against such Seller related
to its Spending Account Business or against or relating to the Acquired Assets in the case of MII Life, or against SamCo in the case of
Aware. Such Seller is not a party to or subject to the provisions of any Order, in the case of MII Life related to its Spending Account
Business and in the case of Aware related to SamCo. There are no Proceedings pending, or to the Knowledge of such Seller, threatened that
question the legality of the transactions contemplated by this Agreement or any of the other Ancillary Documents or that are reasonably
expected to prevent or materially delay the consummation of the transactions contemplated by this Agreement or the other Ancillary Documents.
Such Seller is not subject to any outstanding Order that (i) is reasonably expected to be material to SamCo or the Spending Account Business
taken as a whole or (ii) prohibits or otherwise restricts the ability of such Seller or any of its Affiliates to consummate fully the
transactions contemplated by this Agreement or any other Ancillary Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Data Privacy.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to any Personal Data collected, accessed, stored, used, disclosed, transferred, or otherwise processed by MII Life
and SamCo in the case of Aware, in the last three (3) years MII Life and SamCo have complied in all material respects with (i) the terms
of all published, posted, and internal agreements, policies, procedures, and notices (&ldquo;<B>Privacy Policies</B>&rdquo;), (ii) all
applicable laws pertaining to data protection, data privacy, data security, cybersecurity, cross-border data transfer, including without
limitation, applicable requirements of the Health Insurance Portability and Accountability Act of 1996, as amended, including all rules
and regulations promulgated thereunder, and general consumer protection laws as applied in the context of data privacy, data breach notification,
electronic communication, telephone and text message communications, marketing by email or other channels, and other similar laws (&ldquo;<B>Data
Protection Laws</B>&rdquo;), and (iii) any Contract and/or codes of conduct with respect to the collection, use, disclosure, storage,
cross-border transfer, and protection of Personal Data (collectively with Privacy Policies and Data Protection Laws, the &ldquo;<B>Data
Protection Requirements</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> In the last three (3) years, no notice or Proceeding has been served on, or initiated against, MII Life in respect of its Spending
Account Business or SamCo under any applicable Data Protection Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no pending complaints, actions, fines, or other penalties facing MII Life or SamCo in connection with any Data Protection
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the last three (3) years, MII Life and SamCo have not experienced any security breaches or incidents, unauthorized access, use,
modification, or disclosure, or other adverse events or incidents related to Personal Data and/or business data and Data Systems that
(i) has resulted in or would reasonably be expect to result in a Material Adverse Effect or (ii) would require law enforcement or individual
notification or remedial action under any applicable Data Protection Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MII Life and SamCo established and maintain, and have maintained, physical, technical, and administrative security measures and
policies, that are in material compliance with applicable Data Protection Requirements, that (i) identify internal and organizational
risks to the confidentiality, integrity, security, availability of Personal Data and/or business data and Data Systems taking into account
the sensitivity of the data or systems; (ii) protect the confidentiality, integrity, security, and availability of the software, systems,
and websites that are involved in the collection and/or processing of Personal Data and/or business data and Data Systems; and (iii) maintain
notification procedures in compliance with applicable Data Protection Requirements in the case of any breach of security compromising
Personal Data and/or business data and Data Systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The execution, delivery, and performance of this Agreement shall not cause, constitute, or result in a breach or violation of any
Data Protection Requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Tax Matters.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MII Life and in the case of Aware, SamCo, have filed, or will file in a timely fashion on or before the Closing Date, all Tax Returns
that MII Life or SamCo was required to file on or before the Closing Date. All such Tax Returns are correct and complete in all respects.
All Taxes owed by MII Life or SamCo (whether or not shown on any Tax Return) have been or will be paid prior to their due date. MII Life
and SamCo are currently the beneficiaries of extensions of time within which to file 2020 federal and state Tax Returns. No claim has
been made by any Governmental Body in a jurisdiction where MII Life or SamCo does not file Tax Returns that MII Life or SamCo is, or may
be, subject to taxation by that jurisdiction. There are no Encumbrances on any of the Acquired Assets, the Units or on any of the assets
of SamCo that arose in connection with any failure (or alleged failure) to pay any Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MII Life and in the case of Aware, SamCo, has withheld and timely paid all Taxes required to have been withheld and paid by MII
Life or SamCo in connection with amounts paid or owing to any employee, independent contractor, creditor, or other third Person, if any,
and all sales, use or value added Taxes have been timely withheld and paid by MII Life or SamCo to the applicable Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> There is no dispute or claim concerning any Tax Liability of MII Life and in the case of Aware, SamCo, either (i) claimed or raised
by any Governmental Body or (ii) with respect to which MII Life or SamCo has Knowledge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MII Life and in the case of Aware, SamCo, has not waived or agreed to waive any statute of limitations in respect of Taxes or entered
into, or agreed to enter into, any extension of time with respect to a Tax assessment or deficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MII Life or in the case of Aware, SamCo, has not been a United States real property holding corporation within the meaning of Section
897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code. MII Life or SamCo (i) is not a party
to any Tax allocation, sharing, indemnification or similar agreement under which Buyer could be liable for any Taxes or other claims of
any Person, or (ii) has no Liability for the Taxes of any Person under Treasury Regulation Section 1.1502-6 (or any similar provision
of state, local or foreign law) as a transferee or successor, by Contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since its inception, SamCo has been, and at all times up to and including the Closing Date will be, properly characterized as a
disregarded entity for U.S. federal and all applicable state and local income Tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no requests for rulings in respect of any Taxes pending between MII Life and in the case of Aware, SamCo, and any Governmental
Body relating to MII Life, its Spending Account Business or the Acquired Assets in the case of MII Life, or SamCo or the Units in the
case of Aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Absence of Certain Developments</B>. Except for the transactions contemplated by this Agreement, since October 31, 2020, neither
SamCo nor MII Life&rsquo;s Spending Account Business has:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>sold, assigned or otherwise transferred any Accounts, or disposed of or permitted to lapse any rights in any Permit owned, purported
to be owned or used by such Seller primarily with respect to its Spending Account Business, other than in the Ordinary Course of Business,
or acquired any Accounts outside of the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) disposed of, sold, assigned, transferred, licensed, abandoned, granted, pledged, encumbered, dedicated to the public domain
or permitted to lapse any rights in any Owned Intellectual Property, other than non-exclusive licenses granted in the Ordinary Course
of Business, or (ii) disclosed any Trade Secrets or Source Code to a third party, other than pursuant to a valid and binding confidentiality
agreement or other binding obligation of confidentiality that MII Life or SamCo entered into in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>suffered, sustained or incurred any material Loss related to the Accounts or waived or released any material right or claim related
to the Accounts, in each case whether or not in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> engaged in any transaction related to the Purchased Accounts not in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>subjected any of the Acquired Assets to any Encumbrance (other than Permitted Encumbrances);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>waived, released, instituted, settled or agreed to settle any Proceeding;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>failed to keep in full force and effect insurance in amount and scope of coverage consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>received notice from any customer, Governmental Body or any other Person, or any group thereof, which is reasonably expected to
be material to the Spending Account Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) acquired or agreed to acquire by merging or consolidating with, or by purchasing a substantial portion of the assets of, or
by any other manner, directly or indirectly, any Person or business or any corporation, limited liability company, partnership, joint
venture, association or other business organization or division thereof, or (ii) entered into any Contract with respect to any of the
foregoing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>materially amended any Assumed Contract or terminated any material Contract related to the Spending Account Business or waived,
released or assigned any material rights or claims thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>changed or modified existing credit, collection or payment policies, procedures and practices;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>made any material change to its accounting methods, principles or practices or to the working capital policies applicable to the
Spending Account Business, except as required by GAAP; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>taken any action or omitted to take any action that would result in the occurrence of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Undisclosed Liabilities</B>. Except for deposit liabilities, including savings account balances, with respect to the Account Deposits
identified on <B><U>Schedule 1.6</U></B>, MII Life has no Liability related to the Acquired Assets, and, to the Knowledge of MII Life,
there is no basis for any future Proceeding against MII Life giving rise to any Liability related to the Acquired Assets. SamCo does not
have any Liability which is not reflected on the unaudited balance sheet of SamCo as of December 31, 2020 and the related statements of
operations, changes in members&rsquo; equity and cash flows for the fiscal year ended December 31, 2020 (the &ldquo;<B>SamCo Financial
Statements</B>&rdquo;) that would be required to be reflected or reserved against on a balance sheet prepared in accordance with GAAP.
Except as set forth on the SamCo Financial Statements, SamCo is not, directly or indirectly, liable upon or with respect to (by discount,
repurchase or otherwise), or obligated in any way to provide funds in respect of, or to guarantee or assume, as debt, any obligation or
dividend of any Person. SamCo has no outstanding Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Compliance with Laws and Account Agreements</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the last five (5) years, its Spending Account Business in the case of MII Life and SamCo in the case of Aware, has been operated,
and such Seller or SamCo is, in compliance in all material respects with the requirements of all Applicable Laws. Such Seller or SamCo
has not received any notice of, and such Seller or SamCo has no Knowledge of, any violation of any Applicable Laws, including any violation
that would interfere with the sale of the Acquired Assets or the Units under this Agreement. Without limiting the foregoing, each of the
Purchased Accounts has been originated and administered in compliance in all material respects with the documents governing such Purchased
Account (including any applicable agreements between MII Life and a Purchased Account holder under which such Purchased Account was established
and which contain the terms and conditions applicable to the Purchased Account) and all Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither SamCo nor, in connection with the Spending Account Business, MII Life nor any of their Affiliates, has engaged in or otherwise
incurred any material liability with respect to any &ldquo;prohibited transaction&rdquo; under Section 4975 of the Code, impermissible
inurement under Section 501(c)(9) of the Code, or breach of fiduciary duty under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each program and arrangement for which services are provided by or through the Spending Account Business is administered in accordance
with documents that satisfy the requirements of all Applicable Laws for the intended treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to each client for whom SamCo or the Spending Account Business is responsible for delivering notices and/or disclosures
that are required by Applicable Law (including notices related to COBRA coverage), compliant notices or disclosures, as applicable, have
been timely delivered in a manner reasonably calculated to ensure actual receipt by the required recipient and the requirements of Applicable
Law have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as required to administer the Accounts, including but not limited to MII Life&rsquo;s obligation to file 1099s, 5498s, escheatment
filings, NYDSF cybersecurity certification and Medicare secondary reporting, neither SamCo nor MII Life or any employee, officer, or agent
of the Spending Account Business has any responsibility in respect of filings with the Internal Revenue Service, or any other governmental
entity. To the Knowledge of Sellers and SamCo, all required governmental filings have been timely made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Material Contracts</B>. <B><U>Schedule 2.11</U></B> hereto contains a complete and correct listing of all Contracts relating to
MII Life&rsquo;s Spending Account Business or SamCo of the types described below to which MII Life or SamCo, is a party, or by which MII
Life or SamCo is otherwise bound (such Contracts, the &ldquo;<B>Material Contracts</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that gave rise to revenues or Liabilities related to the Acquired Assets or SamCo in excess of $100,000 during the 2020 calendar
year;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> the top 50 Employer Agreements by total Account assets, all Health Plan Agreements, all distribution partner agreements, each
unique form of MII Life or SamCo&rsquo;s HSA custodial agreement and any other form of agreement between MII Life or SamCo on one hand,
and an Account holder on the other hand;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>joint venture, partnership and similar Contracts involving a sharing of profits or expenses relating to the Purchased Accounts
or SamCo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each Intellectual Property License, but excluding (i) any &ldquo; shrink wrap&rdquo; or similar license for Software that is all
of the following: (A) generally commercially available, (B) licensed to MII Life or, in the case of Aware, SamCo (including on a &ldquo;software-as-a-service&rdquo;
basis) pursuant to a non-exclusive license for a total annual cost of $50,000 or less, and (C) not included in or necessary for the use,
development, or maintenance of any Products and Services or the Owned Intellectual Property, and (ii) non-exclusive licenses granted to
customers or resellers in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>relating to Indebtedness or to the mortgaging, pledging or otherwise placing an Encumbrance on any Acquired Assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that limits or purports to limit the ability of MII Life or SamCo or any of their respective Affiliates to (i) solicit or hire
any Person, (ii) acquire any product or other asset or any service from any other Person, (iii) develop, sell, supply, distribute, offer
support to or service any product or any technology or other asset to or for any other Person, (iv) charge certain prices pursuant to
a &ldquo;most-favored nation&rdquo; or similar clause or (v)&nbsp;operate in any market (whether based on geography, industry or otherwise)
or through any distribution channel;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>which prohibits MII Life or SamCo or any of their respective Affiliates from freely engaging in business anywhere in the world;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>with any Affiliate of either Seller; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any other Contract (or group of related Contracts) that is material to the operation of MII Life&rsquo;s Spending Account Business
or SamCo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sellers have made
available to Buyer a correct and complete copy of each written Material Contract and Assumed Contract (in each case, as amended to
date) and a complete description of each oral Material Contract and Assumed Contract or, where multiple Material Contracts and/or
Assumed Contracts are on the same form, a copy of each separate form of Material Contract and/or Assumed Contract. Each Material
Contract and Assumed Contract is legal, valid, binding, enforceable and in full force and effect, and will continue to be legal,
valid, binding, enforceable and in full force and effect on identical terms following the consummation of the transactions
contemplated hereby. MII Life, and in the case of Aware, SamCo, is not in default under any Material Contract or Assumed Contract,
and no event has occurred that with notice or lapse of time or both would constitute a breach or default, or permit termination,
modification or acceleration, thereunder by MII Life or SamCo, to the Knowledge of Sellers, by any other party thereto. Except as
set forth in <B><U>Schedule 2.3(c)</U></B>, no consent or approval to assignment of the Purchased Accounts or the Assumed Contracts,
or to the transactions contemplated hereby is required. To the Knowledge of Sellers, no other party has repudiated any provision of
any Material Contract or Assumed Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Permits</B>. <B><U>Schedule 2.12</U></B> contains a correct and complete list of all Permits necessary or obtained by MII Life
for the operation of its Spending Account Business or SamCo for the operation of its business. Each Permit has been received, is in full
force and effect and in the case of MII Life is transferable in full with the Acquired Assets to Buyer without the need to obtain any
consent, authorization or approval of any Person. Any applications for the renewal or transfer of any such Permit that are due prior
to the Closing shall have been timely filed prior to the Closing. No Proceeding to modify, suspend, revoke, withdraw, terminate or otherwise
limit any such Permit is pending or, to the Knowledge of such Seller, threatened. No administrative or governmental action has been taken
or, to the Knowledge of such Seller, threatened in connection with the expiration, continuance or renewal of any such Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Intellectual Property.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MII Life and SamCo exclusively own or have valid and enforceable rights to use all right, title and interest in and to all Intellectual
Property used, held for use or necessary to the operation of the Spending Account Business, including the Acquired IP, free and clear
of any Encumbrances. The Owned Intellectual Property is sufficient for the conduct of the Spending Account Business as currently conducted.
Except for any Intellectual Property provided pursuant to the Transition Services Agreement, all Intellectual Property used, held for
use, or necessary to the operation of the Spending Account Business is Owned Intellectual Property or Intellectual Property subject to
an Intellectual Property License.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the Closing, MII Life will have conveyed and transferred to Buyer, pursuant to this Agreement, all Acquired IP and Buyer will
have received from MII Life the right to use all of the Acquired IP, free and clear of any Encumbrances, and on the same terms and conditions
as in effect prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B><U>Schedule
2.13(c)</U></B> sets forth a true, complete and accurate list of (i) all United States, international, and foreign (A) patents and
patent applications, (B) trademarks, service marks and applications for registrations of trademarks and service marks (including
intent to use applications), (C) domain names and social media accounts, (D) registered copyrights and applications for copyright
registration and (E) any other Intellectual Property rights that are the subject of an application, certificate, filing,
registration or other document issued, filed with, or recorded by any Governmental Body, included in the Acquired IP or, in the case
of Aware, owned or purported to be owned by SamCo, including the jurisdictions in which each such item of Intellectual Property has
been issued or registered or in which any application for such issuance and registration has been filed, or in which any other
filing or recordation has been made (&ldquo;<B>Registered Intellectual Property</B>&rdquo;), and (ii) all Software included in the
Acquired IP or, in the case of Aware, owned or purported to be owned by SamCo that is used by, necessary for, or otherwise material
to the Spending Account Business (the &ldquo;<B>Proprietary Software</B>&rdquo;). All registration, maintenance and renewal fees
currently due in connection with such Registered Intellectual Property have been paid and all documents, recordations and
certificates in connection with such Registered Intellectual Property currently required to be filed have been filed with the
relevant patent, copyright, trademark, or other authorities in the United States or foreign jurisdictions, as the case may be, for
the purposes of prosecuting and maintaining such Registered Intellectual Property and recording MII Life&rsquo;s, or in the case of
Aware, SamCo&rsquo;s ownership interests therein. The Registered Intellectual Property is valid, enforceable and subsisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Split-Segment; Name: 3 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the conduct of the Spending Account Business as currently conducted or previously conducted, the Acquired Assets, nor the
use of the Owned Intellectual Property (i) infringes, misappropriates, violates, dilutes or otherwise conflicts with, or has infringed,
misappropriated, violated, diluted or otherwise conflicted with, any rights of any Person in respect of any Intellectual Property, or
(ii) constitutes unfair competition or unfair trade practices under the laws of any jurisdiction. To the Knowledge of Sellers none of
the Owned Intellectual Property is being infringed upon, violated or misappropriated or otherwise used or available for use by any other
Person. There have been no Proceedings filed, and neither MII Life nor Aware (in the case of SamCo) has received any written allegations
or threats, in each case with respect to or otherwise related to (x) the infringement, misappropriation or other violation of any Intellectual
Property of any third party, (y) any breach of any Intellectual Property License or other agreement pursuant to which either MII Life
or SamCo is a licensee of any Intellectual Property, or (z) contesting or otherwise challenging MII Life&rsquo;s or SamCo&rsquo;s ownership
of any Owned Intellectual Property or the validity of any Owned Intellectual Property or the right of MII Life or SamCo, as applicable,
to exercise its rights in any Owned Intellectual Property. Neither MII Life, SamCo or Aware (with respect to the Spending Account Business)
has received any written communication that involves an offer to license or grant any rights or immunities under any third party Intellectual
Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of the Acquired IP is subject to any Proceeding, Contract, or stipulation restricting in any manner the use, transfer, or
licensing by MII Life or SamCo of any Owned Intellectual Property or that may affect the validity, use, or enforceability of any such
Owned Intellectual Property. No Intellectual Property License grants any third party exclusive rights to or under any Owned Intellectual
Property or, grants any third party the right to sublicense any Owned Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Each
of MII Life, SamCo and Aware (in connection with the Spending Account Business) has taken commercially reasonable steps in
accordance with standard industry practices to maintain and protect the Trade Secrets and proprietary information and has preserved
the confidentiality of all nonpublic or confidential information used in connection with the Spending Account Business. All use,
disclosure, or appropriation of any confidential or nonpublic information owned by MII Life, SamCo and Aware (in connection with the
Spending Account Business) to a third party has been pursuant to the terms of a written Contract between MII Life SamCo and Aware
(in connection with the Spending Account Business), as applicable, and such third party. Each current and each former employee,
consultant, and independent contractor of MII Life, SamCo or Aware (in connection with the Spending Account Business) who has or had
access to any confidential or non-public information included in the Owned Intellectual Property has executed and delivered to MII
Life or SamCo a written agreement regarding the protection of such confidential or non-public information. To the Knowledge of
Sellers, no current or former employee, consultant, independent contractor or agent of MII Life, SamCo or Aware (in connection with
the Spending Account Business) has misappropriated any trade secrets or other confidential, non-public, or proprietary information
of any other Person in the course of the performance of his or her duties as an employee, consultant, independent contractor, or
agent of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No current or former employee, consultant, or independent contractor of MII Life, SamCo or Aware has any right, license, claim,
or interest whatsoever in or with respect to any Owned Intellectual Property and MII Life or SamCo has secured from all current and all
former employees, consultants, and independent contractors thereof who independently or jointly contributed to the conception, reduction
to practice, creation, or development of any Owned Intellectual Property (each such consultant, employee, and independent contractor a
 &ldquo;<B>Company Contributor</B>&rdquo;) unencumbered, unrestricted, and exclusive ownership of all such Company Contributor&rsquo;s
Intellectual Property in such contribution which MII Life or SamCo does not already own by operation of law and no such Company Contributor
has retained any rights or licenses with respect thereto. Without limiting the foregoing, MII Life or SamCo has obtained from each such
Company Contributor valid, enforceable and fully executed proprietary information and inventions assignment agreements which fully and
effectively assign, convey and otherwise transfer to MII Life or SamCo unencumbered, unrestricted and exclusive ownership of all of such
Company Contributor&rsquo;s rights in and to any Owned Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the extent that any third party owned Intellectual Property is incorporated into, integrated or bundled with, or used by MII
Life, or in the case of Aware, SamCo, in the development, manufacture, compilation, use, or other exploitation of any of the Products
and Services, MII Life and SamCo have all necessary rights to use or exploit all such third party owned Intellectual Property, subject
to the terms of any applicable Intellectual Property License.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of the Proprietary Software contains, is derived from, or is distributed, integrated, or bundled with any Software or other
materials, including any Software or materials that are distributed as &ldquo;free software,&rdquo; &ldquo;open source software,&rdquo;
or under similar licensing or distribution terms (including the GNU General Public License, GNU Lesser General Public License, Mozilla
Public License, and other licenses of a similar type or kind), that would: (i) require or condition the use or distribution of any Owned
Intellectual Property or Proprietary Software on the disclosure, licensing, or distribution of any portion of the Owned Intellectual Property
or Proprietary Software, (ii) require MII Life or SamCo to distribute or make available any Owned Intellectual Property or Proprietary
Software, or (iii) otherwise impose any limitation, restriction, waiver of rights, or condition on the right or ability of MII or SamCo
to use or distribute any Owned Intellectual Property or Proprietary Software.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No (i) funding, facilities, or personnel of any Governmental Body, or (ii)&nbsp;funding, facilities, or personnel of a university,
college, or other educational institution or research center was used in the development of any Owned Intellectual Property or Proprietary
Software.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> None of MII Life, SamCo, or Aware is now or has ever been a member or promoter of, or a contributor to, any industry standards
body or any similar organization that could reasonably be expected to require or obligate MII Life, SamCo or Aware to grant or offer to
any Person or other third party any license or right to any Owned Intellectual Property. Additionally, no Owned Intellectual Property
was acquired from any Person or other third party which is now or has ever been a member or promoter of, or a contributor to, any industry
standards body or any similar organization that could reasonably be expected to have required or obligated such Person or other third
party to grant or offer to any other Person or other third party any license or right to such Acquired IP. None of MII Life, SamCo or
Aware has a present obligation (and there is no substantial basis to expect that there will be a future obligation) to grant or offer
to any other Person or any other third party any license or right to any Owned Intellectual Property by virtue of a MII Life&rsquo;s,
SamCo&rsquo;s, Aware&rsquo;s or any other Person&rsquo;s or other third party&rsquo;s membership in, promotion of, or contributions to
any industry standards body or any similar organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither MII Life, SamCo, Aware nor any other Person acting on behalf of any of the foregoing has disclosed or delivered to any
third party, agreed to disclose or deliver to any third party, or permitted the disclosure or delivery from any escrow agent or other
third party, any Source Code. No event has occurred, and no circumstance or condition exists that (with or without notice or lapse of
time, or both) will, or would reasonably be expected to, result in the disclosure or delivery by MII Life, SamCo, Aware or any other Person
acting on their behalf of any Source Code. There is no Contract pursuant to which MII Life, SamCo or Aware has deposited, or is or may
be required to deposit, with an escrow agent or any other Person any Source Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MII Life and SamCo maintain (i) machine readable copies of all Proprietary Software and (ii) reasonably complete technical documentation
or user manuals for material releases or versions thereof currently in use, currently made available to customers, or currently supported.
MII Life or SamCo possesses at least one copy of the Source Code, and all Source Code is maintained in strict confidentiality and in accordance
with at least industry-standard safekeeping for proprietary source code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The IT Systems: (i) are sufficient in all material respects for the current needs in the operation of the Spending Account Business
as currently conducted, (ii) have not been subject, in the past twenty-four (24) months, to any material failures, crashes, security breaches,
or other materially adverse events affecting the IT Systems which has caused material disruption to the businesses of MII Life or SamCo,
and (iii) provide for the back-up and recovery of material data consistent with recovery plans, procedures, and facilities implemented
by MII Life and SamCo. The information stored in the IT Systems has been adequately protected by MII Life and SamCo from unauthorized
use, access, or modification by any Person. None of the IT Systems, Proprietary Software or Company Products and Services contains any
computer code or any other mechanisms which may (x) disrupt, disable, erase, or harm in any way any of the foregoing&rsquo;s operation,
or cause any of the foregoing to damage or corrupt any data, hardware, storage media, programs, equipment or communications, or (y) permit
any Person to access without authorization any of the foregoing or any product or system containing or used in conjunction with any of
the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT> All of the Seller-Provided IP is either owned by Sellers or their Affiliates or is used by Sellers or
their Affiliates pursuant to a valid Contract, which Contract permits such Seller or its Affiliates to legally and validly license
or provide access to the Seller-Provided IP to Buyer or SamCo pursuant to the Transition Services Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Products and Services currently comply in all material respects with all applicable warranties and contractual commitments
relating to the use, functionality, and performance of the Products and Services (except for failures to meet service level agreements,
none of which are material to the Spending Account Business), and there are no pending or, to the Knowledge of Sellers, threatened Proceedings
relating to the Spending Account Business alleging any such failure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Guarantees</B>. None of the Liabilities of its Spending Account Business in the case of MII Life, or SamCo in the case of Aware,
are guaranteed by or subject to a similar contingent obligation of any other Person. Neither MII Life nor SamCo has guaranteed or become
subject to similar contingent obligations in respect of Liabilities of any other Person. There are no outstanding letters of credit, surety
bonds or similar instruments in connection with or relating to its Spending Account Business or the Acquired Assets in the case of MII
Life or the Units in the case of Aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Brokers</B>. Except for Wells Fargo Securities, LLC, such Seller has not employed or engaged any broker, finder, agent, banker
or third Person, nor has it otherwise dealt with anyone purporting to act in the capacity of a finder or broker in connection with the
transactions contemplated hereby. No commissions, finder&rsquo;s fees or like charges have been or will be incurred by such Seller that
is chargeable to its Spending Account Business or the Acquired Assets in the case of MII Life, SamCo in the case of Aware, such Seller,
or Buyer in connection with the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby.
Any such commissions, finders&rsquo; fees or like charges shall be directly chargeable to such Seller as contemplated by the terms of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Sanctions</B>.
Neither SamCo, nor, to the Knowledge of Sellers, any director, officer or employee thereof, is an individual or entity that is (a)
currently the subject or target of any Sanctions, (b) included on OFAC&rsquo;s List of Specially Designated Nationals or any similar
list enforced by the United States federal government or (c) located, organized or resident in a Designated Jurisdiction in
violation of any Sanctions. To Sellers&rsquo; Knowledge, SamCo (i) has not been found in violation of, charged with, or convicted
of, money laundering, drug trafficking, terrorist-related activities or other money laundering predicate crimes under the Currency
and Foreign Transactions Reporting Act of 1970 (otherwise known as the Bank Secrecy Act), the USA PATRIOT Act or any other United
States law or regulation governing such activities (collectively, &ldquo;<B>Anti-Money Laundering Laws</B>&rdquo;), or any Sanctions
laws, (ii) is not under investigation by any Governmental Body for possible violation of Anti-Money Laundering Laws or Sanctions,
(iii) has not been assessed civil penalties under any Anti-Money Laundering Laws or any Sanctions, (iv)&nbsp;has not had any of its
funds seized or forfeited in an action under any Anti-Money Laundering Laws or (v) has not filed any voluntary disclosures with any
Governmental Body regarding possible violations of Sanctions. To the Knowledge of Sellers, neither SamCo nor the Spending Account
Business, directly or indirectly, (x) has any investment in, or engages in any dealing or transaction with, any Person in violation
of any applicable Sanctions or (y) engages in any activity that could cause SamCo or the Spending Account Business to become subject
to Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Anti-corruption</B>. Each of Aware, as it concerns SamCo, and MII Life, as it concerns the Spending Account Business, represents
that SamCo and the Spending Account Business, and each of its and their owners, directors, officers, employees, and agents, and each other
Person acting on their behalf, (i) are and at all times have been, in compliance with all applicable U.S. (federal, state, and local)
anti-corruption laws, rules, and regulations, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, and all other applicable
anti-corruption laws (the &ldquo;<B>Anti-Corruption Laws</B>&rdquo;), and (ii) have not been charged with or convicted of violating any
Anti-Corruption Law, or received any notice, request, or citation, or been made aware of any allegation, investigation (formal or informal),
inquiry, action, charge, or proceeding with regard to a potential violation of any Anti-Corruption Law. Each of Aware, as it concerns
SamCo, and MII Life, as it concerns the Spending Account Business, represents that they have developed and implemented an anti-corruption
compliance program that includes internal controls and policies and procedures sufficient to provide reasonable assurances that SamCo
and the Spending Account Business are in compliance with all applicable Anti-Corruption Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Sufficiency and Condition of Acquired Assets</B>. Except as set forth in <B><U>Schedule&nbsp;2.18</U></B>, the Acquired Assets
constitute all of the tangible and intangible assets (including Intellectual Property) primarily used or held for use by MII Life or SamCo
in connection with the Spending Account Business as currently conducted and as currently contemplated to be conducted. Except as set forth
in <B><U>Schedule 2.18</U></B>, together with the services to be provided under the Transition Services Agreement, the Acquired Assets
are sufficient to enable Buyer to conduct the Spending Account Business after the Closing in substantially the same manner as conducted
by Sellers at the Closing. The Acquired Assets are in good operating condition and repair (ordinary wear and tear excepted) and are suitable
for such Acquired Assets&rsquo; intended use in the operation of the Spending Account Business as currently conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Bankruptcy</B>. Neither Seller is involved in any Action or proceeding by or against it as a debtor before any Governmental Body
under the United States Bankruptcy Code or any other insolvency or debtors&rsquo; relief act or Applicable Law or for the appointment
of a trustee, receiver, liquidator, assignee, sequestrator or other similar official for any part of the Acquired Assets. Neither Seller
is, and after giving effect to the consummation of the transactions contemplated at the Closing, or will be &ldquo;insolvent&rdquo; within
the meaning of Section 101(32) of Title 11 of the United States Code or any applicable state fraudulent conveyance or transfer Applicable
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Intracompany Arrangements</B>. Except for employment-related arrangements and the payment of compensation and benefits in the ordinary
course of business, no current officer, manager, director or Affiliate of either Seller is a party to any Contract, or business relationship
with, or has any material interest in any property used by, the Spending Account Business or SamCo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Certain Account Matters</B>. All of the Final Accountholder Cash Deposits and Final Accountholder Investments consist of cash
and actively traded securities, and there are no contractual or, to the Knowledge of Sellers, legal restrictions on the ability to change
the investment and/or cash placement options for any such Final Accountholder Cash Deposits or Final Accountholder Investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.22<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employees; Employee Benefit Plans.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Sellers have made available to Buyer a list, as of March 31, 2021 (the &ldquo;<B>Specified Employee Census</B>&rdquo;), (i) of&nbsp;each
employee of Sellers or their Affiliates who are providing services to the Spending Account Business on a dedicated basis as of such date
(the &ldquo;<B>Specified Employees</B>&rdquo;) and (ii) which includes&nbsp;for each Specified Employee the individual&rsquo;s title or
position, employing entity, hire date, years of credited service, work location, base salary, target annual cash bonus opportunity for
the 2021 fiscal year, actual cash bonus payment for the 2020 fiscal year, outstanding retention or transaction bonus, accrued vacation,
full-time or part-time status, and exempt or non-exempt classification. Each Specified Employee is currently employed by the entity listed
in the Specified Employee Census. Except for any services pursuant to the Transition Services Agreement, the services provided by the
Specified Employees constitute all of the services reasonably required to conduct and operate the Spending Account Business in the same
manner as of the Closing Date, in all material respects, as conducted by MII Life and SamCo as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Sellers and their Affiliates (with respect to the Spending Account Business, the Acquired Assets and the Specified Employees) are
and since December&nbsp;31, 2017 have been in compliance in all material respects with all Applicable Laws relating to labor, the hiring
of employees and the employment of the Specified Employees, including provisions thereof relating to wages and hours (including the classification
of employees as &ldquo;exempt&rdquo; or &ldquo;non-exempt&rdquo; from overtime under Applicable Law and meal and rest breaks), collective
bargaining, plant closings and layoffs (including the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar
Laws (the &ldquo;<B>WARN Act</B>&rdquo;)), employment discrimination, equal opportunity, civil rights, safety and health, workers&rsquo;
compensation, unemployment insurance, pay equity, classification of employees and independent contractors, and the collection and payment
of withholding and/or social security Taxes. Sellers and their Affiliates have, with respect to each Specified Employee, met all requirements
required by Applicable Law or regulation relating to the employment of foreign citizens, including requirements of Form I-9, and, to the
Knowledge of Sellers, each Specified Employee is permitted to work in the jurisdiction in which such Person is employed. Sellers and their
Affiliates (with respect to the Spending Account Business, the Acquired Assets and the Specified Employees) are (and since December 31,
2017 have been), in compliance with all Applicable Laws that could require overtime to be paid to any Specified Employee, and no Specified
Employee has, to the Knowledge of Sellers, threatened to bring a claim for unpaid compensation or employee benefits, including overtime
amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>There
is no, and for the past three (3) years there has been no, unfair labor practice complaint against Sellers or any of their
Affiliates relating to any Specified Employee pending before the National Labor Relations Board or any other Governmental Body.
There are no, and for the past three (3) years there have been no, Proceedings with respect to or relating to Sellers or any of
their Affiliates (with respect to the Spending Account Business or the Acquired Assets) pending before any applicable Governmental
Body responsible for the prevention of unlawful employment practices relating to any Specified Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There is no, and for the past three (3) years there has been no, labor strike, material dispute, material grievance, arbitration,
slowdown or stoppage actually pending or, to the Knowledge of Sellers, threatened against or involving Sellers or any their Affiliates
(with respect to the Spending Account Business, the Acquired Assets and the Specified Employees).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No labor union or other labor organization represents any Specified Employees or any other employees of the Spending Account Business,
and none of the Specified Employees are covered by any collective bargaining or similar agreement or union contract with any labor union
or labor organization in respect of their employment with Sellers or their Affiliates. To the Knowledge of Sellers, in the past three
(3) years, no labor union has taken any action with respect to organizing the Specified Employees or any other employees of the Spending
Account Business or the Acquired Assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the Knowledge of Sellers, no Specified Employee or independent contractor of the Spending Account Business is in any material
respect in violation of any term of any employment agreement, nondisclosure agreement, noncompetition agreement, restrictive covenant
or other obligation: (i)&nbsp;owed to Sellers or their Affiliates (with respect to the Spending Account Business, the Acquired Assets
and the Specified Employees); or (ii)&nbsp;owed to any third party with respect to such Person&rsquo;s right to be employed or engaged
by Sellers or their Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the Knowledge of Sellers, Sellers and their Affiliates (with respect to the Spending Account Business, the Acquired Assets and
the Specified Employees) have investigated all sexual harassment allegations against or involving a Specified Employee of which they are
aware. Sellers do not reasonably expect any material Liability with respect to any such allegations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Schedule 2.22(h)</U></B> sets forth a true, correct and complete list of each material Seller Benefit Arrangement. SamCo
does not currently, and has never, sponsored, maintained, contributed to or been required to contribute to any Benefit Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>With
respect to each Seller Benefit Arrangement, (i)&nbsp;such Seller Benefit Arrangement is currently maintained and administered in all
material respects in accordance with its express terms and with the requirements of Applicable Law, and (ii)&nbsp;there is no
pending or, to the Knowledge of Sellers, threatened action, suit, administrative or regulatory proceeding, claim arbitration or
Order, or any investigation by a Governmental Body, against or relating to any Specified Employee&rsquo;s participation in such
Seller Benefit Arrangement, the assets of any of the trusts under such arrangements or the sponsor or the administrator, or against
any fiduciary of such Seller Benefit Arrangement with respect to the operation of such arrangements (other than routine benefits
claims); in each case, other than as would not reasonably be expected to result in any material Liability to Buyer. With respect to
each Seller Benefit Arrangement, if intended to be qualified under Section&nbsp;401(a) of the Code, such Seller Benefit Arrangement
has received a favorable determination, or may rely upon a favorable opinion letter, from the Internal Revenue Service that it is so
qualified and, to the Knowledge of Sellers, nothing has occurred since the date of such letter that could reasonably be expected to
affect the qualified status of such Seller Benefit Arrangement. SamCo has not incurred (whether or not assessed), and is not
reasonably expected to incur or to be subject to, any Tax or other penalty with respect to the reporting requirements under Sections
6055 and 6056 of the Code, as applicable, or under Section 4980B, 4980D or 4980H of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>During the immediately preceding six&nbsp;(6) years, neither of Sellers nor any of their ERISA Affiliates or predecessors has contributed
to, been required to contribute to, participated in, or had any Liability with respect to, any plan subject to Section&nbsp;302 or Title&nbsp;IV
of ERISA or Section&nbsp;412 or 4971 of the Code, in each case, that could reasonably be expected to result in any Liability to Buyer.
SamCo has no Liability to the Pension Benefit Guaranty Corporation or otherwise under Title IV of ERISA, including on account of an ERISA
Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither of Sellers nor any of their ERISA Affiliates contributes or is required to contribute to any Multiemployer Plan or &ldquo;multiple
employer plan&rdquo; within the meaning of Sections&nbsp;4063 and 4064 of ERISA or Section&nbsp;413(c) of the Code, in each case, in respect
of any Specified Employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as required by Applicable Law, no Seller Benefit Arrangement entitles any Specified Employee or dependent or beneficiary
thereof to any post-termination or post-retirement health or welfare benefits, in each case, other than any continuation coverage required
by COBRA for which the covered Person pays the full cost of coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the execution of this Agreement nor the consummation of the transactions contemplated hereby will (alone or in conjunction
with any other event) (i)&nbsp;result in any payment becoming due to any Specified Employee or any other current or former employee, officer,
director or other service provider of Sellers or their Affiliates that would be an Assumed Liability, (ii)&nbsp;increase any benefits
otherwise payable to any Transferred Employee, or (iii)&nbsp;result in the acceleration of the time of payment or vesting of any such
benefits for any Transferred Employee. The transactions contemplated by this Agreement shall not constitute a &ldquo;change in ownership
or control&rdquo; of Sellers or any of their Affiliates within the meaning of Section&nbsp;280G of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Seller nor any of their Affiliates is bound to provide a gross-up or otherwise reimburse any Specified Employee for Taxes
paid pursuant to Section&nbsp;409A or 4999 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.23<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Ultimate Parent Entity.</B> Aware is the &ldquo;ultimate parent entity&rdquo; (as defined in 16 C.F.R. Section 7 8 801.1(a)(3)
and (b)) of each of BCBSM, Stella Resources Co., Inc. and MII Life.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.24<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> No Other Representations and Warranties</B>. Except with respect to the representations and warranties of such Seller set forth
in this Agreement or the Ancillary Documents, such Seller makes no guarantees, representations or warranties to Buyer in connection with
this Agreement, the Ancillary Documents, or the transactions contemplated hereby or thereby, or the Acquired Assets in the case of MII
Life or the Units in the case of Aware, and hereby disclaim all liability and responsibility for any statement or information made, communicated
or furnished (orally or in writing) to Buyer, other than in this Agreement or the Ancillary Documents, including without limitation any
opinion, information, projection, or advice that may have been or may be provided to Buyer by such Seller in anticipation of the transactions
contemplated hereby or thereby, including any information, documents or material made available by such Seller to Buyer in connection
with Buyer&rsquo;s due diligence process. Buyer expressly acknowledges and agrees that Buyer is not relying on any other representations
or warranties of such Seller, including the accuracy or completeness of any such other representations and warranties, whether express
or implied. Except as set forth in this Agreement, the Acquired Assets and the Units shall be sold, assigned, transferred, conveyed and
delivered to Buyer on the Closing Date &ldquo;AS IS, WHERE IS&rdquo; without any warranty or recourse whatsoever against such Seller.
SUCH SELLER DOES NOT MAKE AND EXPRESSLY DISCLAIMS, AND BUYER EXPRESSLY WAIVES, ANY WARRANTIES OTHER THAN SUCH SELLER&rsquo;S REPRESENTATIONS
AND WARRANTIES SET FORTH IN THIS AGREEMENT AND IN ANY ANCILLARY DOCUMENT, INCLUDING WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE, REGARDLESS OF WHETHER ORAL OR WRITTEN, EXPRESS OR IMPLIED, OR ALLEGEDLY ARISING FROM ANY USAGE OR ANY TRADE OR FROM ANY COURSE
OF DEALING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
III</B></FONT><U><BR>
<B>REPRESENTATIONS AND WARRANTIES OF BUYER</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To induce Sellers to enter
into this Agreement, Buyer represents and warrants to Sellers as set forth in this <U>Article III</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Organization</B>. Each of Buyer and Guarantor is duly incorporated, legally existing and in good standing under the laws of the
State of Delaware. Each of Buyer and Guarantor has all requisite power and authority to own, operate and lease its properties and assets
and to conduct its business as it is now being conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Due
Authorization</B>. The execution, delivery and performance of this Agreement and the Ancillary Documents, and the consummation of
the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary corporate action in
accordance with Applicable Law and each of Buyer&rsquo;s and Guarantor&rsquo;s Constituent Documents. No additional corporate or
shareholder authorization or consent is required in connection with the execution, delivery and performance by Buyer or Guarantor of
this Agreement or any of the Ancillary Documents to which it is or will become party. This Agreement and the Ancillary Documents to
be executed and/or delivered by Buyer and/or Guarantor pursuant to this Agreement have been duly and validly executed and delivered
by Buyer and/or Guarantor, as applicable, and the obligations of Buyer and/or Guarantor hereunder and thereunder, as applicable,
are, or will be upon such execution and delivery (assuming the due authorization, execution and delivery by Sellers), valid, legally
binding and enforceable against Buyer and/or Guarantor, as applicable, in accordance with their respective terms, except as the
enforceability thereof may be limited by the availability of equitable principles or bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting creditors&rsquo; rights generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Breach</B>. Each of Buyer and Guarantor has full power and authority to otherwise perform its obligations under this Agreement
and the Ancillary Documents to be executed and/or delivered pursuant hereto. The execution and delivery of this Agreement, and the Ancillary
Documents and the consummation of the transactions contemplated hereby and thereby by each of Buyer and Guarantor will not: (a) violate
any provision of Buyer&rsquo;s and/or Guarantor&rsquo;s Constituent Documents, (b) violate any Applicable Laws or Order applicable to
Buyer and/or Guarantor, (c) except for applicable requirements of the HSR Act, require of Buyer and/or Guarantor any filing with, Permit
from, authorization, consent or approval of, or the giving of any notice to, any Person or (d) result in a violation or breach of, or
constitute (with or without due notice or lapse of time or both) a default (or give another Party any rights of termination, cancellation
or acceleration) under any of the terms, conditions or provisions of any note, bond, mortgage, indenture, license, franchise, Permit (including
but not limited to, any Permits, approvals or authorizations of any Governmental Body), lease, employee benefit plan or other Contract
to which Buyer and/or Guarantor is a party, or by which Buyer and/or Guarantor may be bound, in each case of the foregoing clause (d),
so as to have a material adverse&nbsp;effect on the ability of Buyer and/or Guarantor to consummate the transactions contemplated by this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Brokers</B>. Neither Buyer nor Guarantor has employed or engaged any broker, finder, agent, banker or third Person, nor has either
of them otherwise dealt with anyone purporting to act in the capacity of a finder or broker in connection with the transactions contemplated
hereby, in each case for which Sellers could become liable or obligated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Litigation</B>. There is no Proceeding pending against or by Buyer or Guarantor which, if adversely determined, could reasonably
be expected to impair the ability of Buyer or Guarantor to perform its obligations hereunder in any material manner, and to the Knowledge
of Buyer, no such Proceeding is or has been threatened against Buyer or Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Sufficiency of Funds</B>. At the Closing, Buyer will have sufficient cash on hand or other sources of immediately available funds
to enable it to make payment of the Consideration and consummate the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>No
Other Representations and Warranties</B>. Except with respect to the representations and warranties of Buyer set forth in this
Agreement or the Ancillary Documents, Buyer makes no guarantees, representations or warranties to Sellers in connection with this
Agreement, the Ancillary Documents, or the transactions contemplated hereby or thereby, and hereby disclaims all liability and
responsibility for any statement or information made, communicated or furnished (orally or in writing) to either Seller, other than
in this Agreement or the Ancillary Documents, including without limitation any opinion, information, projection, or advice that may
have been or may be provided to either Seller by Buyer in anticipation of the transactions contemplated hereby or thereby, including
any information, documents or material made available by Buyer to either Seller. Each Seller expressly acknowledges and agrees that
such Seller is not relying on any other representations or warranties of Buyer, including the accuracy or completeness of any such
other representations and warranties, whether express or implied. BUYER DOES NOT MAKE AND EXPRESSLY DISCLAIMS, AND EACH SELLER
EXPRESSLY WAIVES, ANY WARRANTIES OTHER THAN BUYER&rsquo;S REPRESENTATIONS AND WARRANTIES SET FORTH IN THIS AGREEMENT AND IN ANY
ANCILLARY DOCUMENT, INCLUDING WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, REGARDLESS OF WHETHER ORAL OR
WRITTEN, EXPRESS OR IMPLIED, OR ALLEGEDLY ARISING FROM ANY USAGE OR ANY TRADE OR FROM ANY COURSE OF DEALING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
IV</B></FONT><U><BR>
<B>PRE-CLOSING COVENANTS</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Parties agree as follows
with respect to the period between the execution of this Agreement and the Closing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>General</B>. Each of the Parties will use commercially reasonable efforts to take all action and to do all things necessary, proper
or advisable to consummate and make effective the transactions contemplated by this Agreement (including satisfaction, but not waiver,
of the closing conditions set forth in <U>Article V</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Third Person Notices and Consents.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to Section 4.2(d), Sellers will give any notices to third Persons and use commercially reasonable efforts to obtain those
third Person consents and approvals, in each case in form and substance acceptable to Buyer, that are necessary under any of the Assumed
Contracts or Applicable Law to transfer any of the Acquired Assets and to consummate the transactions contemplated by this Agreement,
it being understood that (i) Sellers shall not be required to pay any material fee or payment or make any concession to any third party
in order to obtain any such consent or amendment and (ii) Sellers delivery to Buyer of only those consents and approvals set forth on
<B><U>Schedule 5.1(c)</U></B> shall be a condition to Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Governmental Body Notices and Consents</B>. In furtherance and not in limitation of the foregoing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Buyer
and each Seller agrees to make its respective required filings, notices, or requests for consent and approval to any Governmental
Body as necessary, proper or advisable under Applicable Law to consummate the transactions contemplated by this Agreement (the
 &ldquo;<B>Governmental Body Consents</B>&rdquo;) within ten (10) Business Days after the date hereof. Buyer, on the one hand, and
Sellers, on the other hand, shall supply as promptly as practicable any additional information or documentation with respect to such
Party or any of its officers, directors, members, partners, shareholders, employees or contractors that may be reasonably requested
by any other Party in connection with obtaining any of the Governmental Body Consents. In no event, however, shall Sellers be
obligated to pay any money (other than immaterial administrative and/or legal costs and expenses) to any Person or offer or grant
financial or other accommodations to any Person in connection with obtaining any such consents and approvals. Buyer and Sellers
shall file additional information requested by any Governmental Body in connection with the Governmental Body Consents within ten
(10) Business Days of such request for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Buyer, on the one hand, and Sellers, on the other hand, shall, in connection with the actions referenced in Section <FONT STYLE="font-size: 10pt"><I>&#8206;</I></FONT>4.2(b)(i),
(A)&nbsp;cooperate with each other in connection with any communication, filing or submission to any Governmental Body, (B)&nbsp;keep
the other Party and/or its counsel informed of any communication received by such Party from, or given by such Party to, any Governmental
Body, in each case regarding any of the transactions contemplated by this Agreement, and (C)&nbsp;permit the other Party and/or its counsel
to review and comment on in advance any submission, filing or communication (and documents submitted therewith) intended to be given by
it to, and consult with each other in advance of any meeting or conference with, any Governmental Body, and to the extent permitted by
such Governmental Body, give each Party and/or its counsel the opportunity to attend and participate in such meetings and conferences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting the foregoing or the obligations set forth in Section &#8206;9.3, to the extent required by any Governmental Body,
Buyer shall use commercially reasonable efforts to take, or cause to be taken, all appropriate action, and to do, or cause to be done,
all things necessary, proper or advisable to obtain all consents, registrations, approvals, permits and authorizations necessary under
the HSR Act or any similar or related law to consummate and make effective the transactions contemplated by this Agreement; provided,
however, in no event shall Buyer be required to make any divestitures, licenses, hold separate arrangements or similar matters in order
to obtain approval of the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Communications with Customers of the Spending Account Business</B>. MII Life and Buyer shall develop a mutually acceptable joint
communication plan (the &ldquo;<B>Communication Plan</B>&rdquo;) (i) to educate MII Life&rsquo;s Spending Account Business customers (e.g.,
Account holders, employers that are parties to Employer Agreements, and health plans that are parties to Health Plan Agreements) about
the benefits of the Accounts that will be available from Buyer or its Affiliates to such customers as of the Closing, (ii) to inform such
customers, as applicable, of the resignation of MII life as custodian of the Purchased Accounts and the appointment of Buyer or its Affiliate
as successor custodian of the Purchased Accounts and (iii) to distribute Buyer&rsquo;s (or any Affiliate thereof) form HSA custodial agreement
and other account documentation to holders of Purchased Accounts, provided that any reasonable and documented out-of-pocket expenses incurred
by MII Life in connection with this Section 4.2(d) shall be borne solely by Buyer. All such mutually acceptable written communications
relating to the transactions contemplated by this Agreement shall be sent by MII Life to its Spending Account Business customers no earlier
than ten (10) Business Days after delivery of drafts thereof to Buyer for Buyer&rsquo;s review and comment, unless earlier agreed upon
by Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B>Appointment
as Successor Custodian and Account Holder Notices</B>. Subject to Section 4.2(d), within five (5) Business Days after the
Communication Plan has been mutually agreed upon (or another date as mutually agreed upon between MII Life and Buyer), MII Life
shall, in accordance with the terms of its HSA custodial agreements, cause notice (in a form mutually acceptable to Sellers and
Buyer, including by physical mail to the extent requested by Buyer) to be sent to each Purchased Account holder informing such
Purchased Account holder of the resignation of MII Life as custodian of the Purchased Accounts and the appointment of Buyer (or its
Affiliate) as successor custodian of the Purchased Accounts, in each case effective as of the Closing Date (the
 &ldquo;<B>Resignation Notices</B>&rdquo;). Buyer (or its Affiliate) agrees to accept such appointment as successor custodian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Split-Segment; Name: 4 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Employer Agreements Notices</B>. Subject to Section 4.2(d), within ten (10) Business Days after the date hereof, MII Life shall
cause written notice (in a form mutually acceptable to Sellers and Buyer) to be sent to each employer party to an Employer Agreement listed
on Section 2.11(b) of the Disclosure Schedules and each health plan party to a Health Plan Agreement requesting consent of such employer
or health plan, as the case may be, to the assignment of such Employer Agreement or Health Plan Agreement from MII Life to Buyer, in each
case effective as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Operation of Business</B>. MII Life will use reasonable best efforts to keep its Spending Account Business and the Acquired Assets
intact. With respect to its Spending Account Business, MII Life will not engage in any practice, take any action or enter into any transaction
outside the Ordinary Course of Business other than the transactions contemplated by this Agreement or any actions necessary to implement
a &ldquo;quiet period&rdquo; prior to Closing (solely to the extent such &ldquo;quiet period&rdquo; is mutually agreed between Sellers
and Buyer) during which Account holders will not be able to make deposits or withdrawals without the prior written consent of Buyer. Aware
will use reasonable best efforts to cause SamCo to keep its operations intact. Aware will cause SamCo to not engage in any practice, take
any action or enter into any transaction outside the Ordinary Course of Business other than the transactions contemplated by this Agreement.
Without limiting the generality of the foregoing, MII Life will not engage in any practice, take any action or enter into any agreement
of the sort described in Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>2.8 without the prior written consent of Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Inspection and Access to Information</B>. MII Life will make available to Buyer and its representatives for inspection and review
in a timely manner all properties, books, records, accounts and documents of or relating to the assets, liabilities or operations of its
Spending Account Business upon reasonable advance notice, at such times as are mutually agreed upon by Buyer and MII Life from time to
time, and permit access (including electronic access) to other third Persons reasonably required for verification of any information so
obtained. Aware will make available to Buyer and its representatives for inspection and review in a timely manner all properties, books,
records, accounts and documents of or relating to the assets, liabilities or operations of SamCo upon reasonable advance notice, at such
times as are mutually agreed upon by Buyer and Aware from time to time, and permit access (including electronic access) to other third
Persons reasonably required for verification of any information so obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Exclusivity</B>.
Until the earlier of the Closing or the termination of this Agreement in accordance with <U>Article VII</U>, each Seller agrees that
neither such Seller, nor any of its controlled Affiliates or any of its or its controlled Affiliates&rsquo; directors, officers,
managers, employees, attorneys, investment bankers, accountants, agents, advisors or other representatives shall, directly or
indirectly, solicit, initiate or engage in (including by way of furnishing information) or participate in any discussions or
negotiations regarding or furnish any action with respect to any negotiations, proposals, or offers of any kind with respect to the
disposition of such Seller or part or all of its Spending Account Business in the case of MII Life or the Units in the case of Aware
(in each case, whether by asset sale, merger, acquisition, business combination, reorganization, recapitalization, unit issuance,
unit issuance, debt or equity investment, consolidation or similar transaction). If a Seller, or any of its Affiliates or any of its
or its Affiliates&rsquo; directors, officers, managers, employees, attorneys, investment bankers, accountants, agents, advisors or
other representatives receives an offer to purchase or acquire (in each case, whether by asset sale, merger, acquisition, business
combination, reorganization, recapitalization, unit issuance, unit issuance, debt or equity investment, consolidation or similar
transaction) all or any part of SamCo, or part or all of MII Life&rsquo;s Spending Account Business, such Seller shall, within five
(5) Business Days of the receipt of such offer, provide written notice of such offer to Buyer along with the details thereof
(including the identity of such Person and copies of any proposals and the specific terms and conditions discussed or proposed).
During the period from the date of this Agreement through the Closing or the earlier termination of this Agreement, Sellers shall
exercise their rights under any confidentiality agreement with any Person (other than Buyer) relating to a proposed transaction to
direct such Person to return or destroy any confidential information of Sellers provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Accrued
Interest on Account Deposits in Purchased Accounts</B>. On the Closing Date, MII Life shall deposit into each Purchased Account all accrued
but previously unpaid interest payable on such Purchased Account through such date (including a prorated amount of interest in the event
the Closing Date occurs mid-month).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B><B><FONT STYLE="font-family: Times New Roman, Times, Serif">Representation
and Warranty Insurance</FONT>. </B>Buyer covenants and agrees that any R&amp;W Insurance Policy, if any, obtained by Buyer in connection
with this Agreement shall expressly require the Insurer to waive any right of subrogation against each Seller, except in cases of fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Termination of Related Party Contracts</B>. Effective as of the Closing, except as set forth on <B><U>Schedule 4.8</U></B>, each
Contract between SamCo or MII Life in respect of its Spending Account Business, on the one hand, and either Seller or any Affiliate of
either Seller, on the other the hand (each, a &ldquo;<B>Related Party Contract</B>&rdquo;), will be automatically terminated and of no
further effect, with no further liability of any party thereto, and Sellers shall execute any and all instruments reasonably requested
by Buyer in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Release</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>In
further consideration of the transactions contemplated hereby, each Seller for itself and on behalf of its controlled Affiliates
hereby irrevocably and unconditionally releases, waives and holds Buyer, SamCo, their respective Affiliates, predecessors and
assigns, and their respective directors (or Persons in similar positions), officers, employees, equityholders and agents harmless
from and against any and all claims of any nature (the &ldquo;<B>Seller Claims</B>&rdquo;), arising from the beginning of the world
to and through the Closing, except for claims that relate to such Seller&rsquo;s rights under this Agreement or any of the other
Ancillary Documents or instruments executed pursuant to this Agreement (the &ldquo;<B>Release</B>&rdquo;). It is further agreed and
understood that this Release is a full and final release of all the Seller Claims whether known or unknown, fixed or contingent,
manifested or unmanifested, except for those exceptions described in the previous sentence. Each Seller hereby waives the protection
of any provision of any Applicable Law that would operate to preserve claims that are unknown as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>By execution and delivery of this Agreement, as of the Closing, Aware, on behalf of itself and its controlled Affiliates and their
respective successors and assigns, hereby ratifies all prior actions of the current and former managers and officers of SamCo, and fully
releases and forever discharges each such manager and officer and his or her respective successors and assigns from any and all claims,
suits, debts and demands whatsoever, whether known or unknown, foreseen or unforeseen, whether at law, in equity or otherwise, which Aware
and its successors and assigns ever had, or now or hereafter may have arising from or relating to such Person&rsquo;s service as a manager
or officer and his or her acts and omissions as such manager or officer (except for fraud or intentional violation of Applicable Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Guarantee.</B> The Guarantor hereby unconditionally and irrevocably guarantees, as primary obligor, to Sellers the payment by Buyer
of all of Buyer&rsquo;s covenants, obligations and agreements set forth in this Agreement, including, without limitation, the obligation
of Buyer to pay the Consideration at the Closing in accordance with the terms herein. The Guarantor hereby waives suretyship defenses,
demand of payment, protest and notice of dishonor or nonperformance of any such guaranteed obligation, and Sellers may institute a legal
proceeding directly against the Guarantor to enforce their rights under this Agreement, without first instituting a legal proceeding against
Buyer. The obligations of the Guarantor hereunder shall terminate, and shall have no further force or effect upon the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
V</B></FONT><U><BR>
<B>CONDITIONS TO OBLIGATIONS TO CLOSE</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Conditions to Obligation of Buyer</B>. The obligation of Buyer to consummate the transactions contemplated by this Agreement is
subject to the satisfaction (or waiver by Buyer in its sole and absolute discretion) of the following conditions on or before the Closing
Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the representations and warranties set forth in <U>&#8206;Article II</U> hereof shall be correct and complete in all material respects
at and as of the Closing Date as though then made and as though the Closing Date had been substituted for the date of this Agreement throughout
such representations and warranties (other than representations and warranties that are qualified by materiality, Material Adverse Effect,
or similar qualifications, which shall be correct and complete in all respects), except that any such representation or warranty made
as of a specified date (other than the date hereof) shall only need to have been correct and complete on and as of such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Sellers shall have performed in all material respects all of the covenants and agreements required to be performed and complied
with by them under this Agreement prior to the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Sellers shall have delivered to Buyer all consents and approvals, if any, set forth on <B><U>Schedule 5.1(c)</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Sellers
shall have delivered to Buyer evidence reasonably satisfactory to Buyer of the release of all Encumbrances related to the Acquired Assets
and the Units (other than Encumbrances solely attributable to Assumed Liabilities);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>no Proceeding shall be pending or threatened before any Governmental Body wherein an unfavorable Order would (i) prevent consummation
of any of the transactions contemplated by this Agreement or (ii) cause any of the transactions contemplated by this Agreement to be rescinded
following consummation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there shall have been no Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Sellers
shall have delivered to Buyer certificates from the Secretary of State of the state of (i) each Seller&rsquo;s jurisdiction of formation,
confirming that such Seller is in good standing in such state, and (ii) SamCo&rsquo;s jurisdiction of formation confirming that SamCo
is in good standing in such state;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Sellers and/or their applicable Affiliates shall have executed and delivered to Buyer each and all of the following, in each case,
in form and substance reasonably satisfactory to Buyer:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a
bill of sale (the &ldquo;<B>Bill of Sale</B>&rdquo;) and such other instruments of sale, transfer, conveyance and assignment as Buyer
and its counsel may reasonably request in order to consummate the transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>an
assignment and assumption agreement (the &ldquo;<B>Assignment and Assumption Agreement</B>&rdquo;) and such other instruments of assignment
as Buyer and its counsel may reasonably request in order to consummate the transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>an
employer group spending account services agreement substantially in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Services
Agreement</B>&rdquo;) by and between Buyer and BCBSM;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a
spending account distribution partnership agreement substantially in the form attached hereto as <B><U>Exhibit B</U></B> (the &ldquo;<B>Distribution
Partnership Agreement</B>&rdquo;) by and between BCBSM and Buyer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>an
intellectual property assignment agreement pursuant to which Sellers will assign, transfer and convey the Acquired IP to Buyer (the &ldquo;<B>Intellectual
Property Assignment Agreement</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a
bring down certificate of an officer of each Seller;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a copy of the resolutions adopted by each Seller&rsquo;s governing body authorizing the execution of this Agreement, the Ancillary
Documents and the consummation of the transactions contemplated herein and therein certified as of the date hereof, and signed by the
secretary of such Seller;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>resignation
and release of claims letters, duly executed by each officer and director of SamCo; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such
other documents or instruments as Buyer may reasonably request to effect the transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>MII Life and/or its applicable Affiliates shall have executed and delivered to Buyer a transition services agreement with Buyer
substantially in the form attached hereto as <B><U>Exhibit C</U></B> (the &ldquo;<B>Transition Services Agreement</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>MII
Life shall have executed and delivered to Buyer a trademark assignment agreement for the assignment of the Trademark registrations and
applications included in the Acquired IP (the &ldquo;<B>Trademark Assignment Agreement</B>&rdquo;), and such other instruments of assignment
as Buyer and its counsel may reasonably request in order to consummate the transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Sellers shall have delivered evidence, in form and substance reasonably satisfactory to Buyer, of the assignment from MII Life
to SamCo of all Assumed Contracts to which MII Life is a party that (i) freely permit MII Life to assign such Assumed Contract to SamCo
and (ii) would not require third-party consent upon a change of control of SamCo, in each case in full compliance with the terms of the
applicable Assumed Contract;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Aware shall have executed and delivered to Buyer a unit transfer power in form and substance mutually agreeable to the Parties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all filings required pursuant to the HSR Act with respect to the transactions contemplated herein shall have been made and any
approvals required thereunder shall have been obtained or the applicable waiting period required thereby shall have expired or have been
terminated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the resignation of MII Life as custodian of the Purchased Accounts shall have become effective in accordance with the terms of
the custodial agreements governing each of the Purchased Accounts; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
transfer of the Final Accountholder Cash Deposits and Final Accountholder Investment Assets to Buyer&rsquo;s designee in accordance with
the terms of this Agreement, including <B><U>Schedule A</U></B>, shall have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Conditions to Obligation of Sellers</B>. The obligation of Sellers to consummate the transactions contemplated by this Agreement
is subject to the satisfaction (or waiver by Sellers in their sole and absolute discretion) of the following conditions on or before the
Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> the representations and warranties set forth in <U>&#8206;Article III</U> hereof shall be correct and complete in all material
respects at and as of the Closing Date as though then made and as though the Closing Date had been substituted for the date of this Agreement
throughout such representations and warranties (other than representations and warranties that are qualified by materiality, Material
Adverse Effect, or similar qualifications, which shall be correct and complete in all respects), except that any such representation or
warranty made as of a specified date (other than the date hereof) shall only need to have been correct and complete on and as of such
date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Buyer shall have performed in all material respects all of the covenants and agreements required to be performed and complied with
by it under this Agreement prior to the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>no Proceeding shall be pending or threatened before any Governmental Body wherein an unfavorable Order would (i) prevent consummation
of any of the transactions contemplated by this Agreement, or (ii) cause any of the transactions contemplated by this Agreement to be
rescinded following consummation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Buyer shall have delivered to Sellers a certificate from the Secretary of State of its jurisdiction of formation confirming that
Buyer is in good standing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all filings required pursuant to the HSR Act and any similar or related Law with respect to the transactions contemplated herein
shall have been made and any approvals required thereunder shall have been obtained or the applicable waiting period required thereby
shall have expired or have been terminated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
resignation of MII Life as custodian of the Purchased Accounts shall have become effective in accordance with the terms of the custodial
agreements governing each of the Purchased Accounts; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&#8239;(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Buyer shall have executed and delivered to Sellers each and all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the Bill of Sale;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Assignment and Assumption Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Services Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Distribution Partnership Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the Transition Services Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Trademark Assignment Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the Intellectual Property Assignment Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a bring down certificate of an officer of Buyer in form and substance reasonably satisfactory to Sellers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the R&amp;W Insurance Policy, if any, duly executed by the underwriter thereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such
other documents or instruments as Sellers may reasonably request to effect the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
VI</B></FONT><U><BR>
<B>SURVIVAL; INDEMNIFICATION</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Non-survival of Representations and Warranties</B>. The representations and warranties made by Sellers in this Agreement or in
any certificate delivered by Sellers pursuant to this Agreement shall expire and be of no further force and effect as of the Closing.
From and after the Closing, except in the event of fraud, Buyer&rsquo;s sole and exclusive recourse and remedy for the inaccuracy or breach
of a representation or warranty made by Sellers in this Agreement or in any certificate delivered by Sellers pursuant to this Agreement
shall be to assert a claim under the R&amp;W Insurance Policy, if any. After the Closing, except in the event of fraud, Buyer may not
bring a claim against Sellers for the inaccuracy or breach of a representation or warranty made by Sellers in this Agreement or in any
certificate delivered by Sellers pursuant to this Agreement. The representations and warranties made by Buyer in this Agreement or in
any certificate delivered by Buyer pursuant to this Agreement shall expire and be of no further force and effect as of the Closing. After
the Closing, except in the event of fraud, Sellers may not bring a claim against Buyer for the inaccuracy or breach of a representation
or warranty made by Buyer in this Agreement or in any certificate delivered by Buyer pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><B><FONT STYLE="font-family: Times New Roman, Times, Serif">Survival of Covenants</FONT>. </B>None of the covenants or other
agreements contained in this Agreement shall survive the Closing Date other than those which by their terms contemplate performance after
the Closing Date, and each such surviving covenant and agreement shall survive the Closing for the period contemplated by its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indemnification by Sellers</B>. Subject to the limitations set forth in this Agreement, including the limitations set forth in
Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>6.5, Sellers jointly and severally agree to indemnify in full, defend and hold harmless
Buyer, Buyer&rsquo;s Affiliates and their respective directors, officers, managers, employees, agents and owners (collectively, the &ldquo;<B>Buyer
Indemnified Parties</B>&rdquo;) from and against any loss, Liability, Tax, settlement payment, award, judgment, fine, penalty, deficiency,
damage, cost or expense (including arbitration fees or costs, witness fees, and reasonable fees and disbursements of legal counsel), including
any of the foregoing relating to, resulting from or arising out of any action, suit, administrative proceeding, investigation, defense,
audit or other Proceeding brought by any Person and any settlement or compromise thereof, but excluding, except to the extent payable
to a third party, consequential, special, indirect, and punitive damages (collectively, &ldquo;<B>Losses</B>&rdquo;) in connection with,
arising from or as a result of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any breach of, or failure to perform, any agreement or covenant of Sellers contained in this Agreement or any of the Ancillary
Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> any fraud by Sellers or their Affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Excluded Asset or Excluded Liability; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Taxes of SamCo for Pre-Closing Tax Periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.5pt">All indemnification rights
hereunder shall survive the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby, regardless
of any investigation, inquiry or examination made for or on behalf of, or any Knowledge of, Buyer and/or any of the other Buyer Indemnified
Parties or the acceptance by Buyer of any certificate or opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indemnification by Buyer</B>. Subject to the limitations set forth in this Agreement, including the limitations set forth in Section
<FONT STYLE="font-size: 13pt">&#8206;</FONT>6.5, Buyer agrees to indemnify in full, defend and hold harmless Sellers, their respective
entity Affiliates and their respective directors, officers, managers, employees, agents and owners (collectively, the &ldquo;<B>Seller
Indemnified Parties</B>&rdquo;) against any Losses in connection with, arising from or as a result of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
breach of, or failure to perform, any agreement or covenant of Buyer contained in this Agreement or the Ancillary Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any fraud by Buyer or its Affiliates; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Assumed Liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><B><FONT STYLE="font-family: Times New Roman, Times, Serif">Indemnity as Sole Recourse</FONT></B>. Without limiting the survival
provisions set forth in Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>6.1, the Parties acknowledge and agree that their sole and
exclusive post-Closing remedy with respect to any and all claims (other than claims arising from fraud) for any breach of any representation,
warranty, covenant, agreement or obligation set forth herein or otherwise relating to the subject matter of this Agreement, shall be pursuant
to the indemnification provisions set forth in this <FONT STYLE="font-size: 13pt"><U>&#8206;</U></FONT><U>Article VI</U>. In furtherance
of the foregoing, each Party hereby waives, to the fullest extent permitted under Law, any and all post-Closing rights, claims and causes
of action for any breach of any representation, warranty, covenant, agreement or obligation set forth herein or otherwise relating to
the subject matter of this Agreement it may have against the other Parties and their Affiliates and each of their respective representatives
arising under or based upon any Applicable Law, except in the event of fraud or pursuant to the indemnification provisions set forth in
this <FONT STYLE="font-size: 13pt"><U>&#8206;</U></FONT><U>Article VI</U>. Nothing in this <FONT STYLE="font-size: 13pt"><U>&#8206;</U></FONT><U>Article
VI</U> shall limit any Person&rsquo;s right to (a) seek and obtain any injunctive relief to which any Person shall be entitled, or (b)
assert claims otherwise allowed against the R&amp;W Insurance Policy, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Method of Asserting Claims</B>. As used herein, an &ldquo;<B>Indemnified Party</B>&rdquo; shall refer to a Buyer Indemnified Party
or a Seller Indemnified Party, as applicable, and the &ldquo;<B>Indemnifying Party</B>&rdquo; shall refer to the Party or Parties obligated
to indemnify such Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>In
the event that any Indemnified Party receives notice of the assertion or commencement of any Proceeding made or instituted by any
third party (any such third party Proceeding being referred to as a &ldquo;<B>Claim</B>&rdquo;) against such Indemnified Party with
respect to which the Indemnifying Party is or may be obligated to provide indemnification under this Agreement, then such
Indemnified Party shall give the Indemnifying Party prompt written notice thereof. The failure to give such notice shall not relieve
the Indemnifying Party of its indemnification obligations hereunder, except and only to the extent that the Indemnifying Party
forfeits material rights or defenses by reason of such failure. The Indemnifying Party shall be entitled to contest and assume the
defense of such Claim at the Indemnifying Party&rsquo;s sole expense, provided, that the Indemnifying Party (i)&nbsp;has a
reasonable basis for concluding that such defense may be successful, (ii) diligently contests and defends such Claim, and (iii)
agrees in writing to indemnify the Indemnified Party with respect to all Losses arising from such Claim. Notice of the intention to
contest and assume the defense of such Claim shall be given by the Indemnifying Party to the Indemnified Party within ten (10) days
after the Indemnified Party&rsquo;s notice of such Claim (but, in any event, at least five (5) Business Days prior to the date that
an answer to such Claim is due to be filed). Such contest and defense shall be conducted by reputable attorneys reasonably
acceptable to the Indemnified Party employed by the Indemnifying Party at the Indemnifying Party&rsquo;s sole cost and expense. If
the Indemnifying Party fails to give such notice or assume such defense, then the Indemnified Party shall be entitled to undertake
such defense and seek indemnification from the Indemnifying Party for any and all Losses based upon, arising from or relating to
such Claim. If the Indemnifying Party elects to contest and assume the defense of a Claim, the Indemnified Party shall be entitled
at any time, at its own cost and expense (which expense shall not constitute a Loss unless the Indemnified Party reasonably
determines that the Indemnifying Party is not adequately representing or, because of a conflict of interest, may not adequately
represent, any interests of the Indemnified Party), to participate in such contest and defense and to be represented by attorneys of
its or their own choosing. Notwithstanding the foregoing, if (A)&nbsp;a Claim involves criminal liability, seeks equitable relief or
any non-monetary remedy or award, (B) the subject matter of a Claim relates to the ongoing business of any of the Indemnified
Parties, (C) the Indemnifying Party fails to provide the Indemnified Party with reasonable assurance of the Indemnifying
Party&rsquo;s financial capacity to diligently defend such Claim, or (D) the conduct of the defense of the Claim by the Indemnifying
Party could reasonably be expected to prejudice the rights or obligations of the Indemnified Party, then, in each such case, the
Indemnified Party alone shall be entitled to contest, defend and settle such Claim in the first instance and, if the Indemnified
Party does not contest, defend or settle such Claim, the Indemnifying Party shall then have the right to contest and defend (but not
settle) such Claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Indemnifying Parties and the Indemnified Parties shall cooperate with each other in all reasonable respects in connection with
the defense of any Claim, including making available (subject to the provisions of Section &#8206;9.2 of this Agreement, records relating
to such Claim, and furnishing, without expense (other than reimbursement of actual out-of-pocket expenses)) to the defending party the
representatives of the non-defending party as may be reasonably necessary for the preparation of the defense of such Claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Indemnified Party nor the Indemnifying Party may concede, settle or compromise any Claim without the consent of the
other party, which consent will not be unreasonably withheld or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> If any Indemnified Party has a claim which does not result from a Claim, the Indemnified Party shall deliver a notice of such
claim to the Indemnifying Party, setting forth in reasonable detail the identity, nature and estimated amount of Losses (if reasonably
determinable) related to such claim or claims, with reasonable promptness and in all events prior to the expiration of the Indemnifying
Party&rsquo;s indemnification obligation hereunder. The failure to give such prompt written notice shall not, however, relieve the Indemnifying
Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason
of such failure. The Indemnifying Party shall have fifteen (15) days after its receipt of such notice to respond in writing to such claim.
If the Indemnifying Party does not so respond within such fifteen (15) day period, the Indemnifying Party shall be deemed to have accepted
such claim, in which case the Indemnified Party shall be entitled to indemnification in the amount of such Claim, subject to the terms
and conditions of this Agreement. If a timely objection is made in writing in accordance with this Section &#8206;6.6(d), the Indemnified
Party shall have fifteen (15) days to respond in a written statement to the objection. If, after such fifteen (15) day period, there remains
a dispute as to the claim, the Parties shall attempt in good faith for thirty (30) days to agree upon the rights of the Parties with respect
to each claim before pursuing any other remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Limitations on Indemnification</B>. Except with respect to Losses due to fraud, the aggregate indemnification obligations of the
Indemnifying Parties under Section&nbsp;6.3 or Section 6.4 shall not exceed an amount equal to the Consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Adjustments to Consideration. </B>Any indemnification payable under this <FONT STYLE="font-size: 13pt"><U>&#8206;</U></FONT><U>Article
VI</U> shall be, to the extent permitted by Applicable Law, an adjustment to the Consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
VII</B></FONT><U><BR>
<B>TERMINATION</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Termination</B>. The Parties may terminate this Agreement as provided below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Buyer and Sellers may terminate this Agreement by mutual written consent at any time prior to the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by Sellers or Buyer if there shall be in effect a final, nonappealable Order of a Governmental Body prohibiting or permanently
enjoining the consummation of the transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>at
the election of Sellers or Buyer on or after September 15, 2021 (the &ldquo;<B>End Date</B>&rdquo;); <U>provided</U>, that neither Sellers
nor Buyer may terminate this Agreement pursuant to this Section 7.1(c) if it is in breach of any of its obligations hereunder and such
breach causes, or results in, either (i) the failure to satisfy the conditions to the obligations of the terminating party to consummate
the transaction set forth in <U>Article V</U> prior to the End Date, or (ii) the failure of the Closing to have occurred prior to the
End Date; <U>provided</U>, <U>further</U>, that no Party shall have the right to terminate this Agreement pursuant to this Section 7.1(c)
in the event any other Party has initiated proceedings to specifically enforce this Agreement while such proceedings are still pending;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Buyer may terminate this Agreement by giving written notice to Sellers at any time prior to the Closing (i) in the event a Seller
has breached any representation, warranty or covenant contained in this Agreement in any material respect, Buyer has notified Sellers
of the breach, and, if susceptible to cure, the breach has continued without cure for a period of ten (10) Business Days after the notice
of breach, or (ii) if the Closing shall not have occurred on or before the End Date by reason of the failure of any condition precedent
under Section &#8206;5.1 hereof (unless the failure of Closing to be consummated by the End Date results primarily from Buyer itself breaching
any representation, warranty, or covenant contained in this Agreement); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Sellers may terminate this Agreement by giving written notice to Buyer at any time prior to the Closing (i) in the event Buyer
has breached any representation, warranty or covenant contained in this Agreement in any material respect, Sellers have notified Buyer
of the breach, and, if susceptible to cure, the breach has continued without cure for a period of ten (10) Business Days after the notice
of breach or (ii) if the Closing shall not have occurred on or before the End Date by reason of the failure of any condition precedent
under Section &#8206;5.2 hereof (unless the failure of Closing to be consummated by the End Date results primarily from a Seller themselves
breaching any representation, warranty or covenant contained in this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Effect of Termination</B>. If any Party terminates this Agreement pursuant to Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>7.1,
this Agreement will become void and have no effect, and no Party will have any Liability or any further obligation to any other Party,
except as provided in this Section 7.2. The obligations of the Parties to this Agreement under <FONT STYLE="font-size: 13pt">&#8206;</FONT><U>Article
VI</U> (Survival; Indemnification), <FONT STYLE="font-size: 13pt"><U>&#8206;</U></FONT><U>Article IX</U> (Miscellaneous) and this Section
7.2 shall survive any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
VIII</B></FONT><U><BR>
<B>POST-CLOSING COVENANTS</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Agreement Not to Compete or Solicit by Sellers and their Affiliates</B>. Each Seller, for itself and on behalf of its controlled
Affiliates, hereby acknowledges and agrees that Buyer and its Affiliates are entitled to protect and preserve the going concern value
of its Spending Account Business and the Acquired Assets in the case of MII Life, and SamCo in the case of Aware, and that Buyer would
not have entered into this Agreement absent the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Non-Compete and Non-Solicitation for Sellers and their Affiliates</B>. For a period of seven (7) years from and after the Closing
Date, each Seller will not, and will cause each of its controlled Affiliates not to (other than on behalf of Buyer or its Affiliates),
directly or indirectly, or individually or collectively, whether as a consultant, agent, shareholder, owner, partner, director, officer,
principal, member, employee, or in any other capacity or manner whatsoever, anywhere in the United States of America, do any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>engage
in or assist others in engaging in a business competitive with the Spending Account Business as it exists as of the Closing (the &ldquo;<B>Restricted
Business</B>&rdquo;); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>contact or solicit any of Buyer&rsquo;s customers, clients, accounts or vendors obtained in connection with the transactions contemplated
by this Agreement (each, a &ldquo;<B>Restricted Party</B>&rdquo;) for the purposes of developing a business relationship with such Restricted
Party that would reasonably be expected to adversely interfere with such Restricted Party&rsquo;s relationship with the Restricted Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">provided, that this
Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>8.1 shall not prohibit, prevent or restrict
a Seller or any of its controlled Affiliates from (x) acquiring any Person who engages in the Restricted Business if the Restricted Business
does not constitute a material portion of such Person&rsquo;s business at the time of acquisition or (y) cooperating with any Restricted
Party as permitted under Section 5 of the Distribution Partnership Agreement; provided, further, that in the event the Distribution Partnership
Agreement is terminated prior to the seven (7) year anniversary of the Closing Date, the restrictions in this Section 8.1(a) shall expire
after the later of (I) the five (5) year anniversary of the Closing Date, and (II) the date on which the Distribution Partnership Agreement
is terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For a period of three (3) years from and after the Closing Date, each Seller will not, and will cause each of its controlled Affiliates
not to (other than on behalf of Buyer or its Affiliates), directly or indirectly, on its own behalf or on behalf of any third party, solicit
for hire or hire any Offered Employee other than such Persons set forth on <U>Schedule 8.1(b)</U>, without the prior written consent of
Buyer (which consent may be withheld in Buyer&rsquo;s sole and absolute discretion). Notwithstanding the foregoing, (A) neither the placement
of general advertisements or conducting general searches that may be targeted to a particular geographic or technical area, nor the hiring
of any person who responds to such general advertisement or general search and (B) neither the solicitation nor the hiring of any Offered
Employee who has been terminated by Buyer, in either case described in clauses (A) or (B) shall be deemed to be a breach of this <U>Section
8.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B>Acknowledgment</B>.
The restrictive covenants contained in this Section &#8206;8.1 are covenants independent of any other provision of this Agreement
and the existence of any claim that a Seller or a Seller Indemnified Party may allege against Buyer or any of its Affiliates,
whether based on this Agreement or otherwise, will not prevent the enforcement of the covenants in this Section &#8206;8.1. Each
Seller, for themselves and on behalf of their controlled Affiliates, agree that Buyer and its Affiliates will be entitled to an
injunction to prevent actual or threatened breaches of the provisions of this Section &#8206;8.1 and to enforce specifically the
terms and provisions hereof, in addition to any other remedy to which Buyer or its Affiliates may be entitled at law or in equity.
In the event of litigation regarding the covenants in this Section &#8206;8.1, the prevailing party in such litigation will, in
addition to any other remedies the prevailing party may obtain in such litigation, be entitled to recover from the other party its
reasonable legal fees and out of pocket costs incurred by such party in enforcing or defending its rights hereunder. To
 &ldquo;prevail&rdquo; hereunder will be determined by the trier of fact in such matter. The length of time for which the covenants
in this Section &#8206;8.1 will be in force will include (and will be extended for) any period of violation or any other period
required for litigation during which Buyer or its Affiliates seeks to enforce covenants in this Section &#8206;8.1. Each Seller, for
themselves and on behalf of their controlled Affiliates, acknowledge and agree that the provisions of this Section &#8206;8.1 are no
greater than necessary to protect Buyer&rsquo;s and its Affiliates&rsquo; legitimate interests in the Spending Account Business, and
covenants, for themselves and on behalf of their controlled Affiliates, not to agree or argue to the contrary. If a court of
competent jurisdiction should conclude that any provision contained herein is too broad or restrictive to be enforceable, then the
Parties agree that the court will have the authority to modify such provision to the minimum extent necessary to make the provision
reasonable and enforceable and, as so modified, the provision shall be fully enforceable. The provisions of this Section &#8206;8.1,
rather than Section &#8206;9.16, shall apply to enforcement of the covenants set forth in this Section &#8206;8.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Split-Segment; Name: 5 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Tax Matters.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Tax Reporting</B>. MII Life shall provide all Tax reporting that it is required to provide under Applicable Law or otherwise
to Purchased Account holders related to the Purchased Accounts for all periods prior to the Closing. Such Tax reporting shall be at MII
Life&rsquo;s sole cost and expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B>Tax
Allocation of Consideration</B>. The Parties agree that the Consideration, and any other amount treated as consideration for U.S.
federal income Tax purposes, that is apportioned between the Acquired Assets and the Units pursuant to Section 1.8 will be allocated
among the Acquired Assets and the assets of SamCo in accordance with Section 1060 of the Code and the Regulations promulgated
thereunder (the &ldquo;<B>Proposed Allocation</B>&rdquo;). The Proposed Allocation will be prepared in accordance with the
methodology set forth on <B><U>Exhibit D</U></B> hereto. The Proposed Allocation will be delivered by Buyer to Sellers within sixty
(60) days after the Closing Date. Buyer and Sellers will work in good faith to resolve any disputes relating to the Proposed
Allocation within ten (10) days after the delivery of the Proposed Allocation to Sellers. If Buyer and Sellers do not reach an
agreement within such period, the dispute will be submitted to an independent public accounting firm which is mutually agreeable to
Buyer and Sellers (the &ldquo;<B>Independent Accountants</B>&rdquo;) for resolution applying the principles, policies and practices
referred to in this Section 8.2. If issues are submitted to the Independent Accountants for resolution, (i) Sellers and Buyer shall
furnish or cause to be furnished to the Independent Accountants such work papers and other documents and information relating to the
disputed issues as the Independent Accountants may request and are available to that Party and its agents and shall be afforded the
opportunity to present to the Independent Accountants any material relating to the disputed issues and to discuss the issues with
the Independent Accountants; and (ii) the determination by the Independent Accountants, as set forth in a notice to be delivered to
Sellers and Buyer within thirty (30) days after the submission to the Independent Accountants of the issues remaining in dispute,
shall be final, binding and conclusive on the Parties. The fees and costs of (A) the Independent Accountants for such determination
and (B) any enforcement of its determination, shall be borne by Sellers on one hand and Buyer on the other hand in inverse
proportion as they may prevail on the matters resolved by the Independent Accountants, which proportionate allocation shall be
calculated on an aggregate basis based on the relative dollar values of the amounts in dispute and shall be determined by the
Independent Accountants at the time of their resolution of the matters in dispute. The Proposed Allocation, as accepted or as
finally agreed or determined, will be the &ldquo;<B>Final Allocation</B>&rdquo; and Buyer and Sellers will prepare and file all
statements, forms, and Tax Returns in a manner consistent with the Final Allocation, and neither Buyer nor Sellers will take a
position that is inconsistent with the Final Allocation before any Governmental Body or in any proceeding relating to Taxes except
as otherwise required by a final determination within the meaning of Section 1313(a) of the Code (or equivalent provision of state,
local, or foreign Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Transfer Taxes</B>. All transfer, documentary, sales, use, registration, value-added and other similar Taxes including, for
the avoidance of doubt, any real property transfer taxes, and related fees (including any penalties, interest and additions to Tax) incurred
in connection with this Agreement and the transactions contemplated hereby shall be paid 50% by Buyer and 50% by Sellers. Sellers and
Buyer shall cooperate in timely making all filings, returns, reports and forms as may be required to comply with the provisions of any
Applicable Law and to the extent any exemptions from such Taxes are available Buyer and Sellers shall cooperate to prepare any certificates
or other documents necessary to claim such exemptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Books and Records</B>. From and after the Closing, each Party shall preserve and keep all Books and Records, Account Information
and Files and other information to the extent relating to the accounting, business and financial affairs of its Spending Account Business
or Acquired Assets in the case of MII Life and SamCo in the case of Aware, that relate to the period prior to the Closing Date, for six
(6) years after the Closing Date or such longer time as required by Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Use of Names</B>. Promptly following the Closing (but no later than thirty (30) days following the Closing), each Seller shall,
and shall cause its controlled Affiliates to, (a) cease and discontinue any and all uses of the Trademarks included in the Owned Intellectual
Property, including any translations thereof or Trademarks confusingly similar thereto, (b) remove, destroy or irrevocably strike over
the labeling, stationery, forms, supplies, displays, advertising and promotional materials, manuals, and other materials existing as of
the Closing Date that bear any such Trademarks, (c) remove all such Trademarks from all assets, websites, email and other online materials
and from all signage and other displays, and (d) change all corporate names (including any applicable Sellers&rsquo; corporate names)
with all applicable Governmental Bodies to corporate names that do not encompass or include any such Trademarks. Neither Seller nor any
of its controlled Affiliates shall seek to register in any jurisdiction any trade, corporate or business name, Trademark or other name
or source identifier that is a derivation, translation, adaptation, combination or variation of, or confusingly similar to, any such Trademarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employee Matters.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Specified Employee Census</B>. Following the date hereof, Sellers shall update the Specified Employee Census periodically prior
to the Closing Date to reflect new hires, leaves of absence, and employment terminations and shall provide a final update of the Specified
Employee Census no later than ten&nbsp;(10) Business Days prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Offers of Employment</B>. Prior to the Closing, Buyer shall, or shall cause one of its Affiliates to, not less than ten (10)
Business Days prior to the Closing Date (or such earlier time as may be required by Applicable Law), extend offers of employment that
are effective as of the Closing Date to each Specified Employee (other than any Inactive Specified Employee or the Specified Employees
identified on <B><U>Schedule&nbsp;8.5(b)</U></B>) listed on the Specified Employee Census (each, an &ldquo;<B>Offeree Employee</B>&rdquo;).
Buyer shall provide Sellers with Buyer&rsquo;s offer letter template for informational purposes only at least three (3) Business Days
prior to extending such offers of employment to the Offeree Employees. All such offers of employment to Offeree Employees shall provide
for employment with Buyer or its Affiliate to commence effective as of the Closing and shall otherwise be on terms acceptable to Buyer,
subject to standard benefits, policies, procedures and employment practices of Buyer. Each Offeree Employee who accepts Buyer&rsquo;s
or its Affiliate&rsquo;s offer of employment and commences employment with Buyer or its Affiliate as described in the immediately following
sentence shall be referred to herein as a &ldquo;<B>Transferred Employee</B>.&rdquo; Except for the outstanding employment offers to
each of the Specified Employees identified on <B><U>Schedule&nbsp;8.5(b)</U></B>, neither Seller nor any of its controlled Affiliates
shall knowingly cause or attempt to cause any Offeree Employee to reject or decline to accept Buyer&rsquo;s or its Affiliate&rsquo;s
offer of employment. Nothing contained in this Agreement shall be construed as an employment contract between Buyer and any Specified
Employee or Transferred Employee. Buyer shall promptly provide Sellers a list of the name of each Offeree Employee that rejects Buyer&rsquo;s
or its Affiliate&rsquo;s offer of employment and the cash salary, annual cash bonus opportunity and health care coverage offered to each
such Offeree Employee, and thereafter Sellers shall, or shall cause their controlled Affiliates to, (i) terminate the employment of each
Offeree Employee who expressly rejects Buyer&rsquo;s offer of employment promptly, but in any event not later than the Closing Date and
(ii) terminate the employment of each Offeree Employee who does not affirmatively accept Buyer&rsquo;s offer of employment, effective
as of the later of ten (10) Business Days following the date of such offer of employment or the Closing Date, except as required under
Section 8.5(c) with respect to Inactive Specified Employees; <U>provided</U>, <U>however</U>, that the foregoing obligations of Sellers
and their controlled Affiliates shall not apply to any Offeree Employee who receives an offer from Buyer or its Affiliate that (x) does
not provide for cash salary and annual cash bonus opportunity that is equal to or greater than such Offeree Employee&rsquo;s cash salary
and annual cash bonus opportunity specified on the Specified Employee Census or (y) does not include health care coverage. From the date
of the execution of this Agreement until the Closing Date, to the extent they remained employed by Sellers or their controlled Affiliates,
Sellers will cause, or will cause their controlled Affiliates to cause, each of the Specified Employees identified on <B><U>Schedule
8.5(b)</U></B> to continue to be engaged in the Spending Account Business in a manner consistent with past practice and to facilitate
the transactions contemplated by this Agreement. Following the Closing Date, to the extent they remain employed by Sellers or their controlled
Affiliates, Sellers will cause, or will cause their controlled Affiliates to cause, each of the Specified Employees on <B><U>Schedule
8.5(b)</U></B> to be available to Buyer and its Affiliates at no cost to provide, on an ad hoc basis, cooperation reasonably requested
by Buyer or its Affiliates to facilitate the transactions contemplated by this Agreement and to provide advice and consultation regarding
the operation of the Spending Account Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B>Special
Provisions for Inactive Specified Employees</B>. With respect to any Specified Employee listed on the Specified Employee Census who
is not actively working on the Closing Date as a result of an approved leave of absence, whether paid or unpaid, including military
leave with reemployment rights under federal law, leave under the Family Medical Leave Act of 1993 and short-term or long-term
disability leave (an &ldquo;<B>Inactive Specified Employee</B>&rdquo;), Buyer shall make an offer of employment in the manner
required by Section&nbsp;8.5(b) to any Inactive Specified Employee who returns to active status within six (6) months following the
Closing Date for a position that is substantially similar to the position held by such Inactive Specified Employee as of the Closing
Date. Unless and until an Inactive Employee returns to active status within such time period and accepts the offer of employment
made by Buyer, the Inactive Employee shall continue to be employed by Sellers or their Affiliates. An Inactive Specified Employee
who accepts the offer of employment in accordance with this Section&nbsp;8.5(c) and actually commences employment with Buyer or its
Affiliate shall be considered a Transferred Employee effective as of 12:01 a.m. Minneapolis time on the date such Inactive Specified
Employee actually commences employment with Buyer or its Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Service Credit</B>. Buyer or its Affiliates, as applicable, shall recognize the service credited to a Transferred Employee as
of the Closing Date to the extent recognized under the Seller Benefit Arrangements for purposes of eligibility or vesting under Buyer&rsquo;s
employee benefits plans, programs, arrangements and policies in which a Transferred Employee may participate, including but not limited
to vacation days and paid time off policies, severance practices, and 401(k) vesting (each, a &ldquo;<B>Buyer Plan</B>&rdquo;); provided
that such service shall not be recognized (i)&nbsp;to the extent that such recognition would result in a duplication of benefits, (ii)&nbsp;with
respect to any plan Buyer or its Affiliates, as applicable, may establish after the Closing for which prior service is not taken into
account for any participant, (iii)&nbsp;with respect to any equity or equity-based compensation plan, program, agreement or arrangement
or (iv)&nbsp;for purposes of benefit accruals under any defined benefit pension plan or retiree health or welfare plan or arrangement.
In addition, Buyer or its Affiliates, as applicable, shall use commercially reasonable efforts to waive any waiting period under any Buyer
Plan. With respect to any welfare benefit plans (within the meaning of Section 3(1) of ERISA) maintained by Buyer or its Affiliates effective
as of the Closing Date in which a Transferred Employee may participate on or after the Closing Date, Buyer shall use commercially reasonable
efforts to (x)&nbsp;cause to be waived any pre-existing condition limitations, (y)&nbsp;give effect in determining deductible and maximum
out-of-pocket limitations to claims incurred and amounts paid by and amounts reimbursed to, such employees with respect to similar plans
maintained by Sellers or their Affiliates prior to the Closing Date and (z)&nbsp;permit those Transferred Employees who are eligible as
of the Closing Date to participate in Buyer&rsquo;s welfare plans to participate as soon as practicable in any applicable welfare plan
of Buyer. As soon as practicable, but in no event later than ten (10) Business Days following the Closing Date, Sellers or Sellers&rsquo;
applicable insurance carrier shall provide Buyer&rsquo;s or its Affiliate&rsquo;s group health plan (in a format usable by Buyer&rsquo;s
applicable insurance carriers) with a report or other documentation setting forth as of the Closing Date all deductibles, co-insurance
and accumulations toward out-of- pocket maximums paid by the Transferred Employees, their spouses, and their dependents for the current
plan year under the Seller Benefit Plans that are employee welfare benefit plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B>COBRA
Continuation Coverage</B>. Sellers agree that Sellers or their Affiliates will be responsible for providing COBRA Continuation
Coverage (and for providing any notices related thereto) attributable to &ldquo;qualifying events&rdquo; with respect to any
Specified Employee who does not become a Transferred Employee and his or her beneficiaries and dependents, whether occurring before,
on or after the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Accrued Vacation; Bonuses</B>. On or as soon as practicable following the Closing Date, but in no event later than the first
regularly scheduled payroll date following the Closing Date, each Seller or its controlled Affiliates shall pay out (i) all accrued but
unused vacation days or paid time-off to Transferred Employees and any retention bonuses set forth on the Specified Employee Census and
(ii) any transaction bonuses. Each Seller or its controlled Affiliates shall also pay out to Transferred Employees a pro-rata portion
of bonuses for the 2021 calendar year (or portion thereof), based on the number of days a Transferred Employee worked for Seller or its
controlled Affiliate, as applicable, during the applicable performance period through the Closing Date, attributable to the Corporate
Incentive Plan (CIP), Long Term Incentive Plan (LTIP), Pay for Performance Plan (PFP) and Sales Incentive Plan (SIP), subject to any required
internal corporate approvals which Sellers shall use commercially reasonable efforts to obtain consistent with the intent of this provision.
Buyer or its Affiliate agrees to provide each Transferred Employee with an initial balance of forty (40) hours of paid time-off effective
as of the commencement of each Transferred Employee&rsquo;s employment with Buyer or its Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Liability</B>. Without limiting the generality of Section 1.3(b), neither Buyer nor any of its Affiliates shall assume or have
any direct or indirect obligation or liability of any nature, whether matured or unmatured, accrued or contingent, due or to become due
or otherwise, with respect to any Excluded Employee Liability (including, for the avoidance of doubt, any Specified Employee&rsquo;s accrued
but unused vacation days or paid time-off) or to any Specified Employee or other present or former employee of Sellers or their respective
Affiliates, or to any dependent, survivor or beneficiary thereof, arising out of or in relation to such Person&rsquo;s employment with
Sellers or their Affiliates or the termination of such employment. In no event shall Buyer or its Affiliates be responsible for severance
payments to any Specified Employee who does not accept Buyer&rsquo;s (or its Affiliate&rsquo;s) offer of employment made pursuant to this
Section&nbsp;8.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Cooperation</B>. Prior to and following the Closing, subject to Applicable Law, each Seller shall, and shall cause its controlled
Affiliates to, cooperate with Buyer and its Affiliates with respect to payroll administration, employee benefit plan administration and
such other integration efforts related to the Specified Employees as reasonably requested by Buyer and its Affiliates, and to provide
to Buyer and its Affiliates, in a timely manner, information that Buyer or its Affiliates may reasonably request prior to and following
the Closing with respect to the terms and conditions of the Specified Employees&rsquo; employment and employee information necessary to
establish payroll and enroll Specified Employees in the Buyer Plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B>Communications</B>.
Prior to the Closing, Sellers and Buyer shall cooperate in good faith to develop appropriate communications to Specified Employees
who are expected to become Transferred Employees regarding the transactions contemplated hereby. Prior to making any written or
broad-based oral communications to the Specified Employees who are expected to become Transferred Employees pertaining to the effect
upon employment, compensation or benefits that will result as a consequence of the transactions, Sellers shall provide Buyer with a
copy of the intended communication, Buyer shall have a reasonable period of time to review and comment on the communication and
Sellers and Buyer shall cooperate in providing any such mutually agreeable communication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Rights</B>. Without limiting Section 9.4, nothing herein expressed or implied shall confer upon any Transferred Employee or
other employee or former employee of Sellers or their Affiliates or legal representatives thereof, any rights or remedies, including right
to employment or continued employment for any specified period, under or by reason of this Agreement. Nothing herein shall be construed
as the creation, amendment or modification of any employee benefit plan, program, arrangement or agreement of Sellers or Buyer or any
of their respective Affiliates or prevent the creation, amendment or termination of any such plan, program, arrangement or agreement.
The Parties acknowledge and agree that all provisions contained in this Section&nbsp;8.5 are included for the sole benefit of the Parties,
and that nothing in this Agreement, whether express or implied, shall create any third party beneficiary or other rights in any other
Person, including any Transferred Employee, Specified Employee, or any dependent or beneficiary thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Amendments to R&amp;W Insurance Policy</B>. In connection with the R&amp;W Insurance Policy, if any, Buyer covenants and agrees
not to, and to ensure that its officers, managers, members, directors, agents and representatives do not, take any action (or omit to
take any action) the effect of which would be to modify the Insurer&rsquo;s waiver of subrogation rights contained in the R&amp;W Insurance
Policy, in a manner adverse to Sellers without the prior written consent of Sellers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> License of Excluded Intellectual Property</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Effective
as of the Closing Date, with respect to any Excluded Intellectual Property used in the Spending Account Business during the twelve
(12) months immediately preceding the date hereof, Sellers do hereby, and shall cause their controlled Affiliates to, grant to Buyer
and its Affiliates a perpetual, irrevocable, worldwide, non-terminable, non-sublicensable (except as set forth within <U>Section
8.7(b)</U>), non-transferable (except as set forth within <U>Section 8.7(c)</U>), non-exclusive, royalty-free, fully paid-up license
to make, have made, use, sell, offer to sell, import, provide, commercialize, practice, copy, perform, display, render, develop,
create derivative works from and otherwise exploit such Excluded Intellectual Property solely in substantially the same manner and
scope such Excluded Intellectual Property was used in connection with the Spending Account Business as conducted during the twelve
(12) months immediately preceding the date hereof, including any natural improvements and extensions to the Spending Account
Business, which license shall survive any transfer, whether in whole or in part, of any such licensed Excluded Intellectual
Property. At any time until twelve (12) months after the Closing Date, Buyer may request, and Sellers shall provide, one (1) copy of
any Software included in such licensed Excluded Intellectual Property, if any, including documentation and source code that is
reasonably available, that (i) is subject to the license granted to Buyer under this <U>Section 8.7(a)</U>; (ii) has not already
been provided to Buyer, and (iii) is not otherwise in the possession of Buyer or its Affiliates. Buyer shall, and shall cause its
Affiliates, to use commercially reasonable efforts to maintain any Trade Secrets contained within such licensed Excluded
Intellectual Property as confidential, including refraining from disclosing such Trade Secrets to any other Person who is not bound
by obligations of confidentiality other than pursuant to reasonable confidentiality terms (including in connection with
sublicenses). Any improvements or modifications to, or derivative works of, such licensed Excluded Intellectual Property made by or
on behalf of Buyer or its Affiliates shall be owned by Sellers; <U>provided</U>, that, for the avoidance of doubt, all such
improvements, modifications and derivative works shall be deemed to be included within the Excluded Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Buyer may sublicense the rights contained within <U>Section 8.7(a)</U> without prior written consent of Sellers only to any of
their respective suppliers, contractors, consultants or representatives for the purpose of providing products and services to or otherwise
acting on behalf of and at the direction of Buyer or its Affiliates and in any event in a manner consistent with how such party sublicenses
its own comparable Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Buyer may not assign the rights contained within <U>Section 8.7(a)</U> without the prior written consent of Sellers, such consent
not to be unreasonably withheld, conditioned or delayed; <U>provided</U>, that Buyer may assign or transfer such rights in whole or in
part without the prior written consent of Sellers in connection with any merger, public offering, consolidation, reorganization, or sale
of any divisions, businesses, operating units or portion of such party or its respective Affiliates or substantially all of the assets
related to any such division, business, operating unit or portion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
IX</B></FONT><U><BR>
<B>MISCELLANEOUS</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Press Releases and Public Announcements</B>. No Party shall issue any press release or make any public announcement relating to
the subject matter of this Agreement without the prior written approval of the other Parties; provided, however, that the Parties or their
Affiliates may make public disclosure following the Closing, and shall also be entitled to disclose the material terms hereof, as required
by Applicable Law (including any applicable securities exchange rules) or in connection with the ordinary course reporting or disclosure
activities of such Party or its Affiliates. Notwithstanding the foregoing, the Parties and their Affiliates may make disclosure of the
transactions contemplated by this Agreement to their employees following the earlier of (x) the close of trading on Nasdaq on the date
of this Agreement or (y) the public announcement of the transactions contemplated by this Agreement, without the prior written approval
of the other Parties. Buyer further acknowledges any notification by Sellers to the Minnesota Department of Commerce of the transactions
contemplated by this Agreement prior to the date hereof is not considered a breach of Aware&rsquo;s obligations pursuant to that certain
Mutual Confidentiality Agreement, dated November 24, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Confidentiality</B>.
Except as set forth in Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>9.1 above, each Seller will maintain in confidence, and
will cause its respective controlled Affiliates and their directors, officers, managers, employees, agents, advisors and owners to
maintain in confidence any written, oral or other confidential information involving or relating to SamCo or the Acquired Assets or
other information provided to it by Buyer in connection with this Agreement or the transactions contemplated hereby, unless (a) such
information becomes publicly available through no fault of such Party which would constitute a breach of this Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>9.2,
(b) the use of such information is necessary or appropriate in making any filing or obtaining any consent or approval required for
the consummation of the transactions contemplated by this Agreement or (c) the furnishing or use of such information is required by
or necessary or appropriate in connection with any Proceedings or under Applicable Laws (including any applicable securities
exchange rules). Except to the extent disclosed in any press release or public announcement pursuant to Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>9.1
above and subject to the terms of this Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>9.2, the Parties shall keep confidential
and not disclose to any Person the existence and terms of the Parties&rsquo; discussions and this Agreement. The Parties acknowledge
that the obligations of the Parties under that certain Mutual Confidentiality Agreement, dated November 24, 2020, shall terminate
and be of no further force and effect as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Further Acts and Assurances</B>. The Parties agree that, at any time and from time to time, on and after the Closing Date, upon
the reasonable request of another Party, they will do or cause to be done all such further acts and things and execute, acknowledge and
deliver, or cause to be executed, acknowledged and delivered any and all papers, documents, instruments, agreements, assignments, transfers,
assurances and conveyances as may be necessary or desirable to carry out and give effect to the provisions and intent of this Agreement.
In addition, from and after the Closing Date, Buyer and Sellers will afford to the other and their respective attorneys, accountants and
other representatives access, during normal business hours, to such personnel, Books and Records relating to MII Life&rsquo;s Spending
Account Business as may reasonably be required in connection with the preparation of financial information, the filing of Tax Returns
and, solely in the case of Buyer, the operation of MII Life&rsquo;s Spending Account Business, and will cooperate in all reasonable respects
in connection with Proceedings asserted by or against third parties, relating to or arising from the transactions contemplated hereby.
In furtherance and not in limitation of the foregoing, MII Life shall promptly provide at Buyer&rsquo;s request any and all consents and
other instruments and documents which allow the use of any of its Spending Account Business&rsquo;s names, or any derivative thereof,
in all jurisdictions where MII Life is registered and/or licensed to do business in order to facilitate Buyer&rsquo;s filings in such
jurisdiction for the purpose of conducting MII Life&rsquo;s Spending Account Business therein. Moreover, subject to the terms of the Transition
Services Agreement, if following the Closing MII Life receives any deposits from Account holders or employers of Account holders with
respect to the Accounts, MII Life shall promptly forward such deposits to Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Third-Party Beneficiaries</B>. Except for the Buyer Indemnified Parties and Seller Indemnified Parties, this Agreement shall
not confer any rights or remedies on any Person other than the Parties and their respective successors and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Entire Agreement</B>. This Agreement, including the schedules, Disclosure Schedules and the other documents delivered by the Parties
in connection herewith, embody the entire agreement and understanding of the Parties in respect of the subject matter contained herein.
This Agreement and the other documents delivered by the Parties in connection herewith supersede all prior agreements and understandings
between the Parties with respect to the subject matter hereof and thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Succession
and Assignment</B>. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and
permitted assigns but, except as hereinafter provided in this Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>9.6, nothing in
this Agreement is to be construed as an authorization or right of any Party to assign its rights or delegate its duties under this
Agreement without the prior written consent of the other Parties, which consent may be withheld at each such Party&rsquo;s sole and
absolute discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Counterparts</B>. This Agreement may be executed in one or more counterparts, including by PDF, DocuSign or other facsimile, each
of which shall be deemed an original but all of which together will constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Headings; Definitions</B>. The section headings contained in this Agreement are inserted for convenience only and shall not affect
in any way the meaning or interpretation of this Agreement. The definitions contained in this Agreement are applicable to the singular
as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notices</B>. All notices, demands and other communications to be given or delivered under or by reason of the provisions of this
Agreement will be in writing and will be deemed to have been given when sent if sent by e-mail (or, if after 5:00 pm in the location of
the recipient&rsquo;s primary office, then on the next Business Day). Notices, demands and communications to Buyer and Sellers will, unless
another address is specified in writing, be sent to the address indicated below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notices to Buyer:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">HealthEquity, Inc.<BR>
    15 West Scenic Pointe Drive</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suite 100</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Draper, UT 84020<BR>
    Attention: Jon Kessler</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Delano Ladd<BR>
    Email: jkessler@healthequity.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">dladd@healthequity.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">with a copy to (which shall not constitute notice):</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Willkie Farr &amp; Gallagher LLP<BR>
    787 Seventh Avenue<BR>
    New York, NY 10019<BR>
    Attention: Matthew Haddad<BR>
    Email:mhaddad@willkie.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notices to Sellers:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MII Life Insurance, Incorporated</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: John Uribe (Corporate Development) and Michelle Schultz
    (Legal)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: <U>John.Uribe@bluecrossmn.com</U> and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michelle.Schultz@bluecrossmn.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aware Integrated, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: John Uribe (Corporate Development) and Michelle Schultz
    (Legal)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: <U>John.Uribe@bluecrossmn.com</U> and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michelle.Schultz@bluecrossmn.com</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">with a copy to (which shall not constitute notice):</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Taft Stettinius &amp; Hollister LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2200 IDS Center</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">80 South Eighth Street</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Minneapolis, Minnesota 55402-2157</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Steve Kozachok</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: skozachok@taftlaw.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Governing Law; Venue</B>. This Agreement, including the documents, instruments and agreements to be executed and/or delivered
by the Parties pursuant hereto, shall be construed, governed by and enforced in accordance with the internal laws of the State of Delaware
without giving effect to the principles of comity or conflicts of laws thereof. Any Proceeding permitted by the terms of this Agreement
to be filed in a court, which Proceeding is brought to enforce, challenge or construe the terms or making of this Agreement or any of
the Ancillary Documents, and any claims arising out of or related to this Agreement or any of the Ancillary Documents, shall be exclusively
brought and litigated exclusively in a state or federal court having subject matter jurisdiction and located in the State of Delaware.
For the purpose of any Proceeding instituted with respect to any claim arising out of or related to this Agreement or any of the Ancillary
Documents, each Party hereby irrevocably submits to the exclusive jurisdiction of the state or federal courts having subject matter jurisdiction
and located in the State of Delaware. Each Party hereby irrevocably waives any objection or defense which it may now or hereafter have
of improper venue, forum non conveniens, or lack of personal jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Amendments and Waivers</B>. No amendment of any provision of this Agreement shall be valid unless the same shall be in writing
and signed by Buyer and Sellers. No waiver by any Party of any default, misrepresentation or breach of warranty or covenant hereunder,
whether intentional or not, shall be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or
covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Severability</B>. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction
shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the
offending term or provision in any other situation or in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Expenses</B>. Except as provided for in <FONT STYLE="font-size: 13pt"><U>&#8206;</U></FONT><U>Article VI,</U> each of the Parties
shall be responsible for and bear all of its own costs and expenses incurred in connection with this Agreement and the transactions contemplated
hereby; provided, however, Buyer shall pay the fees related to filings required pursuant to the HSR Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Construction</B>. The Parties have participated jointly in the negotiation and drafting of this Agreement and the Ancillary Documents.
In the event an ambiguity or question of intent or interpretation arises, this Agreement and the Ancillary Documents shall be construed
as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of
the authorship of any of the provisions of this Agreement or the Ancillary Documents. Any reference to any federal, state, local or foreign
statute or law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise.
The word &ldquo;including&rdquo; shall mean including without limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Incorporation of Exhibits, Annexes and Schedules</B>. The Exhibits, Annexes and Disclosure Schedules identified in this Agreement
are incorporated herein by reference and made a part hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Specific
Performance</B>. The Parties hereby acknowledge and agree that the failure of either Seller, on the one hand, or Buyer, on the other
hand, to perform its agreements and covenants hereunder will cause irreparable injury to the other, for which damages, even if
available, will not be an adequate remedy. Accordingly, each Party hereby consents to the issuance of temporary, preliminary and
permanent injunctive relief by the courts referenced in Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>9.10 to compel
performance of such Party&rsquo;s obligations, or to prevent breaches or threatened breaches of this Agreement, and to the granting
by the courts referenced in Section <FONT STYLE="font-size: 13pt">&#8206;</FONT>9.10 of the remedy of specific performance of its
obligations hereunder, in addition to any other rights or remedies available hereunder or at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[SIGNATURE PAGE FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Split-Segment; Name: 6 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Parties have executed
this Agreement on and as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>BUYER:</B></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>SELLERS:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>Viking Acquisition Corp.</B></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>MII Life Insurance, Incorporated</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 47%">/s/ Jon Kessler</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 47%">/s/ Garrett Black</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Name:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Jon Kessler</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Name:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Garrett Black</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">President &amp; Chief Executive Officer</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">President and Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Aware Integrated, Inc.</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>GUARANTOR:</B></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">/s/ Jay Matushak</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>HealthEquity, Inc.</B></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Name:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Jay Matushak</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">/s/ Jon Kessler</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Name:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Jon Kessler</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">President &amp; Chief Executive Officer</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page &ndash; Asset and Unit Purchase
Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANNEX I<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Agreement,
the following terms have the meanings specified:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Account Deposits</B>&rdquo;
means, collectively, the Final Accountholder Cash Deposits, and (ii) the Final Accountholder Investment Assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Accounts</B>&rdquo;
means HSAs, voluntary employee beneficiary association accounts, health reimbursement accounts, flexible spending accounts, dependent
care assistance program accounts, premium reimbursement accounts, transportation reimbursement accounts and other similar accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Account Information
and Files</B>&rdquo; means the following information with respect to the Purchased Accounts: (a) all customer identifying, demographic
and contact information (e.g., name, telephone number, address, e-mail address, social security number, birthdate) in a Seller&rsquo;s
possession, (b) all Account identifying information (e.g., Account name (if applicable), Account number or other identifying number),
(c) balance information (both deposit balances and investment balances), (d) historical transaction information and other Account history,
(e) the date of last contribution and date of last withdrawal, if any, and (f) such additional information as Buyer may from time to time
reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Acquired Assets</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Acquired IP</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
has the meaning set forth in Rule 12b-2 of the regulations promulgated under the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliated Group</B>&rdquo;
means any affiliated group within the meaning set forth in Section 1504(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Agreement</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Ancillary Documents</B>&rdquo;
means the Bill of Sale, the Assignment and Assumption Agreement, the Transition Services Agreement, the Intellectual Property Assignment,
the Trademark Assignment Agreement, the Services Agreement, the Distribution Partnership Agreement, and any other document, agreement,
instrument or certificate entered into, executed and/or delivered in connection with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Anti-Corruption
Laws</B>&rdquo; has the meaning set forth in Section 2.17</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Anti-Money Laundering
Laws</B>&rdquo; has the meaning set forth in Section 2.16.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Applicable Laws</B>&rdquo;
means any and all applicable laws, ordinances, constitutions, regulations, statutes, treaties, rules, codes, and Orders adopted, enacted,
implemented, promulgated, issued, entered or deemed applicable by or under the authority of any Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Assignment and Assumption
Agreement</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>5.1(h)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Assumed Contracts</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Assumed Liabilities</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Aware</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>BCBSM</B>&rdquo;
means BCBSM, Inc. d/b/a Blue Cross and Blue Shield of Minnesota, a Minnesota nonprofit corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Benefit Arrangement</B>&rdquo;
means each &ldquo;employee benefit plan&rdquo; within the meaning of Section 3(3) of ERISA (whether or not subject to ERISA) and all other
compensation and benefits plans, policies, trust funds, programs, arrangements or payroll practices, including Multiemployer Plans, and
each other stock purchase, stock option, restricted stock, profit sharing, pension, savings, severance, retention, employment, consulting,
commission, change-of-control, collective bargaining, bonus, incentive, deferred compensation, employee loan, fringe benefit, insurance,
welfare, post-retirement health or welfare, health, life, tuition refund, service award, company car, scholarship, relocation, disability,
accident, sick pay, sick leave, accrued leave, vacation, holiday, termination, unemployment, restrictive covenant, and other benefit plan,
policy, trust fund, program, arrangement or payroll practice, whether or not subject to ERISA (including any related funding mechanism
now in effect or required in the future), whether formal or informal, oral or written, funded, unfunded, insured or self-insured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bill of Sale</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>5.1(h)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Books and Records</B>&rdquo;
means all data, books, records, documents and files (including electronic or computerized data, books, records, documents and files) in
the case of MII Life related to its Spending Account Business and operations of MII Life pertaining to its Spending Account Business and
in the case of Aware related to SamCo and operations of SamCo, including client and customer lists and records, referral sources, research
and development reports and records, production reports and records, service and warranty records, operating logs, operating guides and
manuals, creative materials, advertising materials, promotional materials, studies, reports, correspondence, ledgers, lists, plats, drawings,
specifications and other similar documents, and records and copies of all financial and accounting records and personnel records relating
to the Acquired Assets or the Assumed Liabilities, but excluding Sellers&rsquo; Constituent Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business Day</B>&rdquo;
means any day except Saturday, Sunday and any day which is a legal holiday or day which banking institutions in the State of Minnesota
or State of Utah generally are authorized or required by law or other agreements to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Buyer</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Buyer Indemnified
Parties</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>6.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Buyer Plan</B>&rdquo;
has the meaning set forth in Section 8.5(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change</B>&rdquo;
has the meaning set forth in the definition of Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Claim</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>6.6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing Date</B>&rdquo;
has the meaning set forth in Section<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>COBRA Continuation
Coverage</B>&rdquo; means the continuation coverage requirements under Section 4980B of the Code and Part 6 of Title I of ERISA or any
similar provision under other Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Communication Plan</B>&rdquo;
has the meaning set forth in Section 4.2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Contributor</B>&rdquo;
has the meaning set forth in Section 2.13(g).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Consideration</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Constituent Documents</B>&rdquo;
means the organizational and other governing documents of a Party, including, the articles of incorporation, bylaws, operating agreement
or similar documents, if any, and voting agreement, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Contract(s)</B>&rdquo;
means all agreements, contracts, leases, consensual obligations, promises, undertakings, license agreements, commitments, arrangements
or understandings (whether written or oral, express or implied and whether or not legally binding) of any type, nature or description.
As used herein, the word &ldquo;Contract&rdquo; shall be limited in scope if modified by an adjective specifying the type of contract
to which this Agreement or a Section hereof refers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Data Protection
Laws</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>2.6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Data Protection
Requirements</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>2.6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Data Systems</B>&rdquo;
means computer, electronic or telecommunications or network systems of any variety (including data bases, websites, hardware, software,
storage, switching and interconnection devices and mechanisms, whether on-premises or provided as a service by a third party).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Designated Jurisdiction</B>&rdquo;
shall mean any country or territory to the extent that such country or territory itself is the subject of any Sanction, including without
limitation Crimea, Cuba, Iran, North Korea and Syria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Disclosure Schedules</B>&rdquo;
has the meaning set forth in the introductory paragraph to <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT><U>Article
II</U> of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Distribution Partnership
Agreement</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>5.1(h)(iv).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Employer Agreement</B>&rdquo;
means any agreement between a Seller and an employer related to one or more of the Accounts, and any amendments to such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Encumbrance</B>&rdquo;
means any encumbrance, charge, claim, condition, equitable interest, lien (statutory or otherwise), option, pledge, security interest,
mortgage, right of way, easement, encroachment, servitude, restriction on transfer or use, right of first refusal, right of first offer,
encroachment or restriction on exercise of any other attribute of ownership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>End Date</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>7.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA</B>&rdquo;
means the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA Affiliate</B>&rdquo;
means each entity, trade or business that is, or was at the relevant time, a member of a group described in Section 414(b), (c), (m) or
(o) of the Code or Section 4001(b)(1) of ERISA that includes or included any of the Group Companies, or that is, or was at the relevant
time, a member of the same &ldquo;controlled group&rdquo; as any of the Group Companies pursuant to Section&nbsp;4001(a)(14) of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Excluded Assets</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Excluded
Employee Liabilities</B>&rdquo; means (a)&nbsp;any payments, compensation, benefits or entitlements that Sellers or any of their
Affiliates owes or is obligated to provide prior to the Closing or as of the Closing with respect to any Specified Employee
(including any Specified Employees who do not become Transferred Employees), including wages, other remuneration, holiday or
vacation pay, bonus, severance pay (contractual, statutory or otherwise), retention bonuses, commissions, post-employment medical or
life obligations, pension contributions, insurance premiums, and Taxes, (b)&nbsp;any liabilities, payments, obligations, costs,
expenses or disbursements for, or with respect to, payments, compensation, benefits or entitlements to any Specified Employee
(including any Specified Employees who do not become Transferred Employees) arising prior to, on or as a result of the Closing,
(c)&nbsp;any liabilities, payments, obligations, costs, expenses or disbursements related to any employees, including under, or with
respect to ERISA, WARN, COBRA Continuation Coverage or any retiree medical benefits, worker&rsquo;s compensation, any right or
actions under any labor or similar Applicable Laws that is incurred, accrued or arising prior to, on or as a result of the Closing,
(d) any Benefit Arrangement and any liabilities, payments, obligations, costs, expenses or disbursements of Sellers or any of their
Affiliates which arises under or relates to any Benefit Arrangement or any other employee benefit plan or arrangement, including
liability with respect to, or arising under (i)&nbsp;any such plan that is subject to Title IV of ERISA, Sections 302, 303, 304 or
305 of ERISA, or Sections 412, 430, 431, 432 or 4971 of the Code or (ii)&nbsp;any other statute or regulation that imposes liability
on a so-called &ldquo;controlled group&rdquo; basis with or without reference to any provision of Section 414 of the Code or Section
4001 of ERISA, including by reason of Sellers&rsquo; affiliation with any of its ERISA Affiliates or Buyer being deemed a successor
to any ERISA Affiliate of Sellers, and (e)&nbsp;any Liabilities, payments, obligations, costs, expenses or disbursements incurred in
connection with the termination of employment or other service relationship by Sellers or any of their Affiliates, of any employee,
regardless of whether or not such employee becomes a Transferred Employee, arising under any Benefit Arrangement or other severance
policy or agreement or under Applicable Law or otherwise, that is incurred, accrued or arising prior to, or in connection with, the
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Excluded Intellectual
Property</B>&rdquo; means any Intellectual Property (including Software, but excluding Trademarks), owned by Seller and its Affiliates
as of the date hereof that is not Acquired IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Excluded Liabilities</B>&rdquo;
means all Liabilities of MII Life other than the Assumed Liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Final Accountholder
Cash Deposits</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Final Accountholder
Investment Assets</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Final Allocation</B>&rdquo;
has the meaning set forth in Section 8.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Further Investment
Securities</B>&rdquo; means the investment securities that were purchased by MII Life using cash contributions made by Account holders
to the Purchased Accounts and set forth on <B><U>Schedule B</U></B> (as such <B><U>Schedule B</U></B> may be updated upon the mutual written
agreement of Sellers and Buyer from time to time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental Body</B>&rdquo;
means any (<FONT STYLE="font-family: Times New Roman, Times, Serif">a)</FONT> nation, state, county, city, town, village, district or
other jurisdiction of any nature, <FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT> federal, state, local, municipal,
foreign or other government, <FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT> governmental or quasi&#45;governmental
body of any nature (including any administrative agency, governmental agency, branch, board, commission, department, instrumentality,
office or other entity, and any court or other tribunal), and/or <FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT> body
exercising, or entitled or purporting to exercise, any administrative, executive, judicial, legislative, police, regulatory or taxing
authority or power of any nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental Body
Consents</B>&rdquo; has the meaning in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>4.2(b)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Health Plan Agreement</B>&rdquo;
means any agreement between a Seller and a health plan related to one or more of the Accounts, and any amendment to such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>HSA</B>&rdquo; means
a health savings account, which is a savings account created for individuals who are covered under qualified health plans into which money
can be deposited on a tax-free basis for the purpose of paying qualified medical expenses that qualified health plans do not cover as
permitted by Section 223(a) of the Code, which account is comprised of a deposit account, and may be coupled with an investment account,
administered by MII Life and for which MII Life serves as custodian as of Closing. Contributions are made to an HSA by the individual
accountholder or such individual&rsquo;s employer and are limited to a maximum amount each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>HSR Act</B>&rdquo;
means the Hart-Scott-Rodino Antitrust Improvements Act of 1976 or any successor law, and regulations and rules issued pursuant thereto
or any successor law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Inactive Specified
Employee</B>&rdquo; has the meaning set forth in Section 8.5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indebtedness</B>&rdquo;
means, as of any date of determination, (a) all indebtedness of a Person for borrowed money or in respect of loans or advances, (b) all
obligations of a Person evidenced by bonds, notes, debentures, letters of credit (to the extent drawn), bankers acceptances or similar
instruments, (c) all obligations of a Person for the deferred purchase price of assets, property or services, including without limitation,
any royalty or earn-out payments, (d) all capitalized lease obligations of a Person, (e) all payments such Person would have to make in
the event of any early termination on the date Indebtedness is being determined in respect of outstanding interest rate protection agreements,
foreign currency exchange agreements or other interest or exchange rate hedging agreements, (f) all guarantees of any of the foregoing
or any other indebtedness guaranteed in any manner by a Person (including guarantees in the form of an agreement to repurchase or reimburse)
and (g) all accrued interest, prepayment premiums, fees (including loan management fees) or penalties directly related to the payment
of each of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indemnified Party</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>6.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indemnifying Party</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>6.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Independent Accountants</B>&rdquo;
has the meaning set forth in Section 8.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Initial Accountholder
Cash Deposits</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Initial Accountholder
Investment Assets</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Insurer</B>&rdquo;
means the issuer of the R&amp;W Insurance Policy, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Intellectual Property</B>&rdquo;
means all of the following, worldwide, whether registered, unregistered or registrable: (a) patents and patent rights, in any jurisdiction,
including all provisionals, re-issues, continuations, divisionals, continuations-in-part, re-examinations, renewals and extensions, (b)
trademarks and trademark rights, trade names, service marks, trade dress, logos, slogans, product configurations, service names, brand
names, and other indications of origin, in any jurisdiction and all goodwill associated therewith (&ldquo;<B>Trademarks</B>&rdquo;), (c)&nbsp;inventions,
processes, formulae, trade secrets, processes, discoveries, improvements, ideas, models, algorithms, systems, processes, technology, research
schematics, data and database rights, designs, methodologies, customer lists, supplier lists, technical information and information technology,
know-how other rights in confidential and other nonpublic information that derive economic value from not being generally known and not
being readily ascertainable by proper means, including the right in any jurisdiction to limit the use or disclosure thereof (&ldquo;<B>Trade
Secrets</B>&rdquo;), (d) copyrights, writings, designs, mask works, Software (in any form or format, including all source codes), content
and other original works of authorship in any medium, including applications or registrations in any jurisdictions for the foregoing and
all moral rights in the foregoing, (e) all rights in internet web sites, internet domain names, telephone numbers, telecopy numbers, websites,
URLs and email addresses and related documentation, (f) social media accounts, the usernames and passwords associated therewith, and all
content contained therein; (g) any other intellectual property or proprietary rights of any kind, nature or description; (h) all pending
applications for the issuance or registration of any of the foregoing in any jurisdiction, and (i) any tangible embodiments of the foregoing
(in whatever form or medium).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Intellectual Property
License</B>&rdquo; means any Contract pursuant to which (a) MII Life or SamCo obtains a license or any other right to use or otherwise
exploit any Intellectual Property which is not owned by MII Life or SamCo, (b) MII Life or SamCo grants any other Person or other third
party a license or other right to use or otherwise exploit any Owned Intellectual Property or any other Intellectual Property that MII
Life or SamCo controls or otherwise has the right to license or (c) MII Life or SamCo covenants, or is granted a covenant, not to sue
using, or otherwise assert, any Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>IT Systems</B>&rdquo;
means the information technology and computer systems (including all Software, hardware, and firmware, and including all network, information
technology and telecommunication hardware and other equipment) owned, leased, licensed or used by MII Life or SamCo, relating to the transmission,
storage, maintenance, organization, presentation, generation, processing or analysis of data and information (whether or not in electronic
format) used in the conduct of the businesses of MII Life or SamCo, including as part of any product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Knowledge</B>&rdquo;
as it relates to any Person means the actual knowledge of such Person if the Person is an individual, or the knowledge of any officers,
directors, managers, governors or similar positions of such Person if such Person is a corporation, partnership, association, limited
liability company, trust, unincorporated organization, other entity or group, in each case, including such knowledge as has been, or would
be reasonably likely to be, obtained in the normal course of business after the exercise of reasonable diligence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Liability</B>&rdquo;
or &ldquo;<B>Liabilities</B>&rdquo; means any and all debts, accounts payable, liabilities and/or obligations of any type, nature or description
(whether known or unknown, asserted or unasserted, secured or unsecured, absolute or contingent, accrued or unaccrued, liquidated or unliquidated
and whether due or to become due).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Loss</B>&rdquo;
or &ldquo;<B>Losses</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>6.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material
Adverse Effect</B>&rdquo; means with respect to its Spending Account Business in the case of MII Life and SamCo in the case of
Aware, any circumstance, state of facts, development, event, change or effect (&ldquo;<B>Change</B>&rdquo;) that is, has been or
would reasonably be expected to be materially adverse, individually or in the aggregate with other events, to (x) the ability of
Sellers to perform any of their respective obligations, or to consummate the transactions contemplated by, this Agreement or (y) any
of the conditions (financial or otherwise), properties, assets, Liabilities, business, or results of operations taken as a whole;
provided, however, that, solely with respect to clause (y) above, any adverse Change arising from or relating to any of the
following shall not be deemed to constitute and shall not be taken into account in determining whether there has been, a Material
Adverse Effect: (a) conditions affecting the United States economy or the global economy, in each case, as a whole, or the industry
in which Sellers operate; (b) national or international political, social or public health conditions, including the engagement by
the United States in hostilities, whether or not pursuant to the declaration of a national emergency or war, or the occurrence of
any military or terrorist attack upon the United States, or any of its territories, possessions, or diplomatic or consular offices
or upon any military installation, equipment or personnel of the United States; (c) changes in financial, banking, or securities
markets (including any disruption thereof); (d) changes in accounting principles generally accepted in the United States; (e)
changes in Applicable Laws; (f) the taking of any action required to be taken by this Agreement or any of the Ancillary Documents or
the failure to take any action requiring the consent of any Party which consent is withheld; (g) any &ldquo;act of God,&rdquo;
including, but not limited to, natural disasters and earthquakes; or (h) changes resulting from the public announcement of the
execution of this Agreement or any of the Ancillary Documents, except, in each case, to the extent that its Spending Account
Business in the case of MII Life or SamCo in the case of Aware, suffers disproportionately from the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Contracts</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>2.11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Multiemployer Plan</B>&rdquo;
means each Benefit Arrangement that is a &ldquo;multiemployer plan&rdquo; as defined in Section 3(37) or 4001(a)(3) of ERISA or Section
414(f) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>MII Life</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Non-Assignable Contract</B>&rdquo;
has the meaning set forth in Section 1.12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>OFAC</B>&rdquo;
means the Department of the Treasury&rsquo;s Office of Foreign Assets Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offeree Employee</B>&rdquo;
has the meaning set forth in Section 8.5(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Order</B>&rdquo;
means any and all writs, rulings, awards, directives, injunctions (whether temporary, preliminary or permanent), judgments, decrees or
orders (whether executive, judicial or otherwise) adopted, enacted, implemented, promulgated, issued, entered or deemed applicable by
or under the authority of any Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Ordinary Course
of Business</B>&rdquo; for any Person means action that (a) is consistent in nature, scope and magnitude with the past practices of such
Person and is taken in the ordinary course of the normal, day-to-day operations of such Person and (b) is similar in nature, scope and
magnitude to actions customarily taken, without any separate or special authorization, in the ordinary course of the normal, day-to-day
operations of other Persons that are in the same line of business as such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Owned Intellectual
Property</B>&rdquo; means any Intellectual Property (a) owned or purported to be owned by SamCo, or (b) owned or purported to be owned
by a MII Life and included in the Acquired IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parties</B>&rdquo;
or &ldquo;<B>Party</B>&rdquo; has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permits</B>&rdquo;
shall mean all of the federal, state and local governmental permits, licenses, consents and authorizations held by a Seller or any of
its Affiliates, or required in connection with the use, operation or ownership of (i) the Acquired Assets or the conduct of its Spending
Account Business as presently operated in the case of MII Life and (ii) the Units or the conduct of SamCo in the case of Aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted
Encumbrances</B>&rdquo; means only (a) statutory Encumbrances for Taxes not yet due and payable or being contested in good faith by
appropriate proceedings; (b) workers or unemployment compensation Encumbrances arising in the ordinary course of business consistent
with past practice; (c) mechanic&rsquo;s, materialman&rsquo;s, supplier&rsquo;s, vendor&rsquo;s or similar Encumbrances arising in
the ordinary course of business consistent with past practice securing amounts that are not delinquent or past due or that are being
contested in good faith; and (d) zoning ordinances, easements and other restrictions of legal record affecting real property which
would be revealed by a survey or a search of public records and would not, individually or in the aggregate, materially interfere
with the value or usefulness of such real property to the Spending Account Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means any individual, sole proprietorship, firm, corporation (including any non&#45;profit corporation), general, limited or limited liability
partnership, limited liability company, joint venture, estate, trust, association, organization, unincorporated society or association,
or other entity or Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Personal Data</B>&rdquo;
means information that identifies, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked,
directly or indirectly, with a particular individual or household, and when referring to a Data Protection Requirement, has the same meaning
as the similar or equivalent term defined thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Pre-Closing Tax
Period</B>&rdquo; means any Tax period ending prior to the Closing Date and that portion of any Straddle Period ending the day immediately
preceding the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Privacy Policies</B>&rdquo;
has the meaning set forth in Section 2.6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proceeding</B>&rdquo;
means any claim, suit, litigation, arbitration, hearing, audit, examination, investigation or other action (whether civil, criminal, administrative
or investigative) commenced, brought, conducted, or heard by or before, or otherwise involving, any Governmental Body or arbitrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Products and Services</B>&rdquo;
means all products, technology, and services produced, marketed, licensed, sold, distributed, or performed by or on behalf of MII Life
with respect to the Spending Account Business or SamCo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proposed Allocation</B>&rdquo;
has the meaning set forth in Section 8.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proprietary Software</B>&rdquo;
has the meaning set forth in Section 2.13(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Purchased Accounts</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>R&amp;W Insurance
Policy</B>&rdquo; means a policy of insurance issued by the Insurer at or prior to the Closing insuring the accuracy of the representations
and warranties contained in <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&#8206;</U></FONT><U>Article
II</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registered Intellectual
Property</B>&rdquo; has the meaning set forth in Section 2.13(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Related Party Contract</B>&rdquo;
has the meaning set forth in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Release</B>&rdquo;
has the meaning set forth in Section 4.9(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Resignation Notices</B>&rdquo;
has the meaning set forth in Section 4.2(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Restricted Business</B>&rdquo;
has the meaning set forth in Section 8.1(a)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Restricted Party</B>&rdquo;
has the meaning set forth in Section 8.1(a)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SamCo</B>&rdquo;
has the meaning set forth in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SamCo Financial
Statements</B>&rdquo; has the meaning set forth in Section 2.9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sanction(s)</B>&rdquo;
means any sanction administered or enforced by the United States Government, including without limitation OFAC, the Department of State,
or other relevant sanctions authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Seller</B>&rdquo;
or &ldquo;<B>Sellers</B>&rdquo; has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Seller Benefit Arrangement</B>&rdquo;
means each Benefit Arrangement that is maintained, sponsored, or contributed to (or with respect to which any obligation to contribute
has been undertaken) by either Seller or any of its ERISA Affiliates on behalf of any Specified Employees or under which either Seller
or any of its ERISA Affiliates has any Liability in respect of any Specified Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Seller Claims</B>&rdquo;
has the meaning set forth in Section 4.9(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Seller Indemnified
Parties</B>&rdquo; has the meaning set forth in Section 6.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Seller-Provided
IP</B>&rdquo; means all Intellectual Property that is licensed to Buyer or SamCo pursuant to, or for which access thereto is otherwise
provided to Buyer or SamCo in the Transition Services Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Services Agreement</B>&rdquo;
has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>5.1(h)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Software</B>&rdquo;
means all computer software, including assemblers, applets, compilers, source code, object code, binary libraries, development tools,
design tools, user interfaces, virtualization processes, hypervisors, application, performance and database logs, in any form or format,
however fixed, and all associated documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Source Code</B>&rdquo;
means, collectively, any software source code, or any portion of software source code, or any proprietary information or algorithm contained
in or relating to any software source code, including material related documentation, comprising Proprietary Software.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&ldquo;</FONT><B>Specified
Employee</B>&rdquo; has the meaning set forth in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</FONT>2.22(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&ldquo;</FONT><B>Specified
Employee Census</B><FONT STYLE="font-weight: normal">&rdquo; has the</FONT> meaning set forth in Section 2.22(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Spending Account
Business</B>&rdquo; has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Straddle Period</B>&rdquo;
means any Tax period beginning prior to the Closing Date and ending on or after the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax</B>&rdquo;
means all taxes, assessments, charges, duties, fees, levies or other governmental charges, including all federal, state, local,
foreign and other income, gross receipt, franchise, profits, capital gains, capital stock, transfer, sales, use, occupation,
property, unclaimed property, excise, severance, windfall profits, stamp, license, payroll, withholding and other taxes,
assessments, charges, duties, fees, levies or other governmental charges of any kind whatsoever (whether payable directly or by
withholding and whether or not requiring the filing of a Tax Return), all estimated taxes, deficiency assessments, additions to tax,
penalties and interest and any Liability for such amounts, including as a result either of being a member of a combined,
consolidated, unitary or Affiliated Group or of a contractual obligation to indemnify any Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax Liabilities</B>&rdquo;
shall mean any Liabilities for Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax Return</B>&rdquo;
means any return, declaration, report, claim for refund or information return or statement relating to Taxes, including any schedule or
attachment thereto, and including any amendment thereof, filed or required to be filed with any Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trade Secrets</B>&rdquo;
has the meaning set forth in the definition of Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trademark(s)</B>&rdquo;
has the meaning set forth in the definition of Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trademark Assignment
Agreement</B>&rdquo; has the meaning set forth in Section 5.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transaction Expenses</B>&rdquo;
means all fees, costs, charges and expenses of Sellers incurred or required to be paid in connection with the negotiation of this Agreement,
the performance of Sellers&rsquo; obligations hereunder and the preparation for and the consummation of the transactions contemplated
hereby, including fees, expenses and other costs of legal counsel, investment bankers, brokers, accountants and other representatives
and consultants retained by either Seller. For the avoidance of doubt, Transaction Expenses excludes all filing fees related to filings
required to be made by Buyer pursuant to the HSR Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transferred Employee</B>&rdquo;
has the meaning set forth in Section 8.5(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transition Services
Agreement</B>&rdquo; has the meaning set forth in Section 5.1(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Treasury Regulations</B>&rdquo;
means the regulations prescribed pursuant to the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Units</B>&rdquo;
has the meaning set forth in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Warn Act&rdquo;</B>
has the meaning set forth in Section 2.22(b).</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hqy-20210408.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaGI+bOdzZR+iYkxtmBzbYmafycuEH6eDSwVbPEG4bYO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:hqy="http://healthequity.com/20210408" elementFormDefault="qualified" targetNamespace="http://healthequity.com/20210408">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://healthequity.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="hqy-20210408_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="hqy-20210408_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>hqy-20210408_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>hqy-20210408_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://healthequity.com/role/Cover" xlink:href="hqy-20210408.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://healthequity.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>tm2112741d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hqy-20210408.xsd" xlink:type="simple"/>
    <context id="From2021-04-08to2021-04-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2021-04-08</startDate>
            <endDate>2021-04-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-04-08to2021-04-08">0001428336</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-04-08to2021-04-08">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-04-08to2021-04-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-04-08to2021-04-08">2021-04-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-04-08to2021-04-08">HealthEquity, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-04-08to2021-04-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-04-08to2021-04-08">001-36568</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-04-08to2021-04-08">52-2383166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-04-08to2021-04-08">15 West Scenic Pointe Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-04-08to2021-04-08">Suite&#160;100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-04-08to2021-04-08">Draper</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-04-08to2021-04-08">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-04-08to2021-04-08">84020</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-04-08to2021-04-08">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-04-08to2021-04-08">727-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-04-08to2021-04-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-04-08to2021-04-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-04-08to2021-04-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-04-08to2021-04-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-04-08to2021-04-08">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-04-08to2021-04-08">HQY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-04-08to2021-04-08">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-04-08to2021-04-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140638361604344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  08,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HealthEquity, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001428336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2383166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 West Scenic Pointe Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Draper<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HQY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ LH*.4@=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "R@HY2
MW!R8#>X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " "R@HY2F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +*"CE+P,'_X4@0
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M2P$"% ,4    " "R@HY2)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "R@HY299!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2112741d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2112741d1_8k.htm">tm2112741d1_8k.htm</File>
    <File>hqy-20210408.xsd</File>
    <File>hqy-20210408_lab.xml</File>
    <File>hqy-20210408_pre.xml</File>
    <File>tm2112741d1_ex2-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2112741d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2112741d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hqy-20210408_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hqy-20210408_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hqy-20210408.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hqy",
   "nsuri": "http://healthequity.com/20210408",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2112741d1_8k.htm",
      "contextRef": "From2021-04-08to2021-04-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://healthequity.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2112741d1_8k.htm",
      "contextRef": "From2021-04-08to2021-04-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-21-050228-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-050228-xbrl.zip
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M_4>RE%4*4F83^X_RN0S6M>QL'O/]6G,S23/\"U!+ P04    " "R@HY2@2J
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MAP!',@@UH_SC-&<1%\^\]CK%C&]ED[B?\1@>N?1$N45K4!&:@'6&!(39$)\
M;(W0#\4[+XBK.41Y!DCEX)&[BSB6IRLM_[E.&)F"9\&J=<M8A]TF619A0#S!
M[@"*2N4'O8%4#+IE8:%S\H8"G_A'YV0H.B=!HW/R'G26KSPH=$[?4.!3_^B<
M#D7G-&AT3M^%CJS^ -J=F=R\%4O^:GLU'%1Z :=MU8K-018>-"UO?<BH #7.
M42'^8<F'7;?B3O"7A$7P@!J2>\$&,&UEQ]"&!Y#=8!]%U7!9Q_E'J1RX]_[!
M:)F?%J=ITM[<%)KP4&D:ZVUH"K5_,.YXFF'Z[^2Y\Y+=+O8"B=6P%96&,CQ@
M;/;ZL"EBD SR=PE>HJL>C%@GN!GI[J8J6VP=IBK7$H- P>:H/56YN-M2B/Q4
MMN)5$ RT#LUD9U5M,575="TMC(IN&VK5<_XW+C7^_JC5NC3T[I$S^-6#ML15
M?4/F=)V;Z4'4.V#*K/M<AG*=U_OY:H6,U-Z@U]*<]?BFG:J#UPE!U+'IIM5]
MZW0O=?JK2#)Y_!G?;+:L?&9D>U,1T+FJZTZ;NMZMHB 8Z')F\E!J45/L!8X%
MITF49 E;_R(O5D6";66SB5QA 1O43+0500 !VC)I. B15GI!X4X0!221U9%/
M4U1+)8G;AP?K**!+[ J-?L,:$5@9!"J]]DQD9, XJD6@(@3E,2' ,T_3+1%O
M0L@2X@DDT#R 4TL?(E20R5ZTBD#_A"U(M)7]YGYZLEHF&;5=AK8ESGHIP%S5
M1QGI01 "F#*)R-,0?T#3DS^O_H)TE!<(;OA28+4\[F*_67$*K*=E5;E"H<.B
MIL$B"0((V)?)Q U'I1056G_K;34L6PIEI+O"P&I+ ]!(#*+J;8Y:#4&CQKUV
M I>[Z%%:(\#4"+O,=6=@,VEV"'5-$"!T&&M=N)12I+7^ID8<NK)U_^!@[6UP
ML.X9'*Q#'!RLAPX.UIX'!_K@Q4(GLJ6Z7=%DC8$%&#O5KM'HL&Q28I$&!0SL
M#VP_JA!TB/&S=F>^@)OZ0('8Y"ZNY(:EK(#.V>J=73:KY3MMHB!(Z7+66L"S
M6%*O)D9*[8>.;9QD)"XL724,LRC!M%H(TG9/O3_$&3,#S5?X].C#(&F8R194
M19A>K[$*/"SJZ>=F?/&:QZ^$TI\9?V4+@E/.2%S<@;$]=^K6NWTOI\=V\]4<
M0!P$5$,< B_HJ*#QDXI".JR\?^:1IV^<;EF&13[_7=A:*4#GEA_ 9I,;0Q00
M+W9G ">5&!5JG]/)B]4OJB%8\44FL)B0W/'D\D[3QAQSJS8@<CH-0C/.RS5+
M#B/G(LKK)-",J"]I)"_D"\YPZ1 L-21W/>VSR[0YW].F#0BD3H/@#,\J1BUX
M@S59GA>^$3,Y$%OSCC?5#97[Y6]:%MLKX%22@""Q^>I8!T<@K?5(Q&*#*?V\
M31-&4KAK,E1NB;!:;!+1D 1$A,T70$0N15KKD8C+#1%KV>W])/AK]EBN2@N6
M$%"[):33<I,4JS0@8KK\ >3H$%3$Z(6$?2*T.RRL7JPG"9?7(G4,#VC6(*>E
M"PD;R%R+&4HB=7_FAF=HR='7E*#LD:#+\O-]]17QBWS\?H,EBM0$C6+DSF(L
M;"!UB9U_CP4TW/HJ2TL9!$Z]]N OM%012(=X8>=6\BSJ5WRYE7E&-N"\B_X0
M5QP--:]IZM,'P=1 DR99>5CS,CP/1"K2_\I,]:7^X0%@0^1XW&PQ: R;:XH@
M2 %M08/F^I<3?*X,N%W1)+JB',-W91H:Q^L!MNT92P$>! %QT'8%+0"8"U&N
M]$C!9\R>Q/8YB_9W@D>$J#>ZTJK]ZKMK-S#:+3EO*E*3J4&A ='V%K\ AX<L
M4"V/#[4^S/\M0/7BNEJKCD=/BT<L3^/M-DM5SRKMP??1.X,</Z 84 #C,45'
M1$  #K )/;+((U$>^@$5P:@6[?4:+CVL=$CBS_M[\D"$F@&Q)+OLLSS<4\=5
MR(!8UU=X@XMC7O#U!@:!XEO=0I>#*:IG@%;J3;0R"_2;R@3EN=B^#5_?=2VW
MY&Z]2_Y:X93(/?\%4$L#!!0    ( +*"CE)3/L),7 <  #Q9   4    :'%Y
M+3(P,C$P-# X7W!R92YX;6S-G$USVS80AN^=Z7]@E;.L#R=-[-C-V(J5T<2)
M7<M)VEXR$+F2, 8!!00MZ=\7("5%'P2XOF3M@^-0+\A]GZ5 +@'P[-TB%=$C
MZ(PK>=[H'+4;$<A8)5Q.SAM?ALV+86\P:$2983)A0DDX;TC5>/?7[[]%]N?L
MCV8SZG,0R6GT7L7-@1RKM]%GEL)I] $D:&:4?AM]92)W6U2?"]!13Z4S 0;L
M!^6!3Z-71Z]9U&PB=OL59*+TE[O!9K=38V:GK=9\/C^2ZI'-E7[(CF*5XO8W
M-,SDV69G[45[]5,V/Q-</IRZ7R.6061IR>QTD?'SQM9AY\='2D]:W7:[T_KG
MT_4PGD+*FEPZ:C$TUJW<7JK:=4Y.3EK%IVOI@7(QTF)]C./6.IS-GNVG/*#?
MBB3CIUD1WK6*F2F27GN8R*MP_VNN94VWJ=GI-H\[1XLL::SA%P2U$G 'X\C]
M:Y.W.>H4F#!3^)%SLW1):SE!JZ?L*6FC+9I.-8RM_L?2'J#;:;]LOW&[?[&C
M,<N9/3,S[DZL1M3:.?1,0P;2%&ZO[8:=)K P]H2"9+TC=_BG!&>X<0U6YTPG
M:KH3+$_M\>R?I7(5S#H<H>*="(1+A-IW:P/(; 0%[@SBHXEZ;"7 +?9NV_WA
M6+2;[<X*]@N[Z7MQN(M19C2+S7I_@HU %$?Y;C5[DM8OBVU-Y=[NMSJT7<5^
M9-M)O-!QI'0"VG)?[XOI>"=UA^?J2M&:,6UWU(RG7&RR/M8J]3%:\5">0+=Q
MV4/\2J87-HK$1=(7;%(-=4^"I-JAP%KIAI;K>\ABS6>.3@W>'262<I>4<H4W
M$MCK;],=3+B+V@7DKLG@-H9["D\3)/YCRKXCZ)8T#Q=2YDS<P4SI&OR[2B3U
MEY34J[R1POX[9]J %DL,[P,Q$ODK2N0>AZ34[S63&7>4,-@/U4CN?Y+>G'@\
MDH(?3D$(5_TQB3KCJ_1(^*\IX?M]/AO\5X_N'L!>>/ 9V&J"3,*;YY*$ [>D
M>;@%S55B+_L:D8$#,9+]"25[C\-G0/U*)ECF&RFZ:J)'OF>/%'B?9S$395Q]
MNRT+0Z^08\&3U*NU-I\!_'^!:33Z+3$6/$D)6V.1!'LOUWHGI& _XU=CP9,4
MKW4F2<A?2</-T@TL?,[3T<\'L[O$#U58TB0%J\\4(>'U$PMIW+A)B/*^$DN:
MI$X-F2.DW;.N-!,#F<#B(RQ#N ^D6-XD]6G0'B'P6\U3II=#'M=W(X=:+'*2
MJC1LD)#Y/5L,$NN-CWDY%EF/WML$FP&2DA1EES 1 QDK/5-;CZ-[*K??T&5/
M)<&NOJ8A-BDDM>H3K!.FYB))++1L]<\UE] )):12CAZ/HDM#P.:S@M]]&OPN
M'CY)#5MK\UG!/WX:_&,\?)(ZMM8F/?R>_?-&WZNY9_S;*\:")ZEC:RS28R^N
M0S?Z5JM'7D[;JF-_T *; ,+R-FR6/@NK&P',F;]68JD3EKK5YNAIWZK,,/$?
MG]7=<U;KL>0)B]Z049J'EN4YX!Y^^"8X[4FPE$GJW$H[-&!=MC4P_ZF\J\!B
M)2E>J\R04+U6;IQEJF3P2>^A"DN7I KUF:+ID-UDZ,S;&6Q]C)YC1]+=[ML@
M@?E-<V/CZ*DTS>7JB8]G',XCQ4(F*1V#]DB #Y7@,3=<3C[9.TK-F:BF7:7#
MHB8I%/W&2#C?:G!9!WNS7LPT<^LG],UX[.N10WHL=Y(ZL=[H<^ _R+(<]%.S
M4-$*FPN2DA%KFJ;G@3BWW>&RTQW=N_5 GG[G0(4E3E(N^DR1$/ZL[C5SBQ*'
MRW2DA'_!2Z40RYFD. Q8(T&]$TTUY#T)%B])55AIA[27N%K$4R8GX)]'4:W$
M8B:I$D/FB/OD":I/GCRQ3R:I%GVF2 F7,]SM=^QF)/B$^5?+!1N@UP]1<@]8
MI5FI6"QH<LO9=5I$T[=_5,/W2+'8:9:$ANS1 ,\3;B I ^MSR61LR['-"CY/
M?5_?"IL&FC6C2-.$@PC?0(B/4LWE$%BF)"1E@1 :1_ VP>:"<.RRQBYA(KXJ
MD5M6NIB\JCW?!X\4"YYPS-)CCW*F:#DI>W-E*M]G$N+N:X'%3SAX&39+.H/.
M@(N</\)[9M@JSE 6?"VP62 <R R;)5X%H'OVLC11X7'[/2&6.>'TW4IKA*B'
M*1/B,L^XA"S8V^P)L:@)Y^E66B-$?96"GMC.[H-6<S-=K6@-(?<TP*(GG(T;
MM$J9@L7/]?3E2K\@_PHU^ET-A/"])FE?2!+';F)'>;67"=,>]B$]EC[I0E*_
M41+^-V8*>OM.JPAI8&N^T/2+^E;87)"4NEC3E%?>K?<:!"^\.SHL=<*BMLH8
MY8JP?"1XW!>*!>_C=V18RH05;(4M0LB73#[H?&;BY:U6,8 ;JLDVWS]$&87<
M 38QA+7MDU!0/G!0:>J62JGX83BUUK.;W!2OA[51!A\[!-MA$T2Y:!5AG/1.
M*?NYF V2R^4=C$&["1/WL#"7]G /X1LG1'-LEDC?OH3&4)&LL]:!KVN[P;T(
MN/S$_7(ON[5;_@=02P,$%     @ LH*.4OIV_S;:(   5)P  !(   !T;3(Q
M,3(W-#%D,5\X:RYH=&WM7>MWVSBN_YYS\C_P>N_L37;]CO-NL\=-G-;-<^*T
M:?LE1Y9H6XTLJ7KXT;_^ B"IARW%2>JTZ>SLSDP2BP)!$ 1^ $'ZU7\F0XN-
MN.>;COVZ4"M7"XS;NF.8=O]U(0QZI9W"?PY65UX- F@';6W_=6$0!.Y>I3(>
MC\OCC;+C]2NUW=W=R@3;%$2CO4EFNWJU6JM\.COMZ ,^U$JF[0>:K?/H)<NT
M[_+IX].H:=>SS%13_$1ULE&9(PU/C?B%9..MBGB8:AID-MT430/5U/2=1KVV
M?1\?HD7TPB2O;0UYAA'R3V^N3N/F07;[N&DE\#3;[SG>4 M@#I'29JE:+]6W
M$D1*/M=3A.#O<M\9+:2S4]JH*3ISDY,>*3[N:GXD<8//B%OU"0_@C7JU5*TE
MJ'N\ETM\JP)/5</0+_4US8T:]S2_2PWE@PS:\,1S+.YGOD-/,E[2G= .O&GV
M&.3#C-=\+YCO!C[,:#KX%E,?<,T*!OQ;: ;3LNX,L7FMVJCN%&CU<<V GPS_
M]RHP XL?O*J(G_!TR .-(9T2OC]Z73AT[(#;0>EZZL)TZ.*OUX6 3X**6*05
M?*\BR;[ZGU*)'9O<,O98AP?[[%P;\CTV,2;[K'U$O]Q6Z[NW'SI_U(_>-IN7
M\ -'PTJEA[Z]T;B%T=[.CO)6C?(1I!J-Z*VGO+Y9O^6@@3 $^*=E@Q"GAR =
M3[/:ML$G)WQZ6P4KU:CO;&QL/8;N;H)N<\AM _X-CBVM?]O3+)\_@M36&Q#U
MT6WM5AH/01,^>@R-^FUGH'G<OZW?DJT41'SZ[#%TCI"72TEK8XZE7.)=QY@R
M/YA:_'6A!QJXQVI5-V#7YA":G/,QNW*&FET4'Q2! <_LD:X;YDB]9YB^:VG3
M/68[-J>'YF0/E99[N!KH+],PN$UK _^$AN?A$&CI0NTGP17:E6//&:*NE*H-
ML&F!$_]>8#:,&KKBYEZF-A0.8G5X54EU\2.]"D/[N@#&>:_K@ G2;%*3)#\I
M+2H<T/-,%BHI02!'8"^Y!XZ<^Z(%&N<]G[PNL,;(E>X-A,W]-BVI=52>^$9!
M/@W >+PN^.;0M;@P&+*G-&W1F^^$GNH,FI%2[$E9,-.X5Q;*L*G7.$U#]&GT
MN6G@DY[)/48CX9D>[;!]DIZRV9?C[BJ9_<G>7!"O8\QS ;#""XZT@!_$0U"4
MXF=SK\%,YKRDGLRRE6) ?2A%FI9S:)M"R+ >YZ0YY)H?>OQ +MP]:*.(J4?I
M+I!:#GUA!7*[D$*@1D_N([8V<_V 98!IG)<MODOK00L<+_'X\3*8Y3&+:J+3
M(VX[0]->U.UBN<SVFT58/4])84Z@<H4FUJ.P#LIHOJK ^_ 3___*589VJ'E]
MT]YCU0+@"O<@_1"M=ZFG#4T++/&]]GN?"4*EP'&!F!M$'W2=('"&]%GAX)__
MJ&U5]W]"1U$7"4]W%5J\=*GUR2$GG4V*XCR]?38VC6" ;JSZ1R'U9M?Q0+CB
MS3>6IM^Q.G@ZW[%,8Y_)AXJ.>%Z+G].@??,[>-Y:4C@X3?*_">XK*?9_X3P!
MMSN+W+FB2N10@FBZ2IIE]N$C'<PN]T"0W8,/Y^WKUA'K7#>O6YU7E6Z.#BZS
MRT[K\,-5^[K=ZK#F^1%K?3I\USQ_VV*'%V=G[4ZG?7%^+Q\+D<Q#^;C1_ &$
MVH$#[Q^5#\NL7MUL["ZU[]EY7!+1>?X>MR2?;6J/+Z[.Y(A]5[/)J2"4W:T*
MY%\J'3EZB+ *PZ-;/0HFXK#B^]6.Y6WK+;_Q20>:/XHKD_T5#G9*)[,@[E4%
M.3UXEFE?L(B7ILFPGJY:Y]?LJG5Y<77]<U;/9>CYH68'+'#@11WS%F*XM0WF
M>*RVN6:LBP^<WL_AZ'K D9/0,P,3J+4F^D"SP5@W]8 Y/5;;W6@\Z^)^II$A
M0$7^K[CK> %;4W]S#< ']P/&1]!R=<6CY]Q8WV,@C-GUUYQ9?Y>$<%L"_V8O
M1.?]6;5QJ@^KM?J3%V(RU#*@IR&\-S"TZ12XYW;60DTQ5CAHNIYIL9TB0ZH_
M9^W^U:U_H'4M#NIE6:YFB&1SM4!_@S1U]7<:7^F.96FN#T!)_3:#R9"NIUX:
M<2\P=<U2JBSX4#'%J\! *CAUKPNUV9[N!6M(RC(>Y+ RC<2/.KZ"7%>/I$+F
M:79%OI$K4F0^KGC?]#$-'& F*'M!UC;;1G_C^++YP5B"9\SJMW#PCK*$+<H2
M%EG;ULOW+CKYJXLI40/_XRU!$X18;30=UM/G>G:B%- 7BZ&;?H2_JRYE7##F
M9G\0\5$X6&M--#T0C*,4T09[D?28YC/?Y3JF.0QFV@R<#UAC;STEIX2,*K0,
MYZ+!%VIJA,T02S337,R:DT?WG+ F4> V;W6DH4GHSP.MQZPB@JV,^MRH__%
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M5EJ;F6[B;&:\5 1S($S,(-*^:-.,MCFH[O2Z@.T*SEHP *G'O^$GX3A.80O
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MV_;ZM0X8WPC^8*Y&#JI*RS&JLO2IUQ!UYM")0J<WA^I(I@E(6YMPP%UG-N'
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MB3/RA(@%H++!(U_9 X+M[)$"SG*==\7S0)Z TY $$Y8RKH&%.X'J0^8#U4
MX[C7A'Q+;29PV]W JZD83[VNDY#."4Z02'V-G;+GJ88=P:>!S;23U]HTR;S
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M7N%+/8O\^O7.WHLWFNU3O8DNZB%/FB(0OH>3D4A/J0C[DR3!W1:772@4)'<
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MN]NITAA$&EWEL9-(4LI4&PA_7/:Y?(>;YFDB#L5HQE:MNH_YOI$%,/8$-M)
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M20#I)I-;3.PVTY$Z+6]D?/5AF)Z(N.LU=CMHM%GQ-8_\'X[%80/V*O+=RJ(
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MZI_>V87W\?CJ%-X"G^1A:[J+J^.#SW"[;N?\\\7YV>61#P/]O7]Q>(*_@GO
M*M![G5WT3_ &?UT<7UT=G?IJ/O"SXT_G)\='AS[^NP\O_?O1(4Q3_^+X$L?T
M\>+L$PW]\V7_]R/Z#?QQ==$_I#_TUP=GGR\NC[H=>.CA4?\$+ET_"UY9P^Z#
MR22R;2'ZFO<3Z,I?O6HRB7(\]\ATZF-2%7,VQ\?'3 C(^-K/\.4%C!I^4A,V
MKR9K,,4DU'SUY^]%*3C[;1_/]+Q"N%!8#2,=#J->""71D*=DQKD:D=654T"G
MU6YA%YZTJE98%%DNCU;K\X?U$^I%IO[+[4=G-E[H 9Q9!8-NJR]A<81%ETP]
M)UW#*D%;9BA)>SSSB%B8H&EQ(;V90MV\0C/W&?)_:A?%%I4T <6_#J-$*B3F
MC8"8MQ6[3Q%CW"6[DU\%%1R4N4 .LCLT!X61CCBA*'Z.)[F0<ZL&0X%=YV08
M[?"7 ZNA!0,2P5X"&T#UXGBF;2U>;C\Z=^QR\/;#"B2LSV)AR_B5G<GR38=P
M8K"*<C+4J4%!(\>E;,)6#\9P8CD),"Y"6N@O:G;O@>VTT'[#KVYA<4+\M[R.
M%!1CAH3 2C@6O2M5B2TV=JA#Z%L8UR)[QVDOPMEY^M,#R<7@;.AWIQ[T0<C-
M::B=EQH((MO!=,XC8?D.[-60_FZ%U OHQ/FBONYSE@SF1 SMW%(;S3[I;C:H
M;3V);HO966ETF>ZE05U2J;(116E9^2 <\4"]!;L(/U-&7SD)>NSRC1F_R_[I
M/'&.J-A/,H^A['S[<QI 7O4ZI@*U<#2S.TH47M4?6&29_JS?EMHR.<U)"#5.
M3HM),%N#GF(@';:4<A[1OW4$R9]UG2D:W?)Y7O1Y!?,0IXJ<3K4CYS9RXD4M
M.4DM92J<;9(@&1:#4*V*+SV9I'EVMZ,?*D@Y07!(E(+"'X9*5@(#_%/,#OQ+
MVCEAMS 0MTG"R*B![J;C6\US,#9FLP/ (HPSJK^(JW&SKPV=T0QZI\..2(+M
MQCM$2NA=@\].\:!GQ-C_[EDD$UYND@FKQ=C_<OO1DZ2+T^^9MY^C,;'8E4!#
MGF!?L^QW VWATYT,<OL<4@Z%?1H:MH(9!_K<\U>?LJB'RZQF)[H'2\,T])MG
M?[=CGCW#-EPNE6";AO#_HCGS2B=JFH'H8+T7TU=$7%:GV8!;33WGC)MO[?F8
MH5;W)BNJSLL)]Z)R1ILX#\V?62<J0F0CB_G<7%6OZ,3Y^N/R KEU?</Y.=,D
MX7+"1&45?(0>PJG:[6 9FE\W(I0MRD. Z4)&WI%.WTB#-HE0<U]A#=P73"-B
MK,(M&RYO<XCD1&=,J^>3:6PAFWJJX[$*^**5(P\A@I\)YW\8E05W@BVR1:T)
M1@$^JY=1"SE<$#[+SXE[ \<FIS5>;-?M#=%@27AL%#6W06!;GC+E3*TG&S&Z
M"Z542VB.:3,Q8!4-,JS6 QNC1/X.WV.-5J'A!VL;I8@J'2$C,>RB2*V+Q=@,
MYEE54O)!V4'63(\)HJK6B*%=]E+JL31J9K=\C@3X#196+KW0EI!J"(85'^('
MS) QTTR,FX=-Y_]<K#L"'[DP6S7/>&Y>9V1W)0%VX 2)0M(UXK0O,S;Y Y,W
M"D)XR4(J0J1]8*VUT^P=PB$/UDG1 G4D&#WPJ976>X[!CT?/WR\\A_?S[(ON
M6Z8P<;S^J>NQ!44;V0[#3.DFL$EC\>&NZ91#]R*22FYD^&&]Y].-Z7;T-"IE
M@'^,K8,\1+2Y9C!#H"\<N*KR%(&KP]+DNB?!4.0VD!&P]L0QS8H/S!3<;L?D
M9*WM9L#I*I8]%$ N>?B82:>F*LKL>)ZQOM>K)^Y:T$]B19&@ WN*T<$B%]:$
ME!9=0GN<B*2!BNM%IR937>S.Z5VW2DX".E9)]IAZ,K>JWKK:G678FC!*G3J
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M7A^;+;K"#ORA;4$@52+^E1-W8U=#0 DEZC5(23^.Q[E?=#O_303>C>R(+C6
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M$H<V/2G=7.[!+2FIO2Y.%?)V354N:8&FG,$(EL.%^[#)",4F%@7]$XDX/G"
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M*7Z"BS.N-2WGDJ_LRRN<40J6R&DQ_ZJ=Z)4[T=>$]I2!TBFM9 3#@6<C4)B
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MX#&NP=%TZOQPC3-4.3A%X'*W2U-MA,GWX3$57<LN><TGM-X9+=%%/ ,7F",
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M4B,*ZA35F+9": <I\TFT=R1'3:(ZI+@HIVC/C:M\1DTYI[Z@!66\CI"4GC6
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MK@)!(UB8#BDI_#)UH4.X#,1M0?_PZLY]RSAKND%-&+/.QB>],N)2,,%O^4F
M%QWKBT;,_Q5\+Z4^B((B[19'E]FHS@D#AQ&ZJ1E36<#+9WYH+"ON!C7LP420
MA&(5^(G B%H*H@+B><8#@0, C")\@0)EO6TJ)EY7B6FB\,#6#_>' RXN%"27
M_*@=A1""M_93:?(D59%A<FX.\\ !"\;J]<SI0?0J:!! T10RSM86=@K_6I:]
MY^0-FNF9BXP$@$$1<&QV[0>,[)5ZG.'@8S\DET^G+^C4JLL%8DJYH^HD9]7
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MO$F6]%)OS%#X@C<_O]D7,@>DH&C__I1^;@#>+%V<"T.Z&MA-"*+WA;N<;L1
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MK1D\&@N%\A$9UP87:>]E<P]@2;MZHMYSJ*U'-RDV0  C41=C-W>)^YKG<VE
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MH6)HZJ$FY8#X_])%*ET)M<&B%S8'#/! "ZTI?NM=RR6=&4NVC%.R""V?<(I
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M*U^J S7D@"*[F;8LE_LQF.U**X<IS.Y;6HL9\R&5&/-4MY3@GC!E/51J9A>
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M>&_J]Y*0%HQVL]9Q@YS*X?V=3JK\<)=4N26R3(KPJQ?NN@)=!H"/J7DT$?&
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M;1;H#M@2H+:;,4.U6Y78CY.HHV=S[. ,JY%N?C^$DG T?IPPH;TK)C84GW@
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M(X&W!;>->#/ MJCHIV!'I6 ?[(5UL$A;7H!KB\S2%&\:(U<UC<) ?FP?V)H
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MK-4A)1GRE$!+'\B'><3B)2$,VDOH,D1QSHVVY.]0BQ&9L29SS%'CO0ROSEL
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MG8XF2LZ0FJ#9!?.2K$TNPE"FD85SF!Z=9.Y$2JH3/$LD\1)K2J6MLLSI:9O
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M%QC]+ 8!]Y/W=5,SQS=]$:F$Z,I+0[I7'AZ,U6K_1K)N":SXZ/, )/ZEH7T
M&[CXKT[)SA5?G."14W1Q#WJ,ZYR6M41?8O.Z#T0^AU'2B42]\"+?Y0/SZ:@
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M^>[-/W^@?_X'4$L! A0#%     @ LH*.4GV*=YA% P  F0P  !
M     ( !     &AQ>2TR,#(Q,#0P."YX<V102P$"% ,4    " "R@HY2@2J
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I,C$Q,C<T,60Q7V5X,BTQ+FAT;5!+!08     !0 % $4!  !C.P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
